FedInvent™ Patents

Patent Details for Tuesday, February 04, 2020 

This page was updated on Monday, March 27, 2023 at 06:00 AM GMT

Department of Health and Human Services (HHS) 

US 10548474 Dana et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Massachusetts Eye and Ear Infirmary (Boston, Massachusetts)
ASSIGNEE(S) Massachusetts Eye and Ear Infirmary (Boston, Massachusetts)
INVENTOR(S) Reza Dana (Newton, Massachusetts);  Francisco L. Amparo Pulido (Cambridge, Massachusetts);  Haobing Wang (Newton, Massachusetts)
ABSTRACT The present application includes methods, systems and computer readable storage devices for determining a color score for at least a portion of a biological tissue. The subject matter of the application is embodied in a method that includes obtaining a digital image of the biological tissue, and receiving a selection of a portion of the image as an evaluation area. The method also includes determining for each of a plurality of pixels within the evaluation area, a plurality of color components that are based on a Cartesian color space, and determining, from the color components, a hue value in a polar coordinate based color space. The method further includes determining a color value based on the hue value for each of the plurality of pixels, and assigning a color score to the evaluation area based on an average of the color values of the plurality of pixels.
FILED Thursday, December 28, 2017
APPL NO 15/856134
ART UNIT 3795 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 3/14 (20130101) Original (OR) Class

Image Data Processing or Generation, in General
G06T 7/0012 (20130101)
G06T 7/90 (20170101)
G06T 2207/30041 (20130101)

Pictorial Communication, e.g Television
H04N 1/628 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548479 Chen et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Zhongping Chen (Irivne, California);  Jiang Zhu (Irvine, California)
ABSTRACT A system for imaging and quantifying shear wave and shear modulus under orthogonal acoustic radiation force (ARF) excitation using the OCT Doppler variance apparatus. The ARF perpendicular or with at least a perpendicular component to the OCT beam is produced by a remote ultrasonic transducer. The OCT Doppler variance apparatus, which is sensitive to the transverse vibration, is used to measure the ARF induced vibration. For analysis of the shear modulus, the Doppler variance apparatus is utilized to visualize shear wave propagation. The propagation velocity of the shear wave is measured and then used to quantitatively map the shear modulus.
FILED Saturday, February 13, 2016
APPL NO 15/043539
ART UNIT 3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 3/102 (20130101)
A61B 5/0066 (20130101) Original (OR) Class
A61B 5/0084 (20130101)

Image Data Processing or Generation, in General
G06T 7/0012 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548505 Rothgang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Siemens Healthcare GmbH (Erlangen, Germany);  The Johns Hopkins University (Baltimore, Maryland)
ASSIGNEE(S) Siemens Healthcare GmbH (Erlangen, Germany);  The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Eva Rothgang (Nürnberg, Germany);  Arne Hengerer (Möhrendorf, Germany);  Lars Lauer (Neunkirchen, Germany);  Jan Fritz (Baltimore, Maryland);  Paul Bottomley (Columbia, Maryland);  Wesley David Gilson (Northbeach, Maryland);  Robert Grimm (Nürnberg, Germany)
ABSTRACT A magnetic resonance method and system are provided for magnetic resonance (MR) image-guided insertion of an object into a biological tissue along a predetermined trajectory. The trajectory provides a path between a starting point and a target site within the tissue. Sufficiently high resolution images can be generated in real time to precisely guide the needle placement. A compressed sensing approach is used to generate the images based on minimization of a cost function, where the cost function is based on the predetermined needle path, artifact effects associated with the needle, the negligible changes in the images away from the trajectory, and the limited differences between successive images. The improved combination of spatial and temporal resolution facilitates an insertion procedure that can be continuously adjusted to accurately follow a predetermined trajectory in the tissue, without interruptions to obtain verification images.
FILED Tuesday, March 15, 2016
APPL NO 15/070116
ART UNIT 3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/055 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548523 Ahmadi et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) REGENTS OF THE UNIVERSITY OF MINNESOTA (Minneapolis, Minnesota)
ASSIGNEE(S) Regents of the University of Minnesota (Minneapolis, Minnesota)
INVENTOR(S) Mahdi Ahmadi (Minneapolis, Minnesota);  Rajesh Rajamani (Saint Paul, Minnesota);  Gerald Timm (Minneapolis, Minnesota)
ABSTRACT A pressure sensing catheter system includes a urethral catheter and a sensor array formed on the urethral catheter. The sensor array includes a plurality of pressure sensors distributed along a length of the urethral catheter. The sensor array is configured to produce a dynamic pressure distribution profile along a urethra.
FILED Wednesday, April 08, 2015
APPL NO 14/681476
ART UNIT 3792 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/205 (20130101) Original (OR) Class
A61B 5/0492 (20130101)
A61B 5/04882 (20130101)
A61B 5/6853 (20130101)
A61B 5/7203 (20130101)
A61B 2560/0261 (20130101)
A61B 2562/043 (20130101)
A61B 2562/063 (20130101)
A61B 2562/0214 (20130101)
A61B 2562/0247 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548544 Furenlid et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Arizona Board of Regents on Behalf of the University of Arizona (Tucson, Arizona)
ASSIGNEE(S) Arizona Board of Regents on Behalf of the University of Arizona (Tucson, Arizona)
INVENTOR(S) Lars R. Furenlid (Tucson, Arizona);  Xin Li (Tucson, Arizona)
ABSTRACT A method for forming an optimized image of a subject includes steps of acquiring a plurality of one-dimensional images, generating a measured sinogram from the plurality of one-dimensional images, and determining a plurality of trial images. In the step of acquiring, the method acquires a plurality of one-dimensional images of the subject captured by a rotating-slit imager having (a) a detector, and (b) a slit collimator having a slit oriented at one of a respective plurality of slit-rotation angles, relative to the subject, about a longitudinal axis substantially perpendicular to a front surface of the detector. In the step of determining, the method iteratively determines a plurality of trial images each having a respective trial sinogram. The optimized image is one of the plurality of trial images and its corresponding trial sinogram differs from the measured sinogram by less than a predetermined tolerance.
FILED Friday, November 04, 2016
APPL NO 15/773691
ART UNIT 2884 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 6/06 (20130101)
A61B 6/037 (20130101)
A61B 6/4258 (20130101) Original (OR) Class
A61B 6/4275 (20130101)
A61B 6/5205 (20130101)

Image Data Processing or Generation, in General
G06T 11/003 (20130101)
G06T 11/006 (20130101)
G06T 2211/424 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548549 Boone et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) John M. Boone (Folsom, California);  Thomas R. Yellen-Nelson (Del Mar, California)
ABSTRACT A device and methods for performing a simulated CT biopsy on a region of interest on a patient. The device comprises a gantry (22) configured to mount an x-ray emitter (24) and CT detector (26) on opposing sides of the gantry, a motor (28) rotatably coupled to the gantry such that the gantry rotates horizontally about the region of interest, and a high resolution x-ray detector (172) positioned adjacent the CT detector in between the CT detector and the x-ray emitter.
FILED Friday, August 04, 2017
APPL NO 15/669829
ART UNIT 2884 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 6/03 (20130101)
A61B 6/12 (20130101)
A61B 6/037 (20130101)
A61B 6/405 (20130101)
A61B 6/0435 (20130101)
A61B 6/482 (20130101) Original (OR) Class
A61B 6/502 (20130101)
A61B 6/584 (20130101)
A61B 6/4028 (20130101)
A61B 6/4417 (20130101)
A61B 6/4423 (20130101)
A61B 6/5235 (20130101)
A61B 8/0825 (20130101)
A61B 8/4416 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548564 Mauldin, Jr. et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
APPLICANT(S) Rivanna Medical LLC (Charlottesville, Virginia)
ASSIGNEE(S) Rivanna Medical, LLC (Charlottesville, Virginia)
INVENTOR(S) Frank William Mauldin, Jr. (Charlottesville, Virginia);  Kevin Owen (Crozet, Virginia)
ABSTRACT Systems and methods for processing ultrasound data are provided. The disclosure includes using at least one computer hardware processor to perform obtaining ultrasound data generated based, at least in part, on one or more ultrasound signals from an imaged region of a subject, the ultrasound data comprising fundamental frequency ultrasound data and harmonic frequency ultrasound data, calculating shadow intensity data based at least in part on the harmonic frequency ultrasound data, generating, based at least in part on the fundamental frequency ultrasound data, an indication of bone presence in the imaged region, generating, based at least in part on the shadow intensity data, an indication of tissue presence in the imaged region, and generating an ultrasound image of the subject at least in part by combining the indication of bone presence and the indication of tissue presence.
FILED Tuesday, February 16, 2016
APPL NO 15/044425
ART UNIT 3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 8/461 (20130101)
A61B 8/0875 (20130101) Original (OR) Class
A61B 8/4254 (20130101)
A61B 8/5207 (20130101)
A61B 8/5223 (20130101)
A61B 8/5269 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548628 Swaney et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
Directorate for Education and Human Resources (EHR)
Division of Graduate Education (DGE)
APPLICANT(S) Vanderbilt University (Nashville, Tennessee)
ASSIGNEE(S) VANDERBILT UNIVERSITY (Nashville, Tennessee)
INVENTOR(S) Philip J. Swaney (Nashville, Tennessee);  Robert J. Webster, III (Nashville, Tennessee)
ABSTRACT A steerable surgical needle (10) includes an elongated needle shaft (12), a beveled tip portion (14), and a flexural element (16) that connects the needle shaft (12) with the tip portion (14) and permits the tip portion to deflect relative to the needle shaft. A method for steering the surgical needle (10) through tissue includes the steps of advancing the needle in the body tissue to induce tip flexure which causes the needle to follow a curved trajectory, and rotating the needle about its longitudinal axis in place, without advancement, to remove the tip flexure.
FILED Thursday, March 13, 2014
APPL NO 14/208508
ART UNIT 3771 — Medical & Surgical Instruments, Treatment Devices, Surgery and Surgical Supplies
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 17/3403 (20130101) Original (OR) Class
A61B 17/3417 (20130101)
A61B 2017/003 (20130101)
A61B 2017/3454 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/1007 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548842 Vivas-Mejia et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of General Medical Sciences (NIGMS)
National Institute on Minority Health and Health Disparities (NIMHD)
APPLICANT(S) Pablo E. Vivas-Mejia (San Juan, Puerto Rico);  Jeyshka M. Reyes Gonzalez (San Juan, Puerto Rico);  Anil K. Sood (Houston, Texas)
ASSIGNEE(S)
INVENTOR(S) Pablo E. Vivas-Mejia (San Juan, Puerto Rico);  Jeyshka M. Reyes Gonzalez (San Juan, Puerto Rico);  Anil K. Sood (Houston, Texas)
ABSTRACT The present invention discloses c-MYC-siRNA formulation as a potential therapeutic target for cisplatin-resistant ovarian cancer. It is disclosed targeting c-MYC with small interfering RNA (siRNA) in the cisplatin-resistant ovarian cancer cell line inducing a significant cell growth arrest and inhibition of cell proliferation. Apoptosis and arrest of cell cycle progression were also observed after c-MYC-siRNA-based silencing of c-MYC. Furthermore, delivering nanoliposomal c-MYC-siRNA, decreased tumor weight and number of tumor nodules compared with a liposomal-negative control siRNA.
FILED Tuesday, February 20, 2018
APPL NO 15/899682
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 9/1271 (20130101)
A61K 9/1272 (20130101) Original (OR) Class
A61K 31/713 (20130101)
A61K 31/713 (20130101)
A61K 31/7088 (20130101)
A61K 33/24 (20130101)
A61K 33/24 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/11 (20130101)
C12N 2320/31 (20130101)
C12N 2320/32 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548852 Bayley et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Human Genome Research Institute (NHGRI)
APPLICANT(S) Oxford University Innovation Limited (Oxford, United Kingdom)
ASSIGNEE(S) Oxford University Innovation Limited (Botley, Oxford, United Kingdom)
INVENTOR(S) John Hagan Pryce Bayley (Oxford, United Kingdom);  Andrew Heron (Oxford, United Kingdom);  Gabriel Villar (Oxford, United Kingdom)
ABSTRACT The invention provides a droplet encapsulate comprising: a drop of a hydrophobic medium; a peripheral layer of non-polymeric amphipathic molecules around the surface of the drop; and an aqueous droplet within the peripheral layer, the aqueous droplet comprising: (a) an aqueous medium and (b) an outer layer of non-polymeric amphipathic molecules around the surface of the aqueous medium. The invention also provides processes for preparing the droplet encapsulates. Various uses of the droplet encapsulates are also described, including their use as drug delivery vehicles, in synthetic biology, and in the study of membrane proteins.
FILED Friday, November 02, 2012
APPL NO 14/354706
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/50 (20130101) Original (OR) Class
A61K 31/085 (20130101)
A61K 49/0002 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 13/02 (20130101)
B01J 13/025 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 428/2984 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548858 Mehrara
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Memorial Sloan Kettering Cancer Center (New York, New York)
ASSIGNEE(S) Memorial Sloan Kettering Cancer Center (New York, New York)
INVENTOR(S) Babak Mehrara (Chappaqua, New York)
ABSTRACT Provided are methods of and compositions for treating or preventing lymphedema by administering a sphingosine 1-phoshate receptor modulator.
FILED Thursday, August 17, 2017
APPL NO 16/326272
ART UNIT 1629 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 9/0053 (20130101)
A61K 31/40 (20130101)
A61K 31/40 (20130101)
A61K 31/137 (20130101) Original (OR) Class
A61K 31/137 (20130101)
A61K 31/397 (20130101)
A61K 31/397 (20130101)
A61K 31/421 (20130101)
A61K 31/421 (20130101)
A61K 31/426 (20130101)
A61K 31/426 (20130101)
A61K 31/4245 (20130101)
A61K 31/4245 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 7/00 (20180101)
A61P 7/10 (20180101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/92 (20130101)
G01N 2405/08 (20130101)
G01N 2500/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548860 Nicolls et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California);  THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (Washington, District of Columbia);  THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland)
ASSIGNEE(S) The Board Of Trustees of The Leland Stanford Junior University (Stanford, California);  The United States Government as Represented By The Department Of Veterans Affairs (Washington, District of Columbia);  The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Mark R. Nicolls (Palo Alto, California);  Jayakumar Rajadas (Cupertino, California);  Geoffrey C. Gurtner (Woodside, California);  Xinguo Jiang (Palo Alto, California);  Gundeep Dhillon (Stanford, California);  Gregg L. Semenza (Reisterstown, Maryland)
ABSTRACT Formulations and methods are provided for improving the function, i.e. clinical outcome, of solid organ transplants. Lung transplantation is of particular interest. In the methods of the invention, a nanoparticle formulation comprising an effective dose of an iron chelator active agent in nanoparticle form, including without limitation, deferoxamine (DFO), deferasirox (DFX), and deferiprone (DFP), etc. suspended in a carrier compatible with the tissue of interest, is topically applied to the surface of tissues at the site of anastomosis. The nanoparticles are comprised of the active agent and a pharmaceutically acceptable stabilizer.
FILED Tuesday, January 29, 2019
APPL NO 16/260989
ART UNIT 1619 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/5123 (20130101)
A61K 9/5138 (20130101)
A61K 9/5146 (20130101)
A61K 9/5161 (20130101)
A61K 9/5169 (20130101)
A61K 31/164 (20130101) Original (OR) Class
A61K 31/436 (20130101)
A61K 31/4196 (20130101)
A61K 31/4412 (20130101)
A61K 45/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548864 Lu et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Aging (NIA)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) Beth Israel Deaconess Medical Center, Inc. (Boston, Massachusetts);  Pinteon Therapeutics, Inc. (Concord, Massachusetts)
ASSIGNEE(S) Beth Israel Deaconess Medical Center, Inc. (Boston, Massachusetts)
INVENTOR(S) Kun Ping Lu (Newton, Massachusetts);  Xiao Zhen Zhou (Newton, Massachusetts);  Shuo Wei (Chestnut Hill, Massachusetts);  Lijun Sun (Harvard, Massachusetts);  Michelle Lynn Hall (Somerville, Massachusetts)
ABSTRACT The invention features all-trans retinoic acid (ATRA)-related compounds capable of associating with Pin1 and methods of treating a proliferative disorder characterized by elevated Pin1 marker levels, Pin1 degradation, and/or reduced Pin1 Ser71 phosphorylation in a subject by administering an ATRA-related compound. The invention also features methods of treating proliferative disorders, autoimmune diseases, and addiction conditions (e.g., diseases, disorders, and conditions characterized by elevated Pin1 marker levels) by administering an ATRA-related compound in combination with another therapeutic compound.
FILED Thursday, March 10, 2016
APPL NO 15/557731
ART UNIT 1611 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/122 (20130101)
A61K 31/196 (20130101) Original (OR) Class
A61K 31/203 (20130101)
A61K 31/452 (20130101)
A61K 31/4152 (20130101)
A61K 31/4166 (20130101)
A61K 31/4192 (20130101)
A61K 31/4196 (20130101)
A61K 31/4245 (20130101)
A61K 31/5375 (20130101)
A61K 45/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548893 Wise et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Southern Methodist University (Dallas, Texas)
ASSIGNEE(S) Southern Methodist University (Dallas, Texas)
INVENTOR(S) John G. Wise (Dallas, Texas);  Pia D. Vogel (Dallas, Texas);  Frances K. Brewer (Waxahachie, Texas);  Courtney A. Follit (Dallas, Texas)
ABSTRACT The present disclosure provides a method of treating a subject that is resistant to one or more drugs by identifying a subject having one or more drug resistant cells; administering to the subject a pharmaceutically effective amount of an inhibitor compound, and contacting one or more drug resistant cells with the inhibitor compound to reduce the export of the inhibitor compound from the one or more drug resistant tumor cells and to block the transport of drug(s) from the one or more drug resistant cells.
FILED Thursday, November 29, 2018
APPL NO 16/204582
ART UNIT 1623 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/352 (20130101)
A61K 31/353 (20130101)
A61K 31/4196 (20130101)
A61K 31/4525 (20130101)
A61K 31/5025 (20130101) Original (OR) Class
A61K 45/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548897 Dar et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Icahn School of Medicine at Mount Sinai (New York, New York)
ASSIGNEE(S) Icahn School of Medicine at Mount Sinai (New York, New York)
INVENTOR(S) Arvin Dar (New York, New York);  Neil Dhawan (New York, New York);  Alex P. Scopton (New York, New York)
ABSTRACT This invention relates to antagonists of Kinase Suppressor of Ras (KSR). Pharmaceutical compositions comprising KSR inhibitors and methods of treating cancer are also provided.
FILED Friday, April 15, 2016
APPL NO 15/566565
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/517 (20130101) Original (OR) Class
A61K 31/519 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548911 Phipps et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
National Institute of Environmental Health Sciences (NIEHS)
APPLICANT(S) UNIVERSITY OF ROCHESTER (Rochester, New York)
ASSIGNEE(S) University of Rochester (Rochester, New York)
INVENTOR(S) Richard P. Phipps (Pittsford, New York);  Collynn Woeller (Webster, New York)
ABSTRACT Disclosed are methods of treating fibrosis in a patient in need thereof that includes administering to the patient an amount of an active agent, as identified herein, that is therapeutically effective to inhibit myofibroblast formation and thereby treat the fibrosis. Also disclosed is a recombinant cell line that includes a recombinant gene that expresses a detectable expression product in a dose-dependent response to TGFβ, as well as methods of identifying a compound that inhibits TGFβ-mediated expression of the detectable expression product.
FILED Tuesday, June 16, 2015
APPL NO 15/319254
ART UNIT 1623 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/47 (20130101)
A61K 31/166 (20130101)
A61K 31/167 (20130101)
A61K 31/341 (20130101)
A61K 31/351 (20130101)
A61K 31/381 (20130101)
A61K 31/415 (20130101)
A61K 31/519 (20130101)
A61K 31/549 (20130101)
A61K 31/551 (20130101)
A61K 31/635 (20130101)
A61K 31/4184 (20130101)
A61K 31/4409 (20130101)
A61K 31/4412 (20130101)
A61K 31/5375 (20130101)
A61K 31/7048 (20130101) Original (OR) Class
A61K 45/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548930 Deng et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Memorial Sloan Kettering Cancer Center (New York, New York)
ASSIGNEE(S) Memorial Sloan Kettering Cancer Center (New York, New York)
INVENTOR(S) Liang Deng (New York, New York);  Jedd Wolchok (New York, New York);  Taha Merghoub (New York, New York);  Stewart Shuman (New York, New York);  Peihong Dai (New York, New York);  Weiyi Wang (New York, New York)
ABSTRACT The present disclosure relates to modified vaccinia Ankara (MVA) virus or MVAAE3L delivered intratumorally or systemically as an anticancer immunotherapeutic agent, alone, or in combination with one or more immune checkpoint blocking agents for the treatment of malignant solid tumors. Particular embodiments relate to mobilizing the host's immune system to mount an immune response against the tumor.
FILED Monday, April 18, 2016
APPL NO 15/565609
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/768 (20130101) Original (OR) Class
A61K 39/12 (20130101)
A61K 39/3955 (20130101)
A61K 39/3955 (20130101)
A61K 2039/54 (20130101)
A61K 2039/57 (20130101)
A61K 2039/505 (20130101)
A61K 2039/525 (20130101)
A61K 2039/545 (20130101)
A61K 2039/5254 (20130101)
A61K 2300/00 (20130101)

Peptides
C07K 16/2818 (20130101)
C07K 16/2827 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 2710/24122 (20130101)
C12N 2710/24132 (20130101)
C12N 2710/24134 (20130101)
C12N 2710/24171 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548944 Jaynes et al.
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Riptide Bioscience, Inc. (Vallejo, California)
ASSIGNEE(S) Riptide Bioscience, Inc. (Vallejo, California)
INVENTOR(S) Jesse Jaynes (Auburn, Alabama);  L. Edward Clemens (Sacramento, California);  Henry Willfred Lopez (Napa, California);  George R. Martin (Rockville, Maryland);  Kathryn Woodburn (Saratoga, California)
ABSTRACT Aspects of the present invention relate to peptides having antimicrobial activity. In certain aspects, the invention relates to peptides having potent antimicrobial activity, broad-spectrum antimicrobial activity, and/or the ability to kill otherwise antibiotic-resistant microbes, or microbes protected by biofilms.
FILED Friday, October 19, 2018
APPL NO 16/165727
ART UNIT 1658 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0014 (20130101)
A61K 9/0053 (20130101)
A61K 9/0073 (20130101)
A61K 38/10 (20130101) Original (OR) Class
A61K 38/16 (20130101)
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/04 (20180101)
A61P 31/10 (20180101)

Peptides
C07K 7/08 (20130101)
C07K 14/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548949 Wang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Complementary and Integrative Health (NCCIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Feinstein Institute for Medical Research (Manhasset, New York)
ASSIGNEE(S) The Feinstein Institutes for Medical Research (Manhasset, New York)
INVENTOR(S) Haichao Wang (Edison, New Jersey);  Wei Li (Plainview, New York);  Kevin J. Tracey (Old Greenwich, Connecticut);  Ping Wang (Roslyn, New York)
ABSTRACT Methods of treating sepsis or endotoxemia in a subject comprising administering to the subject an amount of an antagonist of a Panx1 hemichannel protein or an amount of an antagonist of a Cx43 hemichannel protein.
FILED Wednesday, August 03, 2016
APPL NO 15/748776
ART UNIT 1649 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/19 (20130101)
A61K 31/22 (20130101)
A61K 31/704 (20130101)
A61K 38/177 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/02 (20180101)
A61P 37/02 (20180101)

Peptides
C07K 16/18 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548950 Trujillo et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) STC.UNM (Albuquerque, New Mexico)
ASSIGNEE(S)
INVENTOR(S) Kristina Trujillo (Placitas, New Mexico);  Nicholas Patrick Gannon (Albuquerque, New Mexico);  Roger Alan Vaughan (High Point, North Carolina)
ABSTRACT In one embodiment, the invention provides methods of treating or preventing cancer, in particular aspects breast and/or prostate cancer, by administering to a subject in need thereof a therapeutically-effective amount of irisin and, optionally, one or more adjuvant therapies (e.g. synergistic co-administration of an additional anti-cancer agent or chemotherapy). Related pharmaceutical compositions, assays and kits are also provided.
FILED Wednesday, November 18, 2015
APPL NO 15/528348
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/337 (20130101)
A61K 31/704 (20130101)
A61K 38/22 (20130101) Original (OR) Class
A61K 45/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548957 Cantor et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
ASSIGNEE(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) Harvey Cantor (Boston, Massachusetts);  Hye-Jung Kim (Brookline, Massachusetts);  Jianmei Wu Leavenworth (Hoover, Alabama)
ABSTRACT Nanoparticles to treat autoimmune diseases and HIV infection are provided. The nanoparticles comprise a biocompatible polymer and a complex, wherein the complex is a major histocompatibility complex (MHC) class I antigen E (HLA-E) linked to a peptide, and wherein the HLA-E-peptide complex is linked to the surface of the nanoparticle. The present invention also relates to methods for treating autoimmune diseases and HIV infection.
FILED Thursday, September 26, 2013
APPL NO 14/431113
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/17 (20130101)
A61K 39/0008 (20130101) Original (OR) Class
A61K 2039/58 (20130101)
A61K 2039/5154 (20130101)
A61K 2039/5158 (20130101)

Peptides
C07K 14/47 (20130101)
C07K 14/70539 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0636 (20130101)
C12N 2501/2315 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548959 Khan et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  Whitehead Institute for Biomedical Research (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambirdge, Massachusetts);  Whitehead Institute for Biomedical Research (Cambridge, Massachusetts)
INVENTOR(S) Omar F. Khan (Cambridge, Massachusetts);  Jasdave S. Chahal (Arlington, Massachusetts);  Daniel G. Anderson (Framington, Massachusetts);  Hidde Ploegh (Brookline, Massachusetts);  Robert S. Langer (Newton, Massachusetts);  Tyler E. Jacks (Newton, Massachusetts);  David A. Canner (Cambridge, Massachusetts)
ABSTRACT Compositions and methods for modified dendrimer nanoparticle (“MDNP”) delivery of therapeutic, prophylactic and/or diagnostic agent such as large repRNA molecules to the cells of a subject have been developed. MDNPs efficiently drive proliferation of antigen-specific T cells against intracellular antigen, and potentiate antigen-specific antibody responses. MDNPs can be multiplexed to deliver two or more different repRNAs to modify expression kinetics of encoded antigens and to simultaneous deliver repRNAs and mRNAs including the same UTR elements that promote expression of encoded antigens.
FILED Friday, September 23, 2016
APPL NO 15/274954
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/713 (20130101)
A61K 39/0012 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548970 Jiang et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH and HUMAN SERVICES (Bethesda, Maryland)
ASSIGNEE(S) THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH and HUMAN SERVICES (Bethesda, Maryland)
INVENTOR(S) Baoming Jiang (Duluth, Georgia);  Yuhuan Wang (Liburn, Georgia)
ABSTRACT Attenuated G9P[6] rotavirus is disclosed herein. In some embodiments, pharmaceutical compositions are disclosed that include an attenuated G9P[6] rotavirus, or a component thereof. These compositions can be used to induce an immune response, such as a protective immune response, to a rotavirus. The compositions can be used as vaccines, such as for children (infants), for example in a prime boost strategy.
FILED Wednesday, September 28, 2016
APPL NO 15/765716
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0053 (20130101)
A61K 39/15 (20130101) Original (OR) Class
A61K 39/39 (20130101)
A61K 2039/54 (20130101)
A61K 2039/5252 (20130101)
A61K 2039/5254 (20130101)
A61K 2039/55505 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/14 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 2720/12021 (20130101)
C12N 2720/12034 (20130101)
C12N 2720/12043 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548983 Wang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Wayne State University (Detroit, Michigan)
ASSIGNEE(S) Wayne State University (Detroit, Michigan)
INVENTOR(S) Jianjun Wang (Troy, Michigan);  Qianqian Li (Troy, Michigan);  Michael Chopp (Southfield, Michigan);  Feng Jiang (Troy, Michigan);  Guojun Wu (Northville, Michigan)
ABSTRACT Methods for treating a subject in need thereof are provided which include administering a pharmaceutical composition comprising a protein transduction reagent-modified reprogramming protein to the subject, wherein the protein transduction reagent is non-covalently bound to the reprogramming protein and wherein the protein transduction reagent comprises a cation reagent and a lipid. According to aspects, such methods provide delivery of protein-transduction reagent-modified reprogramming proteins to cancer cells, such as tumor cells, as well as diseased cells of diseased tissues and provide in vivo conversion of diseased cells into normal cells via protein-induced in situ cell reprogramming without administration of nucleic acids to the subject.
FILED Tuesday, September 04, 2018
APPL NO 16/120829
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 38/00 (20130101)
A61K 38/1709 (20130101)
A61K 47/59 (20170801) Original (OR) Class
A61K 47/543 (20170801)
A61K 48/0041 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0696 (20130101)
C12N 2501/602 (20130101)
C12N 2501/603 (20130101)
C12N 2501/605 (20130101)
C12N 2502/30 (20130101)
C12N 2506/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548987 Dimitrov et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) The U.S.A., as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland);  The Children's Hospital of Philadelphia (Philadelphia, Pennsylvania)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland);  The Children's Hospital of Philadelphia (Philadelphia, Pennsylvania)
INVENTOR(S) Dimiter S. Dimitrov (Frederick, Maryland);  Yang Feng (Frederick, Maryland);  John M. Maris (Philadelphia, Pennsylvania);  Zhongyu Zhu (Frederick, Maryland);  Robyn Tovah Sussman (Philadelphia, Pennsylvania)
ABSTRACT The identification and characterization of two fully human CD56-specific monoclonal antibodies targeting spatially separated epitopes proximal and distal to the plasma membrane is described. Also described are antibody-drug conjugates (ADCs) of the identified antibodies and their use for targeting CD56-expressing tumor cells.
FILED Friday, July 29, 2016
APPL NO 15/747620
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/6803 (20170801) Original (OR) Class
A61K 47/6851 (20170801)
A61K 2039/507 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Peptides
C07K 16/30 (20130101)
C07K 16/2803 (20130101)
C07K 2317/21 (20130101)
C07K 2317/732 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548989 Bradbury et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Memorial Sloan Kettering Cancer Center (New York, New York);  Cornell University (Ithaca, New York);  The Curators of the University of Missouri (Columbia, Missouri)
ASSIGNEE(S) Memorial Sloan Kettering Cancer Center (New York, New York);  Cornell University (Ithaca, New York);  The Curators of the University of Missouri (Columbia, Missouri)
INVENTOR(S) Michelle S. Bradbury (New York, New York);  Thomas P. Quinn (Columbia, Missouri);  Feng Chen (New York, New York);  Barney Yoo (New York, New York);  Jason Lewis (New York, New York);  Ulrich Wiesner (Ithaca, New York);  Kai Ma (Ithaca, New York)
ABSTRACT Disclosed herein are nanoparticle immunoconjugates useful for therapeutics and/or diagnostics. The immunoconjugates have diameter (e.g., average diameter) no greater than 20 nanometers (e.g., as measured by dynamic light scattering (DLS) in aqueous solution, e.g., saline solution). In certain embodiments, the conjugates are silica-based nanoparticles with single chain antibody fragments attached thereto.
FILED Thursday, April 07, 2016
APPL NO 15/564315
ART UNIT 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 45/06 (20130101)
A61K 47/6923 (20170801) Original (OR) Class
A61K 49/0058 (20130101)
A61K 49/1824 (20130101)
A61K 51/1093 (20130101)
A61K 51/1251 (20130101)

Peptides
C07K 16/40 (20130101)
C07K 2317/55 (20130101)
C07K 2317/569 (20130101)
C07K 2317/622 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548993 Xie et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (Athens, Georgia)
ASSIGNEE(S) UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (Athens, Georgia)
INVENTOR(S) Jin Xie (Athens, Georgia);  Hongmin Chen (Athens, Georgia);  Geoffrey D. Wang (Athens, Georgia)
ABSTRACT Nanoparticles described as metal-encapsulated carbonaceous dots or M@C-dots are disclosed. Also disclosed are specific M@C-dots with gadolinium, so called Gd@C-dots. These nanoparticles are biologically inert and preclude the release of metal in biological environments. In addition, despite a dimension exceeding the commonly recognized threshold for renal clearance, the disclosed nanoparticles can be efficiently cleared via urine after systematic injection. Methods of making and using such nanoparticles are also disclosed.
FILED Thursday, July 30, 2015
APPL NO 15/500691
ART UNIT 3792 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0035 (20130101)
A61B 5/055 (20130101)
A61B 5/0071 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 49/1827 (20130101)
A61K 49/1866 (20130101) Original (OR) Class

Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/5601 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548994 Milligan et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) STC.UNM (Albuquerque, New Mexico)
ASSIGNEE(S) STC.UNM (Albuquerque, New Mexico)
INVENTOR(S) Erin Damita Milligan (Placitas, New Mexico);  Jeffrey P. Norenberg (Albuquerque, New Mexico)
ABSTRACT In one embodiment, the invention provides a method of treating a subject suffering from chronic neuropathic pain and/or allodynia by administering a therapeutically-effective amount of at least one LFA1 antagonist to the subject. In a preferred embodiment, the invention provides a method of treating a subject suffering from chronic neuropathic pain and/or allodynia, the method comprising administering intrathecally to the subject a therapeutically-effective amount of microparticles comprising PLGA-encapsulated pDNA-IL-10, optionally in combination with a therapeutically-effective amount of intrathecally-administered CpG oligodeoxynucleotide (CpG ODN) and/or at least one LFA1 antagonist.
FILED Tuesday, March 04, 2014
APPL NO 14/196343
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/4174 (20130101)
A61K 38/34 (20130101)
A61K 38/1841 (20130101)
A61K 38/2013 (20130101)
A61K 38/2026 (20130101)
A61K 38/2066 (20130101)
A61K 38/2086 (20130101)
A61K 51/0453 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548997 Bradbury et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Center for Research Resources (NCRR)
APPLICANT(S) Sloan-Kettering Institute for Cancer Research (New York, New York);  Cornell University (Ithaca, New York)
ASSIGNEE(S) Sloan-Kettering Institute for Cancer Research (New York, New York);  Cornell University (Ithaca, New York)
INVENTOR(S) Michelle S. Bradbury (New York, New York);  Ulrich Wiesner (Ithaca, New York);  Oula Penate Medina (Kiel, Germany);  Hooisweng Ow (Woburn, Massachusetts);  Andrew Burns (Niskayuna, New York);  Jason S. Lewis (New York, New York);  Steven M. Larson (New York, New York)
ABSTRACT The present invention provides a fluorescent silica-based nanoparticle that allows for precise detection, characterization, monitoring and treatment of a disease such as cancer. The nanoparticle has a range of diameters including between about 0.1 nm and about 100 nm, between about 0.5 nm and about 50 nm, between about 1 nm and about 25 nm, between about 1 nm and about 15 nm, or between about 1 nm and about 8 nm. The nanoparticle has a fluorescent compound positioned within the nanoparticle, and has greater brightness and fluorescent quantum yield than the free fluorescent compound. The nanoparticle also exhibits high biostability and biocompatibility. To facilitate efficient urinary excretion of the nanoparticle, it may be coated with an organic polymer, such as poly(ethylene glycol) (PEG). The small size of the nanoparticle, the silica base and the organic polymer coating minimizes the toxicity of the nanoparticle when administered in vivo. In order to target a specific cell type, the nanoparticle may further be conjugated to a ligand, which is capable of binding to a cellular component associated with the specific cell type, such as a tumor marker. In one embodiment, a therapeutic agent may be attached to the nanoparticle. To permit the nanoparticle to be detectable by not only optical fluorescence imaging, but also other imaging techniques, such as positron emission tomography (PET), single photon emission computed tomography (SPECT), computerized tomography (CT), bioluminescence imaging, and magnetic resonance imaging (MRI), radionuclides/radiometals or paramagnetic ions may be conjugated to the nanoparticle.
FILED Wednesday, March 01, 2017
APPL NO 15/446319
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/5115 (20130101)
A61K 9/5146 (20130101)
A61K 9/5169 (20130101)
A61K 49/0019 (20130101)
A61K 49/0032 (20130101)
A61K 49/0054 (20130101)
A61K 49/0056 (20130101)
A61K 49/0093 (20130101)
A61K 51/08 (20130101)
A61K 51/082 (20130101)
A61K 51/086 (20130101)
A61K 51/1244 (20130101) Original (OR) Class
A61K 51/1255 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 5/00 (20130101)
B82Y 15/00 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/60 (20130101)
G01N 33/552 (20130101)
G01N 33/574 (20130101)
G01N 33/582 (20130101)
G01N 33/587 (20130101)
G01N 33/54346 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 977/773 (20130101)
Y10S 977/927 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548998 Bradbury et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Center for Research Resources (NCRR)
APPLICANT(S) Sloan-Kettering Institute for Cancer Research (New York, New York);  Cornell University (Ithaca, New York)
ASSIGNEE(S) Sloan-Kettering Institute for Cancer Research (New York, New York);  Cornell University (Ithaca, New York)
INVENTOR(S) Michelle S. Bradbury (New York, New York);  Ulrich Wiesner (Ithaca, New York);  Oula Penate Medina (Kiel, Germany);  Andrew Burns (Niskayuna, New York);  Jason S. Lewis (New York, New York);  Steven M. Larson (New York, New York)
ABSTRACT The present invention provides a fluorescent silica-based nanoparticle that allows for precise detection, characterization, monitoring and treatment of a disease such as cancer. The nanoparticle has a range of diameters including between about 0.1 nm and about 100 nm, between about 0.5 nm and about 50 nm, between about 1 nm and about 25 nm, between about 1 nm and about 15 nm, or between about 1 nm and about 8 nm. The nanoparticle has a fluorescent compound positioned within the nanoparticle, and has greater brightness and fluorescent quantum yield than the free fluorescent compound. The nanoparticle also exhibits high biostability and biocompatibility. To facilitate efficient urinary excretion of the nanoparticle, it may be coated with an organic polymer, such as poly(ethylene glycol) (PEG). The small size of the nanoparticle, the silica base and the organic polymer coating minimizes the toxicity of the nanoparticle when administered in vivo. In order to target a specific cell type, the nanoparticle may further be conjugated to a ligand, which is capable of binding to a cellular component associated with the specific cell type, such as a tumor marker. In one embodiment, a therapeutic agent may be attached to the nanoparticle. To permit the nanoparticle to be detectable by not only optical fluorescence imaging, but also other imaging techniques, such as positron emission tomography (PET), single photon emission computed tomography (SPECT), computerized tomography (CT), bioluminescence imaging, and magnetic resonance imaging (MRI), radionuclides/radiometals or paramagnetic ions may be conjugated to the nanoparticle.
FILED Friday, June 15, 2018
APPL NO 16/009267
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 49/0002 (20130101)
A61K 49/0093 (20130101)
A61K 51/1244 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/60 (20130101)
G01N 33/552 (20130101)
G01N 33/574 (20130101)
G01N 33/582 (20130101)
G01N 33/587 (20130101)
G01N 33/54346 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10549022 Jeffries et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) University of Pittsburgh Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
ASSIGNEE(S) University of Pittsburgh Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
INVENTOR(S) Richard Garrett Jeffries (Philadelphia, Pennsylvania);  William J. Federspiel (Pittsburgh, Pennsylvania);  Brian Joseph Frankowski (Imperial, Pennsylvania)
ABSTRACT An extracorporeal gas exchange device includes a housing, a rigid shaft rotatable within the housing, a plurality of agitation mechanisms positioned on the rigid shaft, and a plurality of hollow gas permeable fibers adapted to permit diffusion of gas between fluid flowing within the housing and an interior of the plurality of hollow gas permeable fibers. The plurality of hollow gas permeable fibers are positioned radially outward from the plurality of agitation mechanisms. The rotational speed of the rigid shaft is adjustable independent of the flow rate of fluid through the housing.
FILED Wednesday, January 20, 2016
APPL NO 15/542532
ART UNIT 3781 — Body Treatment, Kinestherapy, and Exercising
CURRENT CPC
Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 1/101 (20130101)
A61M 1/262 (20140204) Original (OR) Class
A61M 1/267 (20140204)
A61M 1/1006 (20140204)
A61M 1/1086 (20130101)
A61M 1/1698 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10549108 Efimov et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Washington University (St. Louis, Missouri)
ASSIGNEE(S) The Washington University (St. Louis, Missouri)
INVENTOR(S) Igor R. Efimov (Wildwood, Missouri);  Valentin Krinski (Villeneuve Loubet, France);  Vladmir P. Nikolski (St. Anthony, Minnesota)
ABSTRACT A method for extinguishing a cardiac arrhythmia utilizes destructive interference of the passing of the reentry wave tip of an anatomical reentry through a depolarized region created by a relatively low voltage electric field in such a way as to effectively unpin the anatomical reentry. Preferably, the relatively low voltage electric field is defined by at least one unpinning shock(s) that are lower than an expected lower limit of vulnerability as established, for example, by a defibrillation threshold test. By understanding the physics of the electric field distribution between cardiac cells, the method permits the delivery of an electric field sufficient to unpin the core of the anatomical reentry, whether the precise or estimated location of the reentry is known or unknown and without the risk of inducting ventricular fibrillation. A number of embodiments for performing the method are disclosed.
FILED Monday, August 27, 2018
APPL NO 16/113692
ART UNIT 3792 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0402 (20130101)
A61B 5/0464 (20130101)
A61B 5/7239 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/39 (20130101)
A61N 1/3627 (20130101)
A61N 1/3906 (20130101)
A61N 1/3925 (20130101)
A61N 1/3962 (20130101)
A61N 1/3987 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10549121 Wu et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Duke University (Durham, North Carolina);  The University of North Carolina at Charlotte (Charlotte, North Carolina)
ASSIGNEE(S) Duke University (Durham, North Carolina);  The University of North Carolina at Charlotte (Charlotte, North Carolina)
INVENTOR(S) Qingrong Jackie Wu (Durham, North Carolina);  Yaorong Ge (Matthews, North Carolina);  Fang-Fang Yin (Durham, North Carolina);  Lulin Yuan (Durham, North Carolina)
ABSTRACT Systems and methods for efficient and automatic determination of radiation beam configurations for patient-specific radiation therapy planning are disclosed. According to an aspect, a method includes receiving data based on patient information and geometric characterization of one or more organs at risk proximate to a target volume of a patient. The method includes determining automatically one or more radiation treatment beam configuration sets. Further, the method includes presenting the determined one or more radiation beam configuration sets via a user interface.
FILED Monday, March 07, 2016
APPL NO 15/555489
ART UNIT 3791 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/1031 (20130101)
A61N 5/1038 (20130101) Original (OR) Class
A61N 5/1039 (20130101)
A61N 5/1077 (20130101)
A61N 2005/1041 (20130101)
A61N 2005/1074 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550070 Malkas et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) City of Hope (Duarte, California)
ASSIGNEE(S) CITY OF HOPE (Duarte, California)
INVENTOR(S) Linda H. Malkas (Duarte, California);  David Horne (Altadena, California);  Robert J. Hickey (Duarte, California);  Long Gu (Duarte, California)
ABSTRACT Described herein, inter alia, are compositions of PCNA modulators and methods for treating or preventing cancer.
FILED Friday, September 16, 2016
APPL NO 15/760959
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/167 (20130101)
A61K 31/4409 (20130101)
A61K 33/24 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)
A61P 35/02 (20180101)

Acyclic or Carbocyclic Compounds
C07C 233/76 (20130101) Original (OR) Class

Heterocyclic Compounds
C07D 213/68 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550071 Evans et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Salk Institute for Biological Studies (La Jolla, California);  Mitobridge, Inc. (Cambridge, Massachusetts)
ASSIGNEE(S) Salk Institute for Biological Studies (La Jolla, California);  Mitobridge, Inc. (Cambridge, Massachusetts)
INVENTOR(S) Ronald M. Evans (La Jolla, California);  Michael Downes (La Jolla, California);  Thomas J. Baiga (La Jolla, California);  Joseph P. Noel (La Jolla, California);  Emi Kanakubo Embler (Tustin, California);  Weiwei Fan (La Jolla, California);  John F. W. Keana (Eugene, Oregon);  Mark G. Bock (Boston, Massachusetts);  Arthur F. Kluge (Lincoln, Massachusetts);  Mike A. Patane (Andover, Massachusetts)
ABSTRACT Provided herein are compounds and compositions useful in increasing PPARδ activity. The compounds and compositions provided herein are useful for the treatment of PPARδ related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).
FILED Thursday, February 15, 2018
APPL NO 15/897796
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/44 (20130101)
A61K 31/164 (20130101)
A61K 31/341 (20130101)
A61K 31/381 (20130101)
A61K 31/422 (20130101)
A61K 31/427 (20130101)
A61K 31/4025 (20130101)
A61K 31/4178 (20130101)
A61K 31/5377 (20130101)

Acyclic or Carbocyclic Compounds
C07C 233/73 (20130101)
C07C 233/87 (20130101) Original (OR) Class
C07C 235/42 (20130101)
C07C 235/48 (20130101)
C07C 235/84 (20130101)
C07C 237/22 (20130101)
C07C 237/32 (20130101)
C07C 237/48 (20130101)
C07C 255/57 (20130101)
C07C 259/06 (20130101)
C07C 317/44 (20130101)
C07C 2601/02 (20170501)

Heterocyclic Compounds
C07D 207/04 (20130101)
C07D 209/34 (20130101)
C07D 213/56 (20130101)
C07D 231/12 (20130101)
C07D 271/12 (20130101)
C07D 295/13 (20130101)
C07D 305/06 (20130101)
C07D 307/54 (20130101)
C07D 307/83 (20130101)
C07D 309/06 (20130101)
C07D 333/24 (20130101)
C07D 405/04 (20130101)
C07D 405/10 (20130101)
C07D 405/12 (20130101)
C07D 407/12 (20130101)
C07D 413/04 (20130101)
C07D 413/10 (20130101)
C07D 413/12 (20130101)
C07D 417/04 (20130101)
C07D 417/10 (20130101)
C07D 417/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550074 Zhou et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Duke University (Durham, North Carolina);  The University of North Carolina at Chapel Hill (Chapel Hill, North Carolina)
ASSIGNEE(S) DUKE UNIVERSITY (Durham, North Carolina);  THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (Chapel Hill, North Carolina)
INVENTOR(S) Pei Zhou (Durham, North Carolina);  Eric J. Toone (Durham, North Carolina);  Robert A. Nicholas (Chapel Hill, North Carolina);  Ramesh Gopalaswamy (Durham, North Carolina);  Xiaofei Liang (Durham, North Carolina);  Frank Navas, III (Durham, North Carolina)
ABSTRACT Disclosed are compounds of formulae:
and pharmaceutically acceptable salts thereof, wherein the variables, R1, R2, R3, R4, R5, R6, R7, R11, R12, R13, R14, R15, R16, R17, n, and m are defined herein. These compounds are useful for treating Gram-negative bacteria infections. Also disclosed are methods of making these compounds.
FILED Thursday, February 07, 2019
APPL NO 16/270291
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/04 (20180101)

Acyclic or Carbocyclic Compounds
C07C 259/06 (20130101) Original (OR) Class
C07C 259/18 (20130101)
C07C 311/06 (20130101)
C07C 317/18 (20130101)
C07C 317/44 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550093 Ojima et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Research Foundation for the State University of New York (Albany, New York)
ASSIGNEE(S) THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (Albany, New York)
INVENTOR(S) Iwao Ojima (Port Jefferson, New York);  Changwei Wang (Port Jefferson Station, New York);  Xin Wang (Centereach, New York)
ABSTRACT The invention includes taxoid compounds represented by the formula:
wherein: R1 represents a methyl group or a fluorine; R2 represents an alkyl or alkenyl group having one to six carbon atoms; or a cycloalkyl or cycloalkenyl group having three to seven ring carbon atoms; R3 represents an alkyl, alkenyl, dialkylamino, alkylamino, or alkoxy group having one to six carbon atoms; a cycloalkyl or cycloalkenyl group having three to seven ring carbon atoms; an aryl group having six to eighteen ring carbon atoms; or a heteroaryl group having three to seventeen ring carbon atoms; R4 represents hydrogen or a methyl group; and X represents hydrogen or fluorine.
FILED Friday, July 01, 2016
APPL NO 15/740859
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Heterocyclic Compounds
C07D 305/14 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550108 Tulin
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Institute for Cancer Research (Philadelphia, Pennsylvania)
ASSIGNEE(S) Institute For Cancer Research (Philadelphia, Pennsylvania)
INVENTOR(S) Alexei Tulin (Philadelphia, Pennsylvania)
ABSTRACT Compounds that are not related to NAD, and which target PARP1-histone H4 interaction are provided, as well as compositions of these compounds, and methods for specific inhibition of poly(ADP-ribose) polymerase 1 (PARP-1) using these compounds are provided. These PARP-1 inhibitors may be used to treat cancer in which PARP-1 activation or biologic activity plays a role, including prostate cancer, breast cancer, kidney cancer, ovarian cancer, lymphoma, leukemia, and glioblastoma, among others.
FILED Wednesday, September 30, 2015
APPL NO 15/515773
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 207/06 (20130101)
C07D 263/04 (20130101)
C07D 295/15 (20130101)
C07D 317/28 (20130101)
C07D 317/72 (20130101)
C07D 319/06 (20130101)
C07D 405/06 (20130101)
C07D 405/14 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550112 Gray et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
ASSIGNEE(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) Nathanael S. Gray (Boston, Massachusetts);  Jaebong Jang (Brookline, Massachusetts);  Pasi Janne (Needham, Massachusetts)
ABSTRACT The application relates to a compound having Formula (I′):
which modulates the activity of EGFR, a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease in which EGFR plays a role.
FILED Wednesday, July 20, 2016
APPL NO 15/742113
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/12 (20180101)

Heterocyclic Compounds
C07D 401/14 (20130101)
C07D 403/12 (20130101)
C07D 403/14 (20130101)
C07D 409/14 (20130101)
C07D 413/14 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550121 Gray et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
ASSIGNEE(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) Nathanael S. Gray (Boston, Massachusetts);  Tinghu Zhang (Brookline, Massachusetts);  Nicholas Paul Kwiatkowski (Brookline, Massachusetts)
ABSTRACT The present invention provides novel compounds of Formula (I), (II), or (III), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for treating and/or preventing proliferative diseases (e.g., cancers (e.g., leukemia, acute lymphoblastic leukemia, lymphoma, Burkitt's lymphoma, melanoma, multiple myeloma, breast cancer, Ewing's sarcoma, osteosarcoma, brain cancer, ovarian cancer, neuroblastoma, lung cancer, colorectal cancer), benign neoplasms, diseases associated with angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of a kinase, such as a cyclin-dependent kinase (CDK) (e.g., CDK7, CDK12, or CDK13), and therefore, induce cellular apoptosis and/or inhibit transcription in the subject.
FILED Friday, March 25, 2016
APPL NO 15/561729
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 43/00 (20180101)

Heterocyclic Compounds
C07D 473/16 (20130101) Original (OR) Class
C07D 473/34 (20130101)
C07D 487/04 (20130101)

Peptides
C07K 14/4738 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550149 Evans et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) The Salk Institute for Biological Studies (La Jolla, California)
ASSIGNEE(S) Salk Institute for Biological Studies (La Jolla, California)
INVENTOR(S) Ronald M. Evans (La Jolla, California);  Michael Downes (La Jolla, California)
ABSTRACT Provided herein are deuterated compounds and compositions useful in increasing PPARδ activity. The compounds have a formula
where L5 comprises at least one deuterium. Exemplary species include The compounds and compositions provided herein are useful for the treatment of PPARδ related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).
FILED Thursday, June 28, 2018
APPL NO 16/022578
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Acyclic or Carbocyclic Compounds
C07C 233/73 (20130101)
C07C 233/75 (20130101)
C07C 233/87 (20130101)
C07C 235/42 (20130101)
C07C 235/48 (20130101)
C07C 235/84 (20130101)
C07C 237/32 (20130101)
C07C 255/57 (20130101)
C07C 259/06 (20130101)
C07C 317/44 (20130101)
C07C 2601/02 (20170501)
C07C 2601/08 (20170501)

Heterocyclic Compounds
C07D 205/04 (20130101)
C07D 209/34 (20130101)
C07D 213/40 (20130101)
C07D 213/56 (20130101)
C07D 213/64 (20130101)
C07D 231/12 (20130101)
C07D 271/12 (20130101)
C07D 295/13 (20130101)
C07D 295/155 (20130101)
C07D 305/06 (20130101)
C07D 307/54 (20130101)
C07D 307/68 (20130101)
C07D 307/81 (20130101)
C07D 307/83 (20130101)
C07D 309/04 (20130101)
C07D 309/06 (20130101)
C07D 333/24 (20130101)
C07D 333/38 (20130101)
C07D 401/04 (20130101)
C07D 401/12 (20130101)
C07D 405/04 (20130101)
C07D 405/10 (20130101)
C07D 405/12 (20130101)
C07D 407/12 (20130101)
C07D 409/12 (20130101)
C07D 413/04 (20130101)
C07D 413/12 (20130101)
C07D 417/04 (20130101)
C07D 417/10 (20130101)
C07D 417/12 (20130101)

Peptides
C07K 5/06026 (20130101)
C07K 5/06034 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550151 Sessa et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Yale University (New Haven, Connecticut)
ASSIGNEE(S) Yale University (New Haven, Connecticut)
INVENTOR(S) William C. Sessa (Madison, Connecticut);  Frank J. Giordano (Madison, Connecticut)
ABSTRACT An isolated transport peptide, which crosses the cell membrane of a cell and/or binds to a target cell is described. The transport peptide can be incorporated into a transport construct in which the transport peptide is linked to a cargo moiety to be delivered into a cell. Also described herein is a method of delivering a transport construct into and/or to a cell.
FILED Friday, March 02, 2018
APPL NO 15/910519
ART UNIT 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)
A61K 47/645 (20170801)

Peptides
C07K 7/06 (20130101) Original (OR) Class
C07K 14/4702 (20130101)
C07K 14/4703 (20130101)
C07K 2319/01 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550163 Cai et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Hua Cai (Los Angeles, California);  Qiang Li (Los Angeles, California)
ABSTRACT Disclosed herein are peptide fragments derived from netrin-1 and compositions thereof and methods of using thereof. In some embodiments, the present invention provides a peptide that is 8-65 amino acid residues long and has a core sequence having Formula I as follows: CX(1-2)CX(3-4)TX(0-1)G, wherein X is any amino acid residue. In some embodiments, the present invention provides a composition comprising one or more peptides of the present invention which have a core sequence according to Formula I, Formula IA, or Formula IB.
CX(1-2)CX(3-4)TX(0-1)g  (I)
FILED Monday, March 30, 2015
APPL NO 15/300071
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 14/435 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550164 Schlom et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
INVENTOR(S) Jeffrey Schlom (Potomac, Maryland);  Claudia M. Palena (Potomac, Maryland)
ABSTRACT The invention provides Brachyury deletion mutant polypeptides, nucleic acids encoding the polypeptides, non-yeast vectors comprising the nucleic acids, non-yeast cells, and methods of use.
FILED Wednesday, August 03, 2016
APPL NO 15/749214
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/127 (20130101)
A61K 38/193 (20130101)
A61K 38/1709 (20130101)
A61K 39/0011 (20130101)
A61K 39/00117 (20180801)
A61K 39/001152 (20180801)
A61K 39/001182 (20180801)
A61K 45/06 (20130101)
A61K 2039/70 (20130101)
A61K 2039/5256 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Peptides
C07K 14/4702 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/86 (20130101)
C12N 2710/10043 (20130101)

Technologies for Adaptation to Climate Change
Y02A 50/466 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550169 Teitelbaum et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S) Washington University (St. Louis, Missouri)
ASSIGNEE(S) Washington University (St. Louis, Missouri)
INVENTOR(S) Steven Teitelbaum (St. Louis, Missouri);  Daved Fremont (St. Louis, Missouri);  Julia T. Warren (St. Louis, Missouri);  Christopher Nelson (St. Louis, Missouri)
ABSTRACT Methods for constructing efficient inhibitors of target TNF superfamily receptors, single chain target TNF superfamily ligands that inhibit of target TNF superfamily receptors while failing to engage or inhibit non-target TNF superfamily receptors, and methods of their use to treat diseases are provided. Single chain RANKL, TNF, and TRAIL ligands that effectively inhibit their target receptors while failing to inhibit non-target TNF superfamily receptors are also provided.
FILED Monday, February 12, 2018
APPL NO 15/894502
ART UNIT 1646 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 14/70575 (20130101) Original (OR) Class
C07K 2319/00 (20130101)
C07K 2319/02 (20130101)
C07K 2319/21 (20130101)
C07K 2319/23 (20130101)
C07K 2319/30 (20130101)
C07K 2319/50 (20130101)
C07K 2319/74 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550172 Lucas
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) University of Florida Research Foundation, Incorporated (Gainesville, Florida)
ASSIGNEE(S) University of Florida Research Foundation, Incorporated (Gainesville, Florida)
INVENTOR(S) Alexandra Rose Lucas (Gainesville, Florida)
ABSTRACT Disclosed here are peptides derived from a serpin reactive center loop that have anti¬inflammatory, anti-atherogenic and anti-sepsis activity. Compositions containing such serpin-derived peptides are therefore useful in the treatment of transplant vascular disease and also for the treatment of hemorrhagic viral infections as well as lethal viral, fungal or bacterial sepsis in patients.
FILED Friday, March 18, 2016
APPL NO 15/559867
ART UNIT 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 38/00 (20130101)
A61K 38/07 (20130101)
A61K 38/08 (20130101)
A61K 38/10 (20130101)
A61K 38/55 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 29/00 (20180101)
A61P 31/22 (20180101)

Peptides
C07K 5/1019 (20130101)
C07K 7/06 (20130101)
C07K 7/08 (20130101)
C07K 14/8121 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550176 Yang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Roger Williams Hospital (Providence, Rhode Island)
ASSIGNEE(S) ROGER WILLIAMS MEDICAL CENTER (Providence, Rhode Island)
INVENTOR(S) Wen Yang (Sharon, Massachusetts);  Richard P. Junghans (Boston, Massachusetts);  Anthony J. Bais (Providence, Rhode Island)
ABSTRACT The present invention relates to compositions and methods for creation of vector nucleic acid sequences (e.g., retroviral nucleic acid sequences) that comprise two or more exogenous nucleic acid sequences that encode highly homologous (e.g., identical) polypeptide sequences, yet wherein at least one of the exogenous nucleic acid sequences has been mutated using degenerate codons for purpose of reducing homology between the two or more exogenous nucleic acid sequences while maintaining the encoded polypeptide sequence. Preferred nucleic acid sequences include those encoding multi-chimeric immune receptor (CIR) genes. Specific nucleic acid sequences of such CIR genes are also disclosed.
FILED Friday, December 04, 2015
APPL NO 14/960236
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/00 (20130101)
A61K 38/00 (20130101)
A61K 48/00 (20130101)

Peptides
C07K 14/7051 (20130101)
C07K 14/70521 (20130101)
C07K 16/18 (20130101) Original (OR) Class
C07K 16/40 (20130101)
C07K 16/084 (20130101)
C07K 2317/622 (20130101)
C07K 2319/70 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 15/86 (20130101)
C12N 2740/10032 (20130101)
C12N 2740/10052 (20130101)
C12N 2740/13043 (20130101)
C12N 2740/13045 (20130101)
C12N 2810/855 (20130101)
C12N 2810/859 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550179 Orentas et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Lentigen Technology Inc. (Gaithersburg, Maryland);  The U.S.A., as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
ASSIGNEE(S) Lentigen Technology Inc. (Gaithersburg, Maryland);  The U.S.A., as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
INVENTOR(S) Rimas J. Orentas (Washington, District of Columbia);  Dina Schneider (Potomac, Maryland);  Boro Dropulic (Gaithersburg, Maryland);  Dimiter S. Dimitrov (Frederick, Maryland);  Zhongyu Zhu (Frederick, Maryland)
ABSTRACT Chimeric antigen receptors containing mesothelin antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the chimeric antigen receptors are also disclosed. Methods of treating or preventing cancer in a subject, and methods of making chimeric antigen receptor T cells are also disclosed.
FILED Friday, January 18, 2019
APPL NO 16/252158
ART UNIT 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/17 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)
A61P 35/02 (20180101)

Peptides
C07K 14/7051 (20130101)
C07K 14/70517 (20130101)
C07K 14/70521 (20130101)
C07K 14/70578 (20130101)
C07K 16/18 (20130101) Original (OR) Class
C07K 16/30 (20130101)
C07K 2317/21 (20130101)
C07K 2317/622 (20130101)
C07K 2319/02 (20130101)
C07K 2319/03 (20130101)
C07K 2319/33 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0636 (20130101)
C12N 5/0638 (20130101)
C12N 15/09 (20130101)
C12N 15/10 (20130101)
C12N 15/62 (20130101)
C12N 15/63 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550195 Liu
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Regents of The University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Bin Liu (San Francisco, California)
ABSTRACT Methods are provided for identifying and selecting antibodies that are internalized into cells via the macropinocytosis pathway. Additionally antibodies that are internalized via this pathway are provided as well as immunoconjugates comprising such antibodies.
FILED Thursday, July 09, 2015
APPL NO 15/321684
ART UNIT 1639 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 45/06 (20130101)
A61K 49/00 (20130101)

Peptides
C07K 16/005 (20130101)
C07K 16/30 (20130101) Original (OR) Class
C07K 16/3069 (20130101)
C07K 2317/21 (20130101)
C07K 2317/32 (20130101)
C07K 2317/73 (20130101)
C07K 2317/77 (20130101)

Combinatorial Chemistry; Libraries, e.g Chemical Libraries
C40B 40/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550201 Peterson et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) BioVentures, LLC (Little Rock, Arkansas);  Eric C. Peterson (Little Rock, Arkansas);  Nisha Nanaware-Kharade (Little Rock, Arkansas);  Guillermo Gonzalez, III (Little Rock, Arkansas)
ASSIGNEE(S) BioVentures, LLC (Little Rock, Arkansas)
INVENTOR(S) Eric C. Peterson (Little Rock, Arkansas);  Nisha Nanaware-Kharade (Little Rock, Arkansas);  Guillermo Gonzalez, III (Little Rock, Arkansas)
ABSTRACT The present invention generally relates to an antibody composition including antibodies conjugated to nanoparticles. The antibody composition may be used in methods to treat drug use, drug addiction, and effects of drug use.
FILED Thursday, March 13, 2014
APPL NO 14/775227
ART UNIT 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 16/44 (20130101) Original (OR) Class
C07K 2317/622 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550365 Biggs et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S) The Trustees of Columbia University in the City of New York (New York, New York)
INVENTOR(S) Manus J. P. Biggs (Galway, Ireland);  Ryan Cooper (Oak Ridge, Tennessee);  Jinyu Liao (New York, New York);  Teresa Anne Fazio (Poughkeepsie, New York);  Carl Fredrik Oskar Dahlberg (Stockholm, Sweden);  Jeffrey William Kysar (New York, New York);  Samuel Jonas Wind (White Plains, New York)
ABSTRACT An elastomeric substrate comprises a surface with regions of heterogeneous rigidity, wherein the regions are formed by exposing the elastomeric substrate to an energy source to form the regions such that the regions include a rigidity pattern comprising spots.
FILED Monday, April 10, 2017
APPL NO 15/483754
ART UNIT 1712 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0068 (20130101) Original (OR) Class
C12N 5/0663 (20130101)
C12N 2533/30 (20130101)
C12N 2535/00 (20130101)
C12N 2535/10 (20130101)
C12N 2537/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550372 Konermann et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) The Broad Institute Inc. (Cambridge, Massachusetts);  Massachusetts Institute of Technology (Cambridge, Massachusetts);  University of Tokyo (Tokyo, Japan);  President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) The Broad Institute, Inc. (Cambridge, Massachusetts);  Massachusetts Institute of Technology (Cambridge, Massachusetts);  University of Tokyo (Tokyo, Japan);  President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Silvana Konermann (Zurich, Switzerland);  Alexandro Trevino (Stanford, California);  Mark Brigham (Somerville, Massachusetts);  Fei Ran (Boston, Massachusetts);  Patrick Hsu (San Diego, California);  Chie-yu Lin (Boston, Massachusetts);  Osamu Nureki (Kanagawa, Japan);  Hiroshi Nishimasu (Tokyo, Japan);  Ryuichiro Ishitani (Tokyo, Japan);  Feng Zhang (Cambridge, Massachusetts)
ABSTRACT The invention provides for systems, methods, and compositions for altering expression of target gene sequences and related gene products. Provided are structural information on the Cas protein of the CRISPR-Cas system, use of this information in generating modified components of the CRISPR complex, vectors and vector systems which encode one or more components or modified components of a CRISPR complex, as well as methods for the design and use of such vectors and components. Also provided are methods of directing CRISPR complex formation in eukaryotic cells and methods for utilizing the CRISPR-Cas system. In particular the present invention comprehends optimized functional CRISPR-Cas enzyme systems.
FILED Friday, June 10, 2016
APPL NO 15/179912
ART UNIT 1651 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/465 (20130101)
A61K 48/005 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/22 (20130101) Original (OR) Class
C12N 15/113 (20130101)
C12N 15/902 (20130101)
C12N 15/907 (20130101)
C12N 2310/20 (20170501)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6876 (20130101)

Enzymes
C12Y 301/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550379 Lin et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
INVENTOR(S) Michael Z. Lin (Stanford, California);  Hokyung Chung (Mountain View, California);  Conor Jacobs (Stanford, California)
ABSTRACT Engineered fusion proteins comprising a self-excising degron for controlling protein production are disclosed. In particular, the inventors have constructed fusion proteins comprising a degron connected to a protein of interest through a cleavable linker comprising a hepatitis C virus (HCV) protease site. The degron can be removed from the protein of interest by a czs-encoded HCV protease such that the protein of interest can be produced with minimal structural modification. Clinically available HCV protease inhibitors can be used to block protease cleavage such that the degron is retained after inhibitor addition on subsequently synthesized protein copies. The degron when attached causes rapid degradation of the linked protein. Such fusions of a degron to a protein of interest will be especially useful when control over protein production with minimal structural modification is desired.
FILED Tuesday, June 28, 2016
APPL NO 15/737712
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Peptides
C07K 2319/50 (20130101)
C07K 2319/95 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/506 (20130101) Original (OR) Class
C12N 15/86 (20130101)
C12N 2760/18443 (20130101)

Enzymes
C12Y 304/21098 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/68 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550388 Monje-Deisseroth et al.
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
INVENTOR(S) Michelle Monje-Deisseroth (Stanford, California);  Elizabeth Qin (Palo Alto, California)
ABSTRACT Compositions and methods for treatment of glioma are disclosed. In particular, the invention relates to methods of treating glioma by inhibiting pleiotrophin signaling to limit high-grade glioma invasion.
FILED Wednesday, August 15, 2018
APPL NO 15/998437
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 9/0085 (20130101)
A61K 31/713 (20130101)
A61K 31/4439 (20130101)
A61K 31/5377 (20130101)
A61K 31/7105 (20130101)
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101) Original (OR) Class
C12N 2310/11 (20130101)
C12N 2310/14 (20130101)
C12N 2310/14 (20130101)
C12N 2310/122 (20130101)
C12N 2310/141 (20130101)
C12N 2310/531 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550395 Xiao et al.
FUNDED BY
Department of Justice (DOJ)
Office of Justice Programs (OJP)
National Institute of Justice (NIJ)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) Yi Xiao (Miami, Florida);  Haixiang Yu (Miami, Florida)
ASSIGNEE(S) THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (Miami, Florida)
INVENTOR(S) Yi Xiao (Miami, Florida);  Haixiang Yu (Miami, Florida)
ABSTRACT The subject invention provides methods, assays and products for detecting small-molecules in a sample, in particular, in both clinical and field settings. The method for detecting a small-molecule target in a sample comprises providing a sample, contacting the sample with an aptamer-based sensor selective for the small-molecule target, and sensitively and rapidly detecting the small-molecule target in the sample. Specifically, the method utilizes EATR-amplified small-molecule sensors based on cooperative binding split aptamers (CBSAs).
FILED Friday, April 06, 2018
APPL NO 15/947315
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/115 (20130101) Original (OR) Class
C12N 2310/16 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/92 (20130101)
G01N 33/946 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550405 Li et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) The University of North Carolina at Chapel Hill (Chapel Hill, North Carolina)
ASSIGNEE(S) The University of North Carolina at Chapel Hill (Chapel Hill, North Carolina)
INVENTOR(S) Chengwen Li (Chapel Hill, North Carolina);  Richard Jude Samulski (Hillsborough, North Carolina)
ABSTRACT The present invention provides a polyploid adeno-associated virus (AAV) capsid, wherein the capsid comprises capsid protein VP1, wherein said capsid protein VP1 is from one or more than one first AAV serotype, wherein said capsid protein VP2 is from one or more than one first AAV serotype and capsid protein VP3, wherein said capsid protein VP3 is from one or more than one second AAV serotype and wherein at least one of said first AAV serotype is different from at least one of said second AAV serotype and is different from at least one of said third AAV serotype, in any combination.
FILED Tuesday, July 31, 2018
APPL NO 16/051110
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 3/00 (20180101)

Peptides
C07K 2317/24 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/8645 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550415 Travis
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Alexander Travis (Ithaca, New York)
ASSIGNEE(S) Cornell Research Foundation, Inc. (Ithaca, New York)
INVENTOR(S) Alexander Travis (Ithaca, New York)
ABSTRACT The present invention relates to a system for production of ATP. This system is comprised of a support and one or more enzymes coupled to that support which are capable of collectively producing ATP from glucose or fructose metabolism. The present invention is additionally directed to a device, which includes the system, and to a method for carrying out a reaction involving the conversion of ATP to ADP using the system.
FILED Thursday, October 16, 2008
APPL NO 12/738367
ART UNIT 1653 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 19/32 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550422 Gee et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts);  Life Technologies Corporation (Carlsbad, California)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts);  Life Technologies Corporation (Carlsbad, California)
INVENTOR(S) Kyle R. Gee (Springfield, Oregon);  Brian Agnew (Eugene, Oregon);  Adrian Salic (Cambridge, Massachusetts);  Timothy J. Mitchison (Brookline, Massachusetts)
ABSTRACT The present invention relates to methods for the labeling of nucleic acid polymers in vitro and in vivo. Certain methods are provided that include a [3+2] cycloaddition between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent attached to a label. Other methods are provided that include a Staudinger ligation between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent comprising a substituted triarylphosphine attached to a label. Such methods do not require fixation and denaturation and therefore can be applied to the labeling of nucleic acid polymers in living cells and in organisms. Also provided are methods for measuring cellular proliferation. In these methods, the amount of label incorporated into the DNA is measured as an indication of cellular proliferation. The methods of the invention can be used in a wide variety of applications including clinical diagnosis of diseases and disorders in which cellular proliferation is involved, toxicity assays, and as a tool for the study of chromosomes' ultrastructures.
FILED Monday, October 24, 2016
APPL NO 15/332304
ART UNIT 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/68 (20130101)
C12Q 1/68 (20130101)
C12Q 1/6806 (20130101) Original (OR) Class
C12Q 1/6816 (20130101)
C12Q 1/6816 (20130101)
C12Q 1/6841 (20130101)
C12Q 1/6841 (20130101)
C12Q 2525/101 (20130101)
C12Q 2563/107 (20130101)
C12Q 2563/107 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/582 (20130101)
G01N 33/5011 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550433 Ridker et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) The Brigham and Women's Hospital, Inc. (Boston, Massachusetts);  Celera Corporation (Alameda, California)
ASSIGNEE(S) The Brigham and Women's Hospital, Inc. (Boston, Massachusetts);  Celera Corporation (Alameda, California)
INVENTOR(S) Paul M. Ridker (Chestnut Hill, Massachusetts);  Daniel Chasman (Cambridge, Massachusetts);  Dov Shiffman (Palo Alto, California)
ABSTRACT This invention relates to nucleotide polymorphisms in the human Apo(a) gene and to the use of Apo(a) nucleotide polymorphisms in identifying whether a human subject will respond or not to treatment with acetylsalicylic acid.
FILED Monday, April 03, 2017
APPL NO 15/477206
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/616 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6876 (20130101)
C12Q 1/6883 (20130101) Original (OR) Class
C12Q 2600/106 (20130101)
C12Q 2600/136 (20130101)
C12Q 2600/156 (20130101)
C12Q 2600/158 (20130101)
C12Q 2600/172 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/92 (20130101)
G01N 2333/775 (20130101)
G01N 2500/04 (20130101)
G01N 2800/32 (20130101)
G01N 2800/50 (20130101)
G01N 2800/52 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550437 Donskey et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) CASE WESTERN RESERVE UNIVERSITY (Cleveland, Ohio)
ASSIGNEE(S) CASE WESTERN RESERVE UNIVERSITY (Cleveland, Ohio)
INVENTOR(S) Curtis Donskey (Cleveland, Ohio);  Michelle Nerandzic (Cleveland, Ohio);  Jennifer Cadnum (Cleveland, Ohio)
ABSTRACT A culture medium for culturing Clostridium difficile under aerobic culture conditions, the medium includes a nutrient medium that promotes growth of Clostridium difficile and amounts of thioglycolic and L-cystine effective to consume oxygen in the culture medium and facilitate growth of Clostridium difficile.
FILED Monday, June 01, 2015
APPL NO 15/315240
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/689 (20130101) Original (OR) Class
C12Q 2600/158 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/523 (20130101)
G01N 33/6893 (20130101)
G01N 2333/902 (20130101)
G01N 2800/26 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550441 Petropoulos
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) MONOGRAM BIOSCIENCES, INC. (South San Francisco, California)
ASSIGNEE(S) Monogram BioSciences, Inc. (South San Francisco, California)
INVENTOR(S) Christos J. Petropoulos (Half Moon Bay, California)
ABSTRACT The invention provides a method for determining whether a human immunodeficiency virus is resistance to a viral entry inhibitor. The methods are particularly useful for determining resistance to inhibitors that act by a non-competitive mechanism. In certain aspects, the methods comprise determining whether an HIV population is resistant to an HIV entry inhibitor, comprising determining a log-sigmoid inhibition curve comprising data points for entry of the HIV population in the presence of varying concentrations of the HIV entry inhibitor, wherein if the entry of the HIV population cannot be completely inhibited by the HIV entry inhibitor, the HIV population is resistant to the HIV entry inhibitor.
FILED Monday, December 09, 2013
APPL NO 14/100467
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/703 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550494 Savoy et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Steve M. Savoy (Austin, Texas);  Daniel R. Mitchell (Austin, Texas);  Jeremy J. John (Austin, Texas);  George L. Murphy (Austin, Texas)
ASSIGNEE(S) NANOHMICS, INC. (Austin, Texas)
INVENTOR(S) Steve M. Savoy (Austin, Texas);  Daniel R. Mitchell (Austin, Texas);  Jeremy J. John (Austin, Texas);  George L. Murphy (Austin, Texas)
ABSTRACT Analyte filter arrays and methods for making an analyte filter array are provided. The arrays are formed using a dispersion of filter particles having selected moieties attached to the surface of the particles and a microarray having complementary moieties formed in an array on a substrate, such that each filter particle is attached to a selected region of the microarray. The moiety on the substrate may be RNA or DNA or other molecule. The substrate may be a surface of a detector array, a membrane that may be placed in registration with the detector array or a stamp used to transfer the filter array to a detector array.
FILED Monday, October 23, 2017
APPL NO 15/791403
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 19/0046 (20130101)
B01J 2219/00382 (20130101)
B01J 2219/00576 (20130101)
B01J 2219/00637 (20130101)
B01J 2219/00648 (20130101)
B01J 2219/00722 (20130101)

Combinatorial Chemistry; Libraries, e.g Chemical Libraries
C40B 50/18 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551381 Bosch et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  The United States of America as Represented by the Secretary of the Department of Health and Human Services (Silver Springs, Maryland)
INVENTOR(S) Irene Bosch (Brookline, Massachusetts);  Kimberly Hamad-Schifferli (Somerville, Massachusetts);  Jose Gomez-Marquez (Boston, Massachusetts);  Helena de Puig (Cambridge, Massachusetts);  Lee Gehrke (Cotuit, Massachusetts)
ABSTRACT The present invention provides matched antibody pairs for the specific detection of one or more of the four dengue virus serotypes in a biological sample that may contain one or more of such dengue virus serotypes. Each matched antibody pair is capable of detecting not more than one serotype of dengue virus NS1 protein that may be present in the sample and will not cross react with other serotypes that may be present in the sample. Multiple matched pairs may be used to detect one or more dengue virus serotypes that may be present in a sample. Such matched pair antibodies, facilitate the development of confirmatory in vitro diagnostic tests such as sandwich immunoassays, that detect and distinguish the presence of one or more dengue virus serotypes in a biological sample, preferably a sample derived from human subject. The invention also provides kits comprising the matched antibody pairs of the invention and methods for using the kits for immunoassays for the specific detection of one or more serotypes of dengue virus in a patient population. The present invention also provides monoclonal antibodies specific for the NS1 protein of dengue virus and therapeutic compositions and methods for treating dengue virus infection.
FILED Friday, February 10, 2017
APPL NO 15/429756
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 2317/34 (20130101)
C07K 2317/92 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/56983 (20130101) Original (OR) Class
G01N 2333/08 (20130101)
G01N 2469/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551384 Zheng
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (New Brunswick, New Jersey)
ASSIGNEE(S) Rutgers, The State University Of New Jersey (New Brunswick, New Jersey)
INVENTOR(S) Steven Zheng (New Brunswick, New Jersey)
ABSTRACT Certain embodiments of the invention provide a method of detecting the presence of a biomarker associated with resistance to an mTOR kinase inhibitor in a subject, comprising determining the presence of the biomarker in a physiological sample from the subject, wherein the sample comprises a nucleic acid.
FILED Friday, April 07, 2017
APPL NO 15/482340
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/53 (20130101)
A61K 31/495 (20130101)
A61K 31/519 (20130101)
A61K 31/4709 (20130101)
A61K 31/4745 (20130101)
A61K 31/5377 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/12 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101)
C12Q 2600/106 (20130101)
C12Q 2600/156 (20130101)

Enzymes
C12Y 207/11 (20130101)
C12Y 207/11011 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5011 (20130101)
G01N 33/57415 (20130101)
G01N 33/57419 (20130101)
G01N 33/57423 (20130101)
G01N 33/57484 (20130101) Original (OR) Class
G01N 2333/912 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551393 Thierer et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland);  CARNEGIE INSTITUTION OF WASHINGTON (Washington, District of Columbia)
ASSIGNEE(S) CARNEGIE INSTITUTE OF WASHINGTON (Washington, District of Columbia);  The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) James H. Thierer (Baltimore, Maryland);  Steven A. Farber (Baltimore, Maryland)
ABSTRACT We describe a high-throughput, phenotypic screening method for one or more modulator(s) of Apolipoprotein B (ApoB) in larval zebrafish. The modulator(s) may be enhancers or inhibitors of ApoB expression. This represents a remarkable opportunity to investigate drug targets in every cell and tissue type of a whole animal without bias, thus maximizing the likelihood of identifying viable pre-therapeutic leads for compounds or biologics in a subject (e.g., human).
FILED Thursday, June 01, 2017
APPL NO 15/611780
ART UNIT 1639 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 14/461 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/09 (20130101)
C12N 15/113 (20130101)
C12N 2310/14 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/92 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551450 Halpern et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Howard Halpern (Chicago, Illinois);  Subramanian V. Sundramoorthy (Chicago, Illinois);  Boris Epel (Chicago, Illinois)
ASSIGNEE(S) THE UNIVERSITY OF CHICAGO (Chicago, Illinois)
INVENTOR(S) Howard Halpern (Chicago, Illinois);  Subramanian V. Sundramoorthy (Chicago, Illinois);  Boris Epel (Chicago, Illinois)
ABSTRACT Techniques provide for passive Q switching in a bimodal resonator environment, where magnetic resonators are coupled for power transfer. A passive Q switch is responsive to a driving power from one magnetic resonator coupled to another magnetic resonator. After the driving power reaches a threshold, the passive Q switch shunts the receiving magnetic resonator, at least partially, to reduce the Q of that second resonator, which allows faster detection operation of the second resonator in some applications. The technique allows for fast Q switching in a bimodal resonator system, especially one having resonators having magnetic fields that are orthogonal to one another.
FILED Thursday, June 14, 2012
APPL NO 14/128423
ART UNIT 2866 — Printing/Measuring and Testing
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/60 (20130101)
G01R 33/343 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10552955 Hu et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) YALE UNIVERSITY (New Haven, Connecticut)
ASSIGNEE(S) Yale University (New Haven, Connecticut)
INVENTOR(S) Chenxi Hu (New Haven, Connecticut);  Dana Peters (New London, Connecticut)
ABSTRACT The present invention provides novel methods of accurately and efficiently reconstructing parameter maps in MRI data. In certain embodiments, the methods have reduced data acquisition time or improved spatial resolution when compared to methods standard in the art. In other embodiments, the methods have reduced acquisition and reconstruction time when compared to other acceleration methods in the art in parametric mapping. In other embodiments, the methods are less susceptible to influence of eddy currents when compared to other acceleration methods in the art in parametric mapping.
FILED Wednesday, April 04, 2018
APPL NO 15/945301
ART UNIT 2667 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Image Data Processing or Generation, in General
G06T 7/0012 (20130101) Original (OR) Class
G06T 11/005 (20130101)
G06T 11/006 (20130101)
G06T 11/008 (20130101)
G06T 15/08 (20130101)
G06T 2207/30008 (20130101)
G06T 2207/30016 (20130101)
G06T 2207/30048 (20130101)
G06T 2207/30056 (20130101)
G06T 2207/30068 (20130101)
G06T 2207/30081 (20130101)
G06T 2207/30084 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10552969 Simpson et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, New York)
ASSIGNEE(S) MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, New York)
INVENTOR(S) Amber Lea Simpson (New York, New York);  Richard Kinh Gian Do (New York, New York)
ABSTRACT An exemplary system, method and computer-accessible medium for determining the pixel variation of a tissue(s) in an image(s) can be provided, which can include, for example, receiving first imaging information related to the image(s), segmenting a region(s) of interest from the image(s), generating second imaging information by subtracting a structure(s) from the region(s) of interest, and determining the pixel variation based on the second imaging information. The tissue(s) can include a liver and/or a pancreas. A treatment characteristic(s) can be determined based on the pixel variation, which can include (i) a sufficiency of the tissue(s), (ii) a response to chemotherapy by the tissue(s), (iii) a recurrence of cancer in the tissue(s), or (iv) a measure of a genomic expression of the tissue(s).
FILED Thursday, May 26, 2016
APPL NO 15/577101
ART UNIT 2664 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 6/032 (20130101)
A61B 6/50 (20130101)
A61B 6/54 (20130101)
A61B 6/5217 (20130101)

Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/46 (20130101)

Image Data Processing or Generation, in General
G06T 7/11 (20170101)
G06T 7/0012 (20130101)
G06T 7/0014 (20130101)
G06T 7/40 (20130101)
G06T 7/45 (20170101) Original (OR) Class
G06T 7/155 (20170101)
G06T 7/194 (20170101)
G06T 2207/10072 (20130101)
G06T 2207/10081 (20130101)
G06T 2207/20224 (20130101)
G06T 2207/30004 (20130101)
G06T 2207/30056 (20130101)
G06T 2207/30096 (20130101)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 30/20 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553199 Guenther et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Deafness and Other Communication Disorders (NIDCD)
APPLICANT(S) Trustees of Boston University (Boston, Massachusetts)
ASSIGNEE(S) Trustees of Boston University (Boston, Massachusetts)
INVENTOR(S) Frank Harold Guenther (Boston, Massachusetts);  Alfonso Nieto-Castanon (Ciudad de Buenos Aires, Argentina)
ABSTRACT A method of providing real-time speech synthesis based on user input includes presenting a graphical user interface having a low-dimensional representation of a multi-dimensional phoneme space, a first dimension representing degree of vocal tract constriction and voicing, a second dimension representing location in a vocal tract. One example employs a disk-shaped layout. User input is received via the interface and translated into a sequence of phonemes that are rendered on an audio output device. Additionally, a synthesis method includes maintaining a library of prerecorded samples of diphones organized into diphone groups, continually receiving a time-stamped sequence of phonemes to be synthesized, and selecting a sequence of diphone groups with their time stamps. A best diphone within each group is identified and placed into a production buffer from which diphones are rendered according to their time stamps.
FILED Friday, May 20, 2016
APPL NO 15/570889
ART UNIT 2659 — Linguistics, Speech Processing and Audio Compression
CURRENT CPC
Electric Digital Data Processing
G06F 3/048 (20130101)
G06F 3/0482 (20130101)
G06F 3/04842 (20130101)

Speech Analysis or Synthesis; Speech Recognition; Speech or Voice Processing; Speech or Audio Coding or Decoding
G10L 13/04 (20130101) Original (OR) Class
G10L 13/06 (20130101)
G10L 13/08 (20130101)
G10L 13/027 (20130101)
G10L 15/00 (20130101)
G10L 19/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US RE47838 Wall et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (Knoxville, Tennessee)
ASSIGNEE(S) UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (Knoxville, Tennessee)
INVENTOR(S) Jonathan S. Wall (Knoxville, Tennessee);  Timothy E. Sparer (Knoxville, Tennessee);  Stephen J. Kennel (Knoxville, Tennessee)
ABSTRACT Disclosed are methods of treating and/or inhibiting a viral infection in a subject. The methods include administering a therapeutically effective amount of heparin-binding peptide. Also disclosed herein are methods for blocking viral binding to a cell. Further disclosed are anti-viral compositions for administration to a subject infected with a virus. Administration of the anti-viral composition inhibits viral infection of the subject.
FILED Tuesday, January 30, 2018
APPL NO 15/883982
ART UNIT 3991 — Central Reexamination Unit (Chemical)
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/16 (20130101)

Peptides
C07K 7/08 (20130101) Original (OR) Class
C07K 14/001 (20130101)
C07K 14/035 (20130101)
C07K 14/045 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Defense (DOD) 

US 10548519 Arias et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
National Science Foundation (NSF)
Directorate for Education and Human Resources (EHR)
Division of Graduate Education (DGE)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Ana Claudia Arias (Berkeley, California);  Claire Lochner (Berkeley, California);  Adrien Pierre (Berkeley, California);  Yasser Khan (Berkeley, California)
ABSTRACT Pulse oximeter devices include a first light emitting element that emits red light, a second light emitting element that emits green light or IR light; and a sensor element that detects red and green (or IR) light and that outputs signals representing detected red and green (or IR) light. The pulse oximeter device further includes a flexible substrate, wherein the first light emitting element, the second light emitting element and the sensor element are formed on the flexible substrate. The sensor element is configured to detect the emitted red and green light transmitted through tissue containing blood, and in certain aspects, the sensor element is configured to detect the emitted red and green (or IR) light reflected by tissue containing blood. A signal processing element (e.g., a processor) receives and processes the signals representing detected red and green (or IR) light output by the sensor element to produce signals representing blood oxygenation content.
FILED Tuesday, January 24, 2017
APPL NO 15/414397
ART UNIT 3791 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/024 (20130101)
A61B 5/0205 (20130101)
A61B 5/6815 (20130101)
A61B 5/6826 (20130101)
A61B 5/14552 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548944 Jaynes et al.
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Riptide Bioscience, Inc. (Vallejo, California)
ASSIGNEE(S) Riptide Bioscience, Inc. (Vallejo, California)
INVENTOR(S) Jesse Jaynes (Auburn, Alabama);  L. Edward Clemens (Sacramento, California);  Henry Willfred Lopez (Napa, California);  George R. Martin (Rockville, Maryland);  Kathryn Woodburn (Saratoga, California)
ABSTRACT Aspects of the present invention relate to peptides having antimicrobial activity. In certain aspects, the invention relates to peptides having potent antimicrobial activity, broad-spectrum antimicrobial activity, and/or the ability to kill otherwise antibiotic-resistant microbes, or microbes protected by biofilms.
FILED Friday, October 19, 2018
APPL NO 16/165727
ART UNIT 1658 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0014 (20130101)
A61K 9/0053 (20130101)
A61K 9/0073 (20130101)
A61K 38/10 (20130101) Original (OR) Class
A61K 38/16 (20130101)
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/04 (20180101)
A61P 31/10 (20180101)

Peptides
C07K 7/08 (20130101)
C07K 14/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548946 Golden et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) The United States of America, as represented by the Secretary of the Army, on behalf of the United States (Fort Detrick, Maryland)
ASSIGNEE(S) The government of the United States, as represented by the Secretary of the Army (Fort Detrick, Maryland)
INVENTOR(S) Joseph Golden (Hagerstown, Maryland);  Jay Hooper (New Market, Maryland)
ABSTRACT The inventions describe here cover therapeutic compositions, and methods of use, for neutralizing Type I interferons in a mammal. The compositions contain a soluble Orthopoxvirus IFN-binding protein that is modified to remove the cell-binding region, and that specifically binds to Type I IFNs, and a pharmaceutically acceptable carrier or excipient. Another variation of the invention entails a novel IFN-binding protein that is modified to remove the cell-binding region and the signal sequence.
FILED Friday, December 01, 2017
APPL NO 15/828582
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/162 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548948 Millenbaugh et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Nancy Millenbaugh (San Antonio, Texas);  Jeremy Wesley Gleaton (Cleveland, Ohio);  Dickson Kiprono Kirui (San Antonio, Texas)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Navy (Arlington, Virginia)
INVENTOR(S) Nancy Millenbaugh (San Antonio, Texas);  Jeremy Wesley Gleaton (Cleveland, Ohio);  Dickson Kiprono Kirui (San Antonio, Texas)
ABSTRACT Antifungal pharmaceutical compositions, dosage forms, and methods of use thereof are disclosed.
FILED Tuesday, February 27, 2018
APPL NO 15/906863
ART UNIT 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/1767 (20130101) Original (OR) Class
A61K 45/06 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 15/44 (20130101)
A61L 2300/252 (20130101)
A61L 2300/404 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/00 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548959 Khan et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  Whitehead Institute for Biomedical Research (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambirdge, Massachusetts);  Whitehead Institute for Biomedical Research (Cambridge, Massachusetts)
INVENTOR(S) Omar F. Khan (Cambridge, Massachusetts);  Jasdave S. Chahal (Arlington, Massachusetts);  Daniel G. Anderson (Framington, Massachusetts);  Hidde Ploegh (Brookline, Massachusetts);  Robert S. Langer (Newton, Massachusetts);  Tyler E. Jacks (Newton, Massachusetts);  David A. Canner (Cambridge, Massachusetts)
ABSTRACT Compositions and methods for modified dendrimer nanoparticle (“MDNP”) delivery of therapeutic, prophylactic and/or diagnostic agent such as large repRNA molecules to the cells of a subject have been developed. MDNPs efficiently drive proliferation of antigen-specific T cells against intracellular antigen, and potentiate antigen-specific antibody responses. MDNPs can be multiplexed to deliver two or more different repRNAs to modify expression kinetics of encoded antigens and to simultaneous deliver repRNAs and mRNAs including the same UTR elements that promote expression of encoded antigens.
FILED Friday, September 23, 2016
APPL NO 15/274954
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/713 (20130101)
A61K 39/0012 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10549122 Cheng et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) Vision RT Limited (London, United Kingdom)
ASSIGNEE(S) VISION RT LIMITED (London, United Kingdom)
INVENTOR(S) Chieh C. Cheng (Redlands, California);  David A. Lesyna (Redlands, California);  Michael F. Moyers (Colton, California)
ABSTRACT Apparatus and methods for therapy delivery are disclosed. In one embodiment, a therapy delivery system includes a plurality of movable components including a radiation therapy nozzle and a patient pod for holding a patient, a patient registration module for determining a desired position of at least one of the plurality of movable components, and a motion control module for coordinating the movement of the least one of the plurality of movable components from a current position to the desired position. The motion control module includes a path planning module for simulating at least one projected trajectory of movement of the least one of the plurality of moveable components from the current position to the desired position.
FILED Friday, June 01, 2018
APPL NO 15/995987
ART UNIT 2116 — Computer Error Control, Reliability, & Control Systems
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 6/0442 (20130101)
A61B 6/547 (20130101)
A61B 6/4092 (20130101)
A61B 2090/3937 (20160201)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/107 (20130101) Original (OR) Class
A61N 5/1037 (20130101)
A61N 5/1049 (20130101)
A61N 5/1067 (20130101)
A61N 5/1069 (20130101)
A61N 5/1078 (20130101)
A61N 2005/105 (20130101)
A61N 2005/1059 (20130101)
A61N 2005/1061 (20130101)
A61N 2005/1062 (20130101)
A61N 2005/1087 (20130101)
A61N 2005/1097 (20130101)

Manipulators; Chambers Provided With Manipulation Devices
B25J 9/1666 (20130101)

Control or Regulating Systems in General; Functional Elements of Such Systems; Monitoring or Testing Arrangements for Such Systems or Elements
G05B 15/02 (20130101)
G05B 2219/45117 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10549259 Sengupta et al.
FUNDED BY
Department of Defense (DOD)
Defense Threat Reduction Agency (DTRA)
APPLICANT(S) BAE SYSTEMS Information and Electronic Systems Integration Inc. (Nashua, New Hampshire)
ASSIGNEE(S) BAE Systems Information and Electronic Systems Integration Inc. (Nashua, New Hampshire)
INVENTOR(S) Louise C. Sengupta (Ellicott City, Maryland);  Pierre-Alain S. Auroux (Rockville, Maryland);  Christopher S. Badorrek (Hagerstown, Maryland);  Michael J. Bowers, II (Sykesville, Maryland);  Myeongseob Kim (Ellicott City, Maryland);  John E. King (Ellicott City, Maryland);  Tadd C. Kippeny (Pasadena, Maryland);  Laura A. Swafford (Baltimore, Maryland)
ABSTRACT In the method for scrubbing a chemical from a medium, wherein the improvement comprises the steps of using a carbide derived carbon to adsorb the chemical which may later be released by heating. The carbide derived carbon may be a powder, a fiber, a solid foam, a mesh, or other solid form. The carbide derived carbon can adsorb a chemical in the gaseous, liquid, particulate, or aerosol phase.
FILED Wednesday, August 30, 2017
APPL NO 15/690358
ART UNIT 1772 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Separation
B01D 53/02 (20130101)
B01D 53/0438 (20130101)
B01D 2253/102 (20130101)
B01D 2253/106 (20130101)
B01D 2257/40 (20130101)
B01D 2257/204 (20130101)
B01D 2257/302 (20130101)
B01D 2257/304 (20130101)
B01D 2257/406 (20130101)
B01D 2257/704 (20130101)
B01D 2257/708 (20130101)
B01D 2257/2025 (20130101)
B01D 2257/2064 (20130101)
B01D 2257/7022 (20130101)
B01D 2257/7027 (20130101)
B01D 2258/06 (20130101)
B01D 2259/4508 (20130101)
B01D 2259/4541 (20130101)
B01D 2259/4566 (20130101)
B01D 2259/40096 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/20 (20130101) Original (OR) Class
B01J 20/3483 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 32/318 (20170801)

Indexing Scheme Relating to Structural and Physical Aspects of Solid Inorganic Compounds
C01P 2004/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550003 Hersam et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Northwestern University (Evanston, Illinois)
ASSIGNEE(S) NORTHWESTERN UNIVERSITY (Evanston, Illinois)
INVENTOR(S) Mark C. Hersam (Wilmette, Illinois);  Xiaolong Liu (Evanston, Illinois)
ABSTRACT Articles comprising a boron allotrope and an organic compound having a lateral interface one with the other, together with method(s) of preparation of such articles.
FILED Thursday, February 08, 2018
APPL NO 15/892124
ART UNIT 1761 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Non-metallic Elements; Compounds Thereof;
C01B 35/04 (20130101) Original (OR) Class

Indexing Scheme Relating to Structural and Physical Aspects of Solid Inorganic Compounds
C01P 2002/20 (20130101)
C01P 2002/60 (20130101)
C01P 2004/90 (20130101)
C01P 2006/40 (20130101)
C01P 2006/90 (20130101)

Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 16/04 (20130101)
C23C 16/22 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 51/0011 (20130101)
H01L 51/0053 (20130101)
H01L 51/0096 (20130101)
H01L 2251/301 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550008 MacDougall et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Surface Warfare Center (NSWC)
APPLICANT(S) The United States of America as represented by the Secretary of the Navy (Crane, Indiana)
ASSIGNEE(S) United States of American, as Represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Craig A MacDougall (Norco, California);  Dylan Switzer (Riverside, California);  Aaron Wiest (Norco, California)
ABSTRACT A low energy fluid purification system and method of implementation including some embodiments having a vacuum-rated first chamber placed in or near a body of water with higher temperature near the surface and lower temperatures at greater depths. The vacuum-rated first chamber holds a quantity of non-potable water and a low pressure area less than or equal to the water's vapor pressure. Vaporization occurs when the higher temperature surface water is brought into contact with the low pressure area. A tubular vapor transport passage allows the vaporized water to pass to a lower temperature and lower pressure condensation chamber. The lower temperature condensation chamber is cooled by lower temperature water from a selected depth below the surface. As the temperature of the vapor lowers, the vapor will condense. This condensation is collected as a quantity of potable water. Additional embodiments and methods are also provided.
FILED Saturday, May 07, 2016
APPL NO 15/149084
ART UNIT 1772 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Separation
B01D 3/106 (20130101)
B01D 5/0003 (20130101)
B01D 5/006 (20130101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/06 (20130101)
C02F 1/12 (20130101)
C02F 1/043 (20130101) Original (OR) Class
C02F 1/046 (20130101)
C02F 2103/08 (20130101)
C02F 2301/063 (20130101)
C02F 2307/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550070 Malkas et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) City of Hope (Duarte, California)
ASSIGNEE(S) CITY OF HOPE (Duarte, California)
INVENTOR(S) Linda H. Malkas (Duarte, California);  David Horne (Altadena, California);  Robert J. Hickey (Duarte, California);  Long Gu (Duarte, California)
ABSTRACT Described herein, inter alia, are compositions of PCNA modulators and methods for treating or preventing cancer.
FILED Friday, September 16, 2016
APPL NO 15/760959
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/167 (20130101)
A61K 31/4409 (20130101)
A61K 33/24 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)
A61P 35/02 (20180101)

Acyclic or Carbocyclic Compounds
C07C 233/76 (20130101) Original (OR) Class

Heterocyclic Compounds
C07D 213/68 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550145 Han et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Dongran Han (Brookline, Massachusetts);  Cameron Myhrvold (Cambridge, Massachusetts);  Peng Yin (Brookline, Massachusetts)
ABSTRACT The present disclosure relates to nanostructures assembled from nucleic acid consisting of a single strand of DNA rationally-designed to self-assemble into a hairpin loop, helical domains, and locking domains.
FILED Friday, March 04, 2016
APPL NO 15/556436
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 5/00 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 1/00 (20130101)
C07H 21/04 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/10 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 19/34 (20130101)

Enzymes
C12Y 207/00 (20130101)
C12Y 301/11003 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550271 Haddad et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) Government of the United States as Represented by the Secretary of the Air Force (Wright-Patterson AFB, Ohio)
ASSIGNEE(S) United States of America as represented by the Secretary of the Air Force (Wright Patterson AFB, Ohio)
INVENTOR(S) Timothy S. Haddad (Lancaster, California);  Joseph M. Mabry (Lancaster, California);  Sean Ramirez (Lancaster, California)
ABSTRACT A method of forming a hydrophobic and oleophobic surface. The method including spin coating an F-POSS with 3,3-dichloro-1,1,1,2,2,-pentafluoropropane/1,3-dichloro-1,1,2,2,3-pentafluoropropane onto an inert surface. The F-POSS has a structure: Each Rf represents a nonreactive, fluorinated organic group, R1 represents a first monovalent organic group comprising at least two carbon atoms, and R2 represents hydrogen or a second monovalent organic group comprising at least two carbon atoms. The F-POSS with 3,3-dichloro-1,1,1,2,2,-pentafluoropropane/1,3-dichloro-1,1,2,2,3-pentafluoropropane are then dried on the inert surface.
FILED Tuesday, September 19, 2017
APPL NO 15/708382
ART UNIT 1767 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Processes for Applying Fluent Materials to Surfaces, in General
B05D 5/083 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 7/21 (20130101)

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 77/045 (20130101)

Use of Inorganic or Non-macromolecular Organic Substances as Compounding Ingredients
C08K 5/549 (20130101)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 5/1662 (20130101) Original (OR) Class
C09D 7/63 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550272 Aizenberg et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Joanna Aizenberg (Boston, Massachusetts);  Benjamin Hatton (Toronto, Canada);  Donald Ingber (Boston, Massachusetts);  Michael Super (Lexington, Massachusetts);  Tak Sing Wong (State College, Pennsylvania)
ABSTRACT A self-healing, scratch resistant slippery surface that is manufactured by wicking a chemically-inert, high-density liquid coating over a roughened solid surface featuring micro and nanoscale topographies is described. Such a slippery surface shows anti-wetting properties, as well as exhibits significant reduction of adhesion of a broad range of biological materials, including particles in suspension or solution. Specifically, the slippery surfaces can be applied to medical devices and equipment to effectively repel biological materials such as blood, and prevent, reduce, or delay coagulation and surface-mediated clot formation. Moreover, the slippery surfaces can be used to prevent fouling by microorganisms such as bacteria.
FILED Tuesday, April 03, 2018
APPL NO 15/944619
ART UNIT 1767 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 15/24 (20130101)
A61L 15/24 (20130101)
A61L 15/34 (20130101)
A61L 15/42 (20130101)
A61L 15/46 (20130101)
A61L 27/28 (20130101)
A61L 27/34 (20130101)
A61L 27/34 (20130101)
A61L 27/50 (20130101)
A61L 33/064 (20130101)
A61L 33/064 (20130101)
A61L 33/0094 (20130101)
A61L 2400/12 (20130101)

Processes for Applying Fluent Materials to Surfaces, in General
B05D 5/083 (20130101)

Compositions of Macromolecular Compounds
C08L 27/12 (20130101)
C08L 27/12 (20130101)
C08L 27/12 (20130101)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 5/1656 (20130101)
C09D 5/1681 (20130101)
C09D 5/1693 (20130101) Original (OR) Class

Fluid Dynamics, i.e Methods or Means for Influencing the Flow of Gases or Liquids
F15D 1/02 (20130101)
F15D 1/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550303 Trice et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
APPLICANT(S) Purdue Research Foundation (West Lafayette, Indiana)
ASSIGNEE(S) Purdue Research Foundation (West Lafayette, Indiana)
INVENTOR(S) Rodney Trice (West Lafayette, Indiana);  Winnie Tan (West Lafayette, Indiana)
ABSTRACT A hypersonic refractory material, including a refractory leading edge portion for a hypersonic vehicle and a high emissivity oxide coating adhered to the refractory leading edge portion. The high emissivity oxide coating is ZrB2 doped with a cation dopant material selected from the group including Sm, Tm, and mixtures thereof. The cation dopant material is present in a concentration of between 3 mole percent and 8 mole percent.
FILED Monday, June 26, 2017
APPL NO 15/632506
ART UNIT 1731 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Aeroplanes; Helicopters
B64C 30/00 (20130101)

Lime, Magnesia; Slag; Cements; Compositions Thereof, e.g Mortars, Concrete or Like Building Materials; Artificial Stone; Ceramics; Refractories; Treatment of Natural Stone
C04B 35/58078 (20130101)
C04B 35/62222 (20130101)
C04B 2235/443 (20130101)
C04B 2235/3224 (20130101)
C04B 2235/3813 (20130101)
C04B 2235/3826 (20130101)
C04B 2235/9607 (20130101)

Materials for Miscellaneous Applications, Not Provided for Elsewhere
C09K 5/14 (20130101) Original (OR) Class

Details of Heat-exchange and Heat-transfer Apparatus, of General Application
F28F 19/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550330 Yelvington et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) Mainstream Engineering Corporation (Rockledge, Florida)
ASSIGNEE(S) Mainstream Engineering Corporation (Rockledge, Florida)
INVENTOR(S) Paul E. Yelvington (Rockledge, Florida);  Dustin J. Zastrow (Wausau, Wisconsin);  Nicholas R. Schwartz (Rockledge, Florida)
ABSTRACT An apparatus and method are described for high-yield fast pyrolysis of biomass feedstock to produce a liquid bio-oil product. A bubbling fluidized bed reactor is provided having an integrated, rapid quench apparatus for minimizing secondary cracking reactions that can otherwise lower the yield of bio-oil. A quench stream is provided inside the reactor to minimize the residence time that the product vapors spend at high temperature where cracking can occur. The quench stream is introduced downstream of the fluidized bed but still internal to the reactor. The fluidized bed medium is constrained to the bottom of the reactor and is not cooled by the quench stream.
FILED Tuesday, October 24, 2017
APPL NO 15/791916
ART UNIT 1771 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 8/24 (20130101)

Cracking Hydrocarbon Oils; Production of Liquid Hydrocarbon Mixtures, e.g by Destructive Hydrogenation, Oligomerisation, Polymerisation; Recovery of Hydrocarbon Oils From Oil-shale, Oil-sand, or Gases; Refining Mixtures Mainly Consisting of Hydrocarbons; Reforming of Naphtha; Mineral Waxes
C10G 1/08 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550343 Patel
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Corps of Engineers (USACE)
Engineer Research and Development Center (ERDC)
Construction Engineering Research Laboratory (CERL)
Department of Energy (DOE)
Office of Fossil Energy and Carbon Management (FECM)
APPLICANT(S) Nikhil Manubhai Patel (Grand Forks, North Dakota)
ASSIGNEE(S) Nikhil Manubhai Patel (Grand Forks, North Dakota)
INVENTOR(S) Nikhil Manubhai Patel (Grand Forks, North Dakota)
ABSTRACT The present invention discloses a gasifier and/or a gasification process that provides a long, uniform temperature zone in the gasifier, regardless of the particle size, chemical composition, and moisture content of the fuel by sandwiching a reduction zones between two oxidation zones. The gasifier and/or gasification process has a char that is more energy-dense and almost devoid of moisture that affords for an additional (or char) oxidation zone with a temperature that is higher than a first oxidation zone which is closer to a evaporation and devolatilization zone. As such, the additional (or char) oxidation zone contributes to augmenting the reduction zone temperature, thereby providing a favorable dual impact in improving syngas composition and near-complete conversion of the tar.
FILED Monday, May 28, 2018
APPL NO 15/990725
ART UNIT 1725 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Production of Producer Gas, Water-gas, Synthesis Gas From Solid Carbonaceous Material, or Mixtures Containing These Gases; Carburetting Air or Other Gases
C10J 3/08 (20130101) Original (OR) Class
C10J 3/22 (20130101)
C10J 3/26 (20130101)
C10J 3/723 (20130101)
C10J 2300/092 (20130101)
C10J 2300/093 (20130101)
C10J 2300/0946 (20130101)
C10J 2300/0956 (20130101)
C10J 2300/0959 (20130101)
C10J 2300/0976 (20130101)
C10J 2300/1246 (20130101)

Purifying or Modifying the Chemical Composition of Combustible Gases Containing Carbon Monoxide
C10K 1/024 (20130101)
C10K 1/026 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550388 Monje-Deisseroth et al.
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
INVENTOR(S) Michelle Monje-Deisseroth (Stanford, California);  Elizabeth Qin (Palo Alto, California)
ABSTRACT Compositions and methods for treatment of glioma are disclosed. In particular, the invention relates to methods of treating glioma by inhibiting pleiotrophin signaling to limit high-grade glioma invasion.
FILED Wednesday, August 15, 2018
APPL NO 15/998437
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 9/0085 (20130101)
A61K 31/713 (20130101)
A61K 31/4439 (20130101)
A61K 31/5377 (20130101)
A61K 31/7105 (20130101)
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101) Original (OR) Class
C12N 2310/11 (20130101)
C12N 2310/14 (20130101)
C12N 2310/14 (20130101)
C12N 2310/122 (20130101)
C12N 2310/141 (20130101)
C12N 2310/531 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550392 Eberly
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) Jed O. Eberly (Vicksburg, Mississippi)
ASSIGNEE(S) UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (Alexandria, Virginia)
INVENTOR(S) Jed O. Eberly (Vicksburg, Mississippi)
ABSTRACT The present invention provides synthetic DNA aptamers that bind a target explosive to allow detection of that explosive. In various embodiments, the synthetic DNA aptamers may include one or more aptamers selected from the group consisting of SEQ ID 1-6. The various synthetic DNA aptamers are sensitive to different explosives. The synthetic DNA aptamers provide an inexpensive, in situ means for testing for explosive, which may be used for both soil and water samples. This testing may include an assay method using the synthetic DNA aptamers or a biosensor linked to the synthetic DNA aptamers.
FILED Thursday, September 22, 2016
APPL NO 15/273592
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/115 (20130101) Original (OR) Class
C12N 2310/16 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6825 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/227 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550423 Gray
FUNDED BY
Department of Defense (DOD)
Defense Threat Reduction Agency (DTRA)
APPLICANT(S) IBIS BIOSCIENCES, INC. (Carlsbad, California)
ASSIGNEE(S) IBIS BIOSCIENCES, INC. (Carlsbad, California)
INVENTOR(S) Phillip N. Gray (Carlsbad, California)
ABSTRACT Provided herein is technology relating to depositing and/or placing a macromolecule at a desired site for an assay and particularly, but not exclusively, to methods and systems for transporting a macromolecule such as a protein, a nucleic acid, or a protein:nucleic acid complex to an assay site, such as the bottom of a nanopore, a nanowell, or a zero mode waveguide.
FILED Monday, October 30, 2017
APPL NO 15/797982
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6806 (20130101) Original (OR) Class
C12Q 1/6869 (20130101)
C12Q 1/6869 (20130101)
C12Q 2521/543 (20130101)
C12Q 2522/101 (20130101)
C12Q 2565/631 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550431 Rahme et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) THE GENERAL HOSPITAL CORPORATION (Boston, Massachusetts)
ASSIGNEE(S) THE GENERAL HOSPITAL CORPORATION (Boston, Massachusetts)
INVENTOR(S) Laurence Rahme (Brookline, Massachusetts);  Shuangchun Yan (Cambridge, Massachusetts);  Yok-Ai Que (Pully, Switzerland);  Amy Tsurumi (Boston, Massachusetts)
ABSTRACT The technology described herein is directed to the diagnosis, prognosis, and treatment of infection, e.g. after burn injury.
FILED Thursday, November 13, 2014
APPL NO 15/027067
ART UNIT 1646 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6883 (20130101) Original (OR) Class
C12Q 2600/106 (20130101)
C12Q 2600/156 (20130101)
C12Q 2600/158 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6893 (20130101)
G01N 2800/26 (20130101)
G01N 2800/52 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550494 Savoy et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Steve M. Savoy (Austin, Texas);  Daniel R. Mitchell (Austin, Texas);  Jeremy J. John (Austin, Texas);  George L. Murphy (Austin, Texas)
ASSIGNEE(S) NANOHMICS, INC. (Austin, Texas)
INVENTOR(S) Steve M. Savoy (Austin, Texas);  Daniel R. Mitchell (Austin, Texas);  Jeremy J. John (Austin, Texas);  George L. Murphy (Austin, Texas)
ABSTRACT Analyte filter arrays and methods for making an analyte filter array are provided. The arrays are formed using a dispersion of filter particles having selected moieties attached to the surface of the particles and a microarray having complementary moieties formed in an array on a substrate, such that each filter particle is attached to a selected region of the microarray. The moiety on the substrate may be RNA or DNA or other molecule. The substrate may be a surface of a detector array, a membrane that may be placed in registration with the detector array or a stamp used to transfer the filter array to a detector array.
FILED Monday, October 23, 2017
APPL NO 15/791403
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 19/0046 (20130101)
B01J 2219/00382 (20130101)
B01J 2219/00576 (20130101)
B01J 2219/00637 (20130101)
B01J 2219/00648 (20130101)
B01J 2219/00722 (20130101)

Combinatorial Chemistry; Libraries, e.g Chemical Libraries
C40B 50/18 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550708 Paulino et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Research Laboratory (AFRL)
APPLICANT(S) United Technologies Corporation (Farmington, Connecticut)
ASSIGNEE(S) United Technologies Corporation (Farmington, Connecticut)
INVENTOR(S) Jose R. Paulino (Saco, Maine);  Conway Chuong (Manchester, Connecticut);  Joey Wong (Enfield, Connecticut);  Christopher J. Peters (West Hartford, Connecticut);  Ross Wilson (South Glastonbury, Connecticut)
ABSTRACT Aspects of the disclosure are directed to a floating, non-contact seal comprising: a shoe, and at least three beams, each beam having a first axial end and a second axial end, where the first axial ends are coupled to the shoe and the second axial ends are coupled to a ring structure. Aspects of the disclosure are directed to an engine comprising: a first structure, a second structure configured to rotate relative to the first structure, and a floating, non-contact seal that interfaces the first structure and the second structure, where the seal includes: a shoe, and at least three beams, where each beam has a first axial end and a second axial end, where the first axial ends are coupled to the shoe and the second axial ends are coupled to a ring structure.
FILED Wednesday, August 31, 2016
APPL NO 15/252942
ART UNIT 3745 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 5/02 (20130101)
F01D 11/025 (20130101) Original (OR) Class
F01D 25/24 (20130101)

Non-positive-displacement Pumps
F04D 29/053 (20130101)
F04D 29/083 (20130101)
F04D 29/321 (20130101)
F04D 29/522 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2220/32 (20130101)
F05D 2240/60 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550860 Perkins et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Boston Dynamics, Inc. (Waltham, Massachusetts)
ASSIGNEE(S) Boston Dynamics, Inc. (Waltham, Massachusetts)
INVENTOR(S) Alexander Douglas Perkins (Arlington, Massachusetts);  Kevin Blankespoor (Arlington, Massachusetts);  Alfred Anthony Rizzi (Waltham, Massachusetts)
ABSTRACT In some applications, a piston of a hydraulic actuator may move at high speeds, and large undesired forces may be generated if the piston reaches an end-stop of the hydraulic actuator at a high speed. The undesired forces may, for example, cause mechanical damage in the hydraulic actuator. A controller may receive information indicative of the piston reaching a first position at a first threshold distance from the end-stop, and, in response, may modify a signal to a valve assembly controlling flow of hydraulic fluid to and from the hydraulic actuator. Further, the controller may receive information indicative of the piston reaching a second position at a second threshold distance closer to the end-stop of the hydraulic actuator, and, in response, the controller may further modify the signal to the valve assembly so as to apply a force on the piston in a away from the end-stop.
FILED Friday, December 09, 2016
APPL NO 15/373626
ART UNIT 3745 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Systems Acting by Means of Fluids in General; Fluid-pressure Actuators, e.g Servomotors; Details of Fluid-pressure Systems, Not Otherwise Provided for
F15B 9/09 (20130101)
F15B 11/048 (20130101)
F15B 13/021 (20130101) Original (OR) Class
F15B 15/28 (20130101)
F15B 15/2815 (20130101)
F15B 21/08 (20130101)
F15B 2211/665 (20130101)
F15B 2211/755 (20130101)
F15B 2211/6336 (20130101)
F15B 2211/6654 (20130101)
F15B 2211/6656 (20130101)
F15B 2211/6658 (20130101)
F15B 2211/7053 (20130101)
F15B 2211/7653 (20130101)
F15B 2211/8606 (20130101)
F15B 2211/30575 (20130101)

Control or Regulating Systems in General; Functional Elements of Such Systems; Monitoring or Testing Arrangements for Such Systems or Elements
G05B 19/042 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551131 Lockwood et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
Air Force Life Cycle Management Center (AFLCMC)
APPLICANT(S) Hamilton Sundstrand Corporation (Charlotte, North Carolina)
ASSIGNEE(S) Hamilton Sundstrand Corporation (Windsor Locks, Connecticut)
INVENTOR(S) William T. Lockwood (Windsor Locks, Connecticut);  Matthew William Miller (Enfield, Connecticut);  Luke J. Mayo (Coventry, Connecticut)
ABSTRACT A method for manufacturing a heat exchanger includes stacking a plurality of parting sheets, a plurality of lengthwise closure bars, and a plurality of widthwise closure bars to form a rectangular first heat exchanger section. The first heat exchanger section includes at least one widthwise passage extending between a pair of the widthwise closure bars and at least one lengthwise passage extending between a pair of the lengthwise closure bars. The method also includes brazing the rectangular first heat exchanger section together and cutting a first side and a second side of the rectangular first heat exchanger section to give the first heat exchanger section a tapered-trapezoid profile. The method further includes brazing an end of a second heat exchanger section to the first or second side of the first heat exchanger section.
FILED Monday, January 08, 2018
APPL NO 15/864760
ART UNIT 3763 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Soldering or Unsoldering; Welding; Cladding or Plating by Soldering or Welding; Cutting by Applying Heat Locally, e.g Flame Cutting; Working by Laser Beam
B23K 1/0012 (20130101)

Heat-exchange Apparatus, Not Provided for in Another Subclass, in Which the Heat-exchange Media Do Not Come into Direct Contact
F28D 1/0246 (20130101)
F28D 1/05366 (20130101)
F28D 7/005 (20130101)
F28D 9/0025 (20130101)
F28D 9/0062 (20130101)
F28D 2021/0021 (20130101)

Details of Heat-exchange and Heat-transfer Apparatus, of General Application
F28F 3/025 (20130101) Original (OR) Class
F28F 9/26 (20130101)
F28F 2210/10 (20130101)
F28F 2240/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551162 Floyd et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
APPLICANT(S) North Carolina State University (Raleigh, North Carolina)
ASSIGNEE(S) NORTH CAROLINA STATE UNIVERSITY (Raleigh, North Carolina)
INVENTOR(S) Brian Floyd (Raleigh, North Carolina);  Vikas Chauhan (Raleigh, North Carolina);  Kevin Greene (Raleigh, North Carolina)
ABSTRACT Embodiments of a code modulated phased-array interferometer are described. In one embodiment, a code modulated phased-array interferometer includes a phased array having a plurality of receiver elements that receive a plurality of received signals. A code multiplexer multiplexes each of the plurality of received signals to generate a plurality of code multiplexed signals, and a combiner combines the plurality of code multiplexed signals into a combined signal. After other processing for signal reception, a code demultiplexer demultiplexes the combined baseband signal, and a complex correlator correlates unique pairs of baseband signals to generate a plurality of visibility products. Finally, the plurality of visibility products are transformed to generate an image. The concepts described herein may be relied upon to reconfigure or repurpose a phased-array receiver to achieve imaging.
FILED Friday, May 06, 2016
APPL NO 15/570096
ART UNIT 2886 — Optics
CURRENT CPC
Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 9/02041 (20130101)
G01B 9/02084 (20130101) Original (OR) Class

Measuring Temperature; Measuring Quantity of Heat; Thermally-sensitive Elements Not Otherwise Provided for
G01K 11/006 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 22/00 (20130101)

Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 13/003 (20130101)
G01S 13/90 (20130101)

Antennas, i.e Radio Aerials
H01Q 3/36 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551196 Wu et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Air Systems Command (NAVAIR)
APPLICANT(S) Raytheon Company (Waltham, Massachusetts)
ASSIGNEE(S) Raytheon Company (Waltham, Massachusetts)
INVENTOR(S) Shuwu Wu (Yorba Linda, California);  Ji Li (Broomfield, Colorado);  Tyler Thomas (Fullerton, California);  Howard E. Wan (Diamond Bar, California)
ABSTRACT Technology for correcting a misalignment between an inertial measurement unit (IMU) and a moving platform is described. A first attitude of the moving platform can be identified based on a truth source. A second attitude of the moving platform can be calculated using IMU measurements. A delta attitude can be calculated from a difference between the first attitude and the second attitude. Natural error can be removed from the delta attitude to produce an angular misalignment value between axes of the IMU and axes of the moving platform. A total misalignment value can be determined by adding the angular misalignment value to a baseline misalignment value. The IMU can incorporate the total misalignment value for subsequent attitude measurements of the moving platform in order to produce substantially accurate attitude measurements of the moving platform when the axes of the IMU are misaligned with the axes of the moving platform.
FILED Thursday, April 30, 2015
APPL NO 14/701254
ART UNIT 2895 — Semiconductors/Memory
CURRENT CPC
Measuring Distances, Levels or Bearings; Surveying; Navigation; Gyroscopic Instruments; Photogrammetry or Videogrammetry
G01C 21/165 (20130101) Original (OR) Class

Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 19/41 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551283 Ghosh et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Strategic Environmental Research and Development Program (SERDP)
APPLICANT(S) University of Maryland, Baltimore County (Baltimore, Maryland)
ASSIGNEE(S) UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (Baltimore, Maryland)
INVENTOR(S) Upal Ghosh (Ellicott City, Maryland);  Mehregan Jalalizadeh (Huntington Beach, California)
ABSTRACT A vibrating platform for the deploying of passive sampling devices in sediments and other media to be sampled. The vibrating platform can greatly enhance the rate of mass transfer of analytes, such as polycyclic aromatic hydrocarbons and polychlorinated biphenyls, into passive sampler material by disrupting the formation of a depletion layer in proximity of the passive sampler material.
FILED Thursday, September 28, 2017
APPL NO 15/718119
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/10 (20130101) Original (OR) Class
G01N 1/4055 (20130101)
G01N 33/1826 (20130101)
G01N 2001/1025 (20130101)
G01N 2001/4061 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551319 Cao et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Princeton University (Princeton, New Jersey)
ASSIGNEE(S) Princeton University (Princeton, New Jersey)
INVENTOR(S) Han Cao (San Diego, California);  Jonas O. Tegenfeldt (Lund, Sweden);  Stephen Chou (Princeton, New Jersey);  Robert H. Austin (Princeton, New Jersey)
ABSTRACT A fluidic chip includes at least one nanochannel array, the nanochannel array including a surface having a nanofluidic area formed in the material of the surface; a microfluidic area on said surface; a gradient interface area having a gradual elevation of height linking the microfluidic area and the nanofluidic area; and a sample reservoir capable of receiving a fluid in fluid communication with the microfluidic area. In another embodiment, a fluidic chip includes at least one nanochannel array, the nanochannel array includes a surface having a nanofluidic area formed in the material of the surface; a microfluidic area on said surface; and a gradient interface area linking the microfluidic area and the nanofluidic area, where the gradient interface area comprises a plurality of gradient structures, and the lateral spacing distance between said gradient structures decreases towards said nanofluidic area; and a sample reservoir capable of receiving a fluid in fluid communication with the microfluidic area.
FILED Monday, July 31, 2017
APPL NO 15/664196
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/502707 (20130101)
B01L 3/502715 (20130101)
B01L 3/502746 (20130101)
B01L 3/502761 (20130101)
B01L 2200/12 (20130101)
B01L 2200/027 (20130101)
B01L 2200/0663 (20130101)
B01L 2300/0654 (20130101)
B01L 2300/0896 (20130101)
B01L 2400/086 (20130101)
B01L 2400/0415 (20130101)

Microstructural Devices or Systems, e.g Micromechanical Devices
B81B 2201/058 (20130101)

Processes or Apparatus Specially Adapted for the Manufacture or Treatment of Microstructural Devices or Systems
B81C 1/00119 (20130101)
B81C 2201/0157 (20130101)
B81C 2201/0159 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/6486 (20130101) Original (OR) Class
G01N 33/48721 (20130101)

Photomechanical Production of Textured or Patterned Surfaces, e.g for Printing, for Processing of Semiconductor Devices; Materials Therefor; Originals Therefor; Apparatus Specially Adapted Therefor;
G03F 7/2008 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 436/143333 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551330 Atre et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California);  STICHTING VOOR FUNDAMENTEEL ONDERZOEK DER MATERIE (Utrecht, Netherlands);  Ashwin C. Atre (Stanford, California);  Jennifer A. Dionne (Stanford, California);  Benjamin Brenny (Utrecht, Netherlands);  Toon Coenen (Utrecht, Netherlands);  Albert Polman (Utrecht, Netherlands)
ASSIGNEE(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California);  STICHTING VOOR FUNDAMENTEEL ONDERZOEK DER MATERIE (Utrecht, Netherlands)
INVENTOR(S) Ashwin C. Atre (Stanford, California);  Jennifer A. Dionne (Stanford, California);  Benjamin Brenny (Utrecht, Netherlands);  Toon Coenen (Utrecht, Netherlands);  Albert Polman (Utrecht, Netherlands)
ABSTRACT In one aspect, a cathodoluminescence (CL) spectroscopic tomography device includes a sample stage to support a sample. An electron beam source scans an electron beam over the sample to yield light emission by the sample. A reflective element directs the light emission by the sample to a light detector. A controller controls operation of the sample stage, the electron beam source, and the light detector. In one aspect, a CL spectroscopic tomography device includes an electron beam source which directs an electron beam at an object to yield an emission by the object. A detector detects the emission. A controller receives information from the detector related to the detected emission. The controller derives a two-dimensional (2D) CL map from the information related to the detected emission, and derives a three-dimensional (3D) CL tomogram from the 2D CL map.
FILED Wednesday, April 22, 2015
APPL NO 15/305329
ART UNIT 2881 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/00 (20130101)
A61B 5/0073 (20130101)
A61B 5/0075 (20130101)

Measurement of Intensity, Velocity, Spectral Content, Polarisation, Phase or Pulse Characteristics of Infra-Red, Visible or Ultra-violet Light; Colorimetry; Radiation Pyrometry
G01J 3/44 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 23/2254 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551338 Potyrailo et al.
FUNDED BY
Department of Defense (DOD)
APPLICANT(S) GENERAL ELECTRIC COMPANY (Schenectady, New York)
ASSIGNEE(S) GENERAL ELECTRIC COMPANY (Schenectady, New York)
INVENTOR(S) Radislav Alexandrovich Potyrailo (Niskayuna, New York);  Zhexiong Tang (Niskayuna, New York);  Igor Tokarev (Waterford, New York);  Binil Itty Ipe Kandapallil (Summerville, South Carolina)
ABSTRACT The subject matter of the present disclosure generally relates to systems and methods for sensing analytes with a high selectivity and low responses to interferences in an environment. In one embodiment, a sensor was developed which comprises a sensor electrode, a coupling element operationally coupled to a discrete segment of the sensor electrode, and an activation material in operational contact with the coupling element and configured to induce an irreversible sensor response for a selected sensing application.
FILED Thursday, September 29, 2016
APPL NO 15/280028
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/221 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551368 McNeil et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Michigan)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Michigan)
INVENTOR(S) Anne J. McNeil (Dexter, Michigan);  Kelsey N. Carter (Ann Arbor, Michigan)
ABSTRACT A method and kit for detecting the presence of lead in a solid sample is disclosed. The solid sample is brought into contact with a nonaqueous solution of a dithiocarbamate capable of forming a gel upon contact with lead, with the formation of a gel showing that lead is present in the solid sample.
FILED Friday, May 01, 2015
APPL NO 15/307021
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 31/22 (20130101)
G01N 33/20 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551423 Siddiqui et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) U.S. Government as Represented by the Secretary of the Army (Picatinny Arsenal, Dover, New Jersey)
ASSIGNEE(S) The United States of America as Represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Jeffrey Siddiqui (Sacramento, California);  Kevin Geoghegan (Roseville, California);  Tom Shepherd (Roseville, California)
ABSTRACT The present invention relates to a system and method for the simultaneous testing of radiation, environmental and electrical reliability of multiple semiconductor devices. The system provides a simultaneous simulation of the space environment in which a device under test (DUT) is expected to operate under thereby providing an accurate test environment. One or more DUTs are simultaneously subject to each of a radiating dose, electrical bias and varying temperature. Additionally, each of the above may be varied over a range of values to provide test data under multiple testing conditions. Finally, a method for operating the system is provided which ensures reliable and high fidelity data from the system. The system comprises seven (7) interconnected subsystems, an electrical environmental subsystem, a radiation subsystem, an environmental control system, a radiation source control system, a temperature monitoring subsystem, an electrical stimulation and data acquisition subsystem and a data processing and analysis subsystem.
FILED Wednesday, January 13, 2016
APPL NO 14/994700
ART UNIT 2866 — Printing/Measuring and Testing
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 31/003 (20130101) Original (OR) Class
G01R 31/265 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551427 Beck
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) U.S. Army Research Laboratory ATTN: RDRL-LOC-I (Adelphi, Maryland)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) William A. Beck (Woodbine, Maryland)
ABSTRACT A method for determining a two-dimensional spectrum of a specified carrier having a specified mobility and density in a material of an electronic device, the method including performing a magnetic field-dependent Hall measurement on the material of the electronic device; determining, using the magnetic field-dependent Hall measurement, a probability density function of a conductance of the material of the electronic device, wherein the probability density function describes a spectrum of a plurality of m-carriers, wherein the plurality of m-carriers includes the specified carrier having the specified mobility and density; and determining an electrical transport of a plurality of electrons and holes inside the material of the electronic device by observing a variation of the probability density function with any of the specified mobility and density of the specified carrier.
FILED Tuesday, February 14, 2017
APPL NO 15/431941
ART UNIT 2862 — Printing/Measuring and Testing
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 31/2648 (20130101) Original (OR) Class
G01R 33/07 (20130101)
G01R 33/1253 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551583 Stone
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
APPLICANT(S) Wavefront Research, Inc. (Bethlehem, Pennsylvania)
ASSIGNEE(S) Wavefront Research, Inc. (Northampton, Pennsylvania)
INVENTOR(S) Thomas W. Stone (Hellertown, Pennsylvania)
ABSTRACT Methods and systems for optical interconnection.
FILED Monday, May 07, 2018
APPL NO 15/972897
ART UNIT 2874 — Optics
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/06 (20130101)
G02B 6/423 (20130101)
G02B 6/4249 (20130101)
G02B 6/4292 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551719 Kim et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) Government of the United States, as represented by the Secretary of the Air Force (Wright-Patterson AFB, Ohio)
ASSIGNEE(S) United States of America as represented by the Secretary of the Air Force (Wright-Patterson AFB, Ohio)
INVENTOR(S) Richard S Kim (Mason, Ohio);  Attila A Szep (Bellbrook, Ohio);  Michael L Fanto (Rome, New York);  Paul M Alsing (Chittenango, New York);  Gordon E Lott (Beavercreek, Ohio);  Christopher C Tison (Boynton Beach, Florida)
ABSTRACT An electro-optical directional coupler is provided having a substrate and a first and second optical waveguide formed on the substrate, where the second waveguide extends adjacent to and parallel with the first waveguide for at least one interaction length. The interaction length has a first end and a second end such that an optical signal applied only to one of the first and second waveguides couples to the other of the first and second waveguides between the ends. A first electrode is proximate the first and second waveguides and between the ends of the interaction length. A first voltage applied to the first electrode independently tunes a coupling of a TE mode. A second electrode located proximate the first and second waveguides and the first electrode and between the ends of the interaction length. A second voltage applied to the second electrode independently tunes a coupling of a TM mode.
FILED Monday, February 13, 2017
APPL NO 15/430775
ART UNIT 2872 — Optics
CURRENT CPC
Devices or Arrangements, the Optical Operation of Which Is Modified by Changing the Optical Properties of the Medium of the Devices or Arrangements for the Control of the Intensity, Colour, Phase, Polarisation or Direction of Light, e.g Switching, Gating, Modulating or Demodulating; Techniques or Procedures for the Operation Thereof; Frequency-changing; Non-linear Optics; Optical Logic Elements; Optical Analogue/digital Converters
G02F 1/0136 (20130101)
G02F 1/3133 (20130101)
G02F 3/00 (20130101) Original (OR) Class
G02F 2201/12 (20130101)
G02F 2202/20 (20130101)

Computer Systems Based on Specific Computational Models
G06N 10/00 (20190101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551919 Keesling
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) Applied Invention, LLC (Burbank, California)
ASSIGNEE(S) Applied Invention, LLC (Burbank, California)
INVENTOR(S) Michael Keesling (Agoura Hills, California)
ABSTRACT Various embodiments relate to apparatuses and methods of using light transmission thought compressed living tissue to detect force. Transmission of light through living tissue such as a finger is affected by how much the tissue is compressed, for example by the finger being pressing on a surface. Light is introduced into the tissue, passes through the tissue, and a sensor receives the light exiting the tissue. The compression of the tissue can be determined using various characteristics of the received light, such as the light intensity, as determined based at least partly on sensor readings.
FILED Monday, May 20, 2019
APPL NO 16/417503
ART UNIT 2623 — Selective Visual Display Systems
CURRENT CPC
Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 11/16 (20130101)

Electric Digital Data Processing
G06F 3/014 (20130101) Original (OR) Class
G06F 3/017 (20130101)
G06F 3/0304 (20130101)
G06F 3/0325 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10552250 Biran et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) Giora Biran (Zichron-Yaakov, Israel);  Pradip Bose (Yorktown Heights, New York);  Alper Buyuktosunoglu (White Plains, New York);  Pierce I-Jen Chuang (Briarcliff Manor, New York);  Preetham M. Lobo (Bangalore, India);  Ramon Bertran Monfort (New York, New York);  Phillip John Restle (Katonah, New York);  Christos Vezyrtzis (New Rochelle, New York);  Tobias Webel (Schwaebisch Gmuend, Germany)
ABSTRACT Techniques facilitating voltage droop reduction and/or mitigation in a processor core are provided. In one example, a system can comprise a memory that stores, and a processor that executes, computer executable components. The computer executable components can comprise an observation component that detects one or more events at a first stage of a processor pipeline. An event of the one or more events can be a defined event determined to increase a level of power consumed during a second stage of the processor pipeline. The computer executable components can also comprise an instruction component that applies a voltage droop mitigation countermeasure prior to the increase of the level of power consumed during the second stage of the processor pipeline and a feedback component that provides a notification to the instruction component that indicates a success or a failure of a result of the voltage droop mitigation countermeasure.
FILED Tuesday, October 10, 2017
APPL NO 15/729242
ART UNIT 2113 — Computer Error Control, Reliability, & Control Systems
CURRENT CPC
Electric Digital Data Processing
G06F 1/28 (20130101)
G06F 1/305 (20130101)
G06F 1/324 (20130101)
G06F 11/0721 (20130101)
G06F 11/0793 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10552278 Jenkins et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) Keith A. Jenkins (Sleepy Hollow, New York);  Barry P. Linder (Hastings-on-Hudson, New York);  Emily A. Ray (Hastings on Hudson, New York);  Raphael P. Robertazzi (Ossining, New York);  Peilin Song (Lagrangeville, New York);  James H. Stathis (Poughquag, New York);  Kevin G. Stawiasz (Bethel, Connecticut);  Franco Stellari (Waldwick, New Jersey);  Alan J. Weger (Mohegan Lake, New York);  Emmanuel Yashchin (Yorktown Heights, New York)
ABSTRACT A method and system are provided for chip testing. The method includes selectively deploying a chip for future use or discarding the chip to prevent the future use, responsive to a stress history of the chip determined using a non-destructive test procedure. The test procedure includes ordering each of a plurality of functional patterns by a respective minimum operating period corresponding thereto. The test procedure further includes ranking each of the plurality of patterns based on at least one preceding available pattern to provide a plurality of pattern ranks. The test procedure also includes calculating a sum by summing the plurality of pattern ranks. The sum calculated during an initial performance of the test procedure is designated as a baseline, and the sum calculated during a subsequent performance of the test procedure is compared to a threshold derived from the baseline to determine the stress history of the chip.
FILED Friday, July 13, 2018
APPL NO 16/035032
ART UNIT 2113 — Computer Error Control, Reliability, & Control Systems
CURRENT CPC
Electric Digital Data Processing
G06F 11/008 (20130101)
G06F 11/24 (20130101)
G06F 11/263 (20130101)
G06F 11/2236 (20130101) Original (OR) Class
G06F 11/2273 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10552461 Katz et al.
FUNDED BY
Department of Defense (DOD)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Edward G. Katz (Washington, District of Columbia);  Kristen M. Summers (Takoma Park, Maryland)
ABSTRACT A method, system and a computer program product are provided for scoring candidate answers for geographic relevance by identifying document location information that is associated with a document, associating each token in the document with the document location information, and then comparing geographic foci identified for a candidate answer from the tokens with geographic foci identified for an input question to generate a geographic relevance score for the candidate answer to the input question.
FILED Friday, September 16, 2016
APPL NO 15/267568
ART UNIT 2153 — Data Bases & File Management
CURRENT CPC
Electric Digital Data Processing
G06F 16/29 (20190101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10552740 Alpert et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) Charles J. Alpert (Austin, Texas);  Pallab Datta (San Jose, California);  Myron D. Flickner (San Jose, California);  Zhuo Li (Cedar Park, Texas);  Dharmendra S. Modha (San Jose, California);  Gi-Joon Nam (Austin, Texas)
ABSTRACT Embodiments of the present invention relate to providing fault-tolerant power minimization in a multi-core neurosynaptic network. In one embodiment of the present invention, a method of and computer program product for fault-tolerant power-driven synthesis is provided. Power consumption of a neurosynaptic network is modeled as wire length. The neurosynaptic network comprises a plurality of neurosynaptic cores connected by a plurality of routers. At least one faulty core of the plurality of neurosynaptic cores is located. A placement blockage is modeled at the location of the at least one faulty core. A placement of the neurosynaptic cores is determined by minimizing the wire length.
FILED Monday, November 10, 2014
APPL NO 14/537844
ART UNIT 2129 — AI & Simulation/Modeling
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 3/10 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10552749 Riabov et al.
FUNDED BY
Department of Defense (DOD)
National Security Agency (NSA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Anton Viktorovich Riabov (Ann Arbor, Michigan);  Shirin Sohrabi Araghi (Port Chester, New York);  Octavian Udrea (Ossining, New York)
ABSTRACT A mechanism is provided for computing a solution to a plan recognition problem. The plan recognition problem includes the model and a partially ordered sequence of observations or traces. The plan recognition is transformed into an AI planning problem such that a planner can be used to compute a solution to it. The approach is general. It addresses unreliable observations: missing observations, noisy observations (or observations that need to be discarded), and ambiguous observations). The approach does not require plan libraries or a possible set of goals. A planner can find either one solution to the resulting planning problem or multiple ranked solutions, which maps to the most plausible solution to the original problem.
FILED Tuesday, December 08, 2015
APPL NO 14/962714
ART UNIT 2123 — AI & Simulation/Modeling
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 5/045 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10552764 Carlin
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Aptima, Inc. (Woburn, Massachusetts)
ASSIGNEE(S) Aptima, Inc. (Woburn, Massachusetts)
INVENTOR(S) Alan Carlin (Waltham, Massachusetts)
ABSTRACT In one embodiment of the invention, a training model for students is provided that models how to present training items to students in a computer based adaptive trainer. The training model receives student performance data and uses the training model to infer underlying student skill levels throughout the training sequence. Some embodiments of the training model also comprise machine learning techniques that allow the training model to adapt to changes in students skills as the student performs on training items presented by the training model. Furthermore, the training model may also be used to inform a training optimization model, or a learning model, in the form of a Partially Observable Markov Decision Process (POMDP).
FILED Friday, December 30, 2016
APPL NO 15/395574
ART UNIT 3715 — Amusement and Education Devices
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 7/005 (20130101)
G06N 20/00 (20190101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553005 Lin et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) Chung-Ching Lin (White Plains, New York);  Sharathchandra U. Pankanti (Darien, Connecticut);  Karthikeyan Natesan Ramamurthy (Yorktown Heights, New York);  Aleksandr Y. Aravkin (Bronx, New York);  John R. Smith (New York, New York)
ABSTRACT A method and system of stitching a plurality of image views of a scene, including grouping matched points of interest in a plurality of groups, and determining a similarity transformation with smallest rotation angle for each grouping of the matched points. The method further includes generating virtual matching points on non-overlapping area of the plurality of image views and generating virtual matching points on overlapping area for each of the plurality of image views.
FILED Friday, February 10, 2017
APPL NO 15/430057
ART UNIT 2663 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/0063 (20130101)
G06K 9/4609 (20130101)
G06K 9/4638 (20130101)
G06K 9/4671 (20130101)
G06K 9/6211 (20130101)
G06K 2009/2045 (20130101)
G06K 2009/6213 (20130101)

Image Data Processing or Generation, in General
G06T 3/4038 (20130101)
G06T 5/006 (20130101)
G06T 7/33 (20170101)
G06T 11/60 (20130101) Original (OR) Class
G06T 2207/10032 (20130101)
G06T 2207/20104 (20130101)
G06T 2207/20221 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553022 Massaro
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) United States of America US Army (Alexandria, Virginia)
ASSIGNEE(S) UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (Alexandria, Virginia)
INVENTOR(S) Richard D Massaro (Burke, Virginia)
ABSTRACT This invention is a system for photogrammetric analysis of full motion video (FMV), which converts FMV to image files, extracts metadata, and produces accurate 2-D and 3-D geospatial images in real time.
FILED Friday, September 29, 2017
APPL NO 15/720133
ART UNIT 2668 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Electric Digital Data Processing
G06F 16/75 (20190101)
G06F 16/78 (20190101)
G06F 16/735 (20190101)

Image Data Processing or Generation, in General
G06T 17/05 (20130101)
G06T 17/10 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553090 Tolliver et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Space and Naval Warfare Systems Center (SPAWAR)
APPLICANT(S) The United States of America as represented by the Secretary of the Navy (San Diego, California)
ASSIGNEE(S) United States of America as represented by Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Laura C. Tolliver (Mt. Pleasant, South Carolina);  Peyton B. Cavaroc (Charleston, South Carolina);  Kevin P. Votapka (Charleston, South Carolina);  Robert R. Regal (Charleston, South Carolina);  Lucas D. Powell (Charleston, South Carolina);  Hunter J. Smith (Charleston, South Carolina)
ABSTRACT A device for signaling including a top member adjacent to a bottom member, a button adjacent to the top member, a sensor adjacent to the top member, a radio adjacent to the top member, a microprocessor board adjacent to the radio, a battery adjacent to the microprocessor board, and a switch adjacent to the bottom member. A button slot and sensor hole formed through the top member. The button is received in the button slot and the sensor in the sensor slot. The microprocessor board further comprises a light emitting diode. The bottom member has a bottom recess and a switch slot. The switch is received in the switch slot. The top member has a sensor recess and a screw hole. The sensor is retained in the sensor recess. The bottom member has a screw recess. The radio, microprocessor board, and battery are slidably received in the bottom slot.
FILED Thursday, August 23, 2018
APPL NO 16/110774
ART UNIT 2632 — Digital Communications
CURRENT CPC
Signalling or Calling Systems; Order Telegraphs; Alarm Systems
G08B 13/19 (20130101) Original (OR) Class
G08B 13/19602 (20130101)
G08B 25/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553342 Lazarus et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) U.S. Army Research Laboratory ATTN: RDRL-LOC-I (Adelphi, Maryland)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Nathan S. Lazarus (Bethesda, Maryland);  Christopher D. Meyer (Silver Spring, Maryland)
ABSTRACT A deformable inductive device includes an elastomer material having at least one deformable electrode and a liquid magnetic core formed in the elastomer material and containing a magnetic liquid. Depending on the device's configuration, the deformable element may be embedded in, attached to, or in close proximity with the liquid magnetic core. In some embodiments, the deformable inductive device may be configured as an inductor, solenoid, or transformer and the deformable electrode is at least partially embedded in the liquid magnetic core, for instance. In another embodiment, the deformable inductive device may be configured as part of a wireless power transfer system which includes a coil and a magnetic backplane having the liquid magnetic core with the coil being attached to or in close proximity to the magnetic backplane.
FILED Wednesday, July 13, 2016
APPL NO 15/209115
ART UNIT 2837 — Electrical Circuits and Systems
CURRENT CPC
Magnets; Inductances; Transformers; Selection of Materials for Their Magnetic Properties
H01F 27/022 (20130101) Original (OR) Class
H01F 27/24 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553414 Youngner et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) Honeywell International Inc. (Morristown, New Jersey)
ASSIGNEE(S) Honeywell International Inc. (Morris Plains, New Jersey)
INVENTOR(S) Daniel Youngner (Maple Grove, Minnesota);  Thomas Ohnstein (Roseville, Minnesota)
ABSTRACT Devices, methods, and systems for trapping multiple ions are described herein. One device includes two or more ovens wherein each oven includes a heating element and a cavity for emitting atoms of a particular atomic species from an atomic source substance, a substrate having a number of apertures that allow atoms emitted from the atomic source substance to exit the oven and enter an ion trapping area and wherein each oven is positioned at a different ion loading area within the ion trapping area, and a plurality of electrodes that can be charged and wherein the charge can be used to selectively control the movement of a particular ion from a particular loading area to a particular ion trap location.
FILED Friday, June 26, 2015
APPL NO 14/752368
ART UNIT 2881 — Optics
CURRENT CPC
Electric Discharge Tubes or Discharge Lamps
H01J 49/0031 (20130101)
H01J 49/062 (20130101) Original (OR) Class
H01J 49/063 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553740 Cornfeld et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) SolAero Technologies Corp. (Albuquerque, New Mexico)
ASSIGNEE(S) SolAero Technologies Corp. (Albuquerque, New Mexico)
INVENTOR(S) Arthur Cornfeld (Sandy Springs, Georgia);  Mark A. Stan (Albuquerque, New Mexico)
ABSTRACT A multijunction solar cell includes an InGaAs buffer layer and an InGaAlAs grading interlayer disposed below, and adjacent to, the InGaAs buffer layer. The grading interlayer achieves a transition in lattice constant from one solar subcell to another solar subcell.
FILED Friday, April 27, 2018
APPL NO 15/965219
ART UNIT 1726 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 31/06 (20130101) Original (OR) Class
H01L 31/184 (20130101)
H01L 31/0693 (20130101)
H01L 31/1844 (20130101)
H01L 31/03046 (20130101)
H01L 31/06875 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/544 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553743 Yoon et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of the Navy (Arlington, Virginia)
ASSIGNEE(S) The Government of the United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Woojun Yoon (Fairfax, Virginia);  Phillip Jenkins (Cleveland Heights, Ohio);  Robert J. Walters (Alexandria, Virginia);  David Scheiman (Alexandria, Virginia)
ABSTRACT A novel, low cost method for manufacturing flexible crystalline ultra-thin Si solar cells using previously fabricated inflexible crystalline Si solar cells. A stack of metal layers is coated onto a front side of previously completed inflexible crystalline Si solar cells. The stack serves as a bonding layer as well as an electrically conducting layer between the inflexible solar cell and the carrier substrate. The front side of the coated inflexible Si solar cell is bonded onto the carrier substrate. Back side layers from the starting inflexible solar cell are removed, as is much of the base layer, so that only a thin base layer remains, with the thin base layer and emitter region having a total thickness of between 1 μm and 30 μm and the final cell having a total thickness of about 10 to about 125 μm.
FILED Tuesday, November 20, 2018
APPL NO 16/196093
ART UNIT 2895 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 31/182 (20130101)
H01L 31/186 (20130101)
H01L 31/0682 (20130101)
H01L 31/1804 (20130101)
H01L 31/1896 (20130101) Original (OR) Class
H01L 31/02363 (20130101)
H01L 31/03921 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553751 Mi et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
APPLICANT(S) The Royal Institution for the Advancement of Learning/McGill University (Montreal, Canada)
ASSIGNEE(S) THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (Montreal, Quebec, Canada)
INVENTOR(S) Zetian Mi (Verdun, Canada);  Songrui Zhao (Montreal, Canada);  Renjie Wang (Montreal, Canada)
ABSTRACT GaN-based nanowire heterostructures have been intensively studied for applications in light emitting diodes (LEDs), lasers, solar cells and solar fuel devices. Surface charge properties play a dominant role on the device performance and have been addressed within the prior art by use of a relatively thick large bandgap AlGaN shell covering the surfaces of axial InGaN nanowire LED heterostructures has been explored and shown substantial promise in reducing surface recombination leading to improved carrier injection efficiency and output power. However, these lead to increased complexity in device design, growth and fabrication processes thereby reducing yield/performance and increasing costs for devices. Accordingly, there are taught self-organising InGaN/AlGaN core-shell quaternary nanowire heterostructures wherein the In-rich core and Al-rich shell spontaneously form during the growth process.
FILED Tuesday, April 02, 2019
APPL NO 16/372946
ART UNIT 2895 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 33/06 (20130101) Original (OR) Class
H01L 33/007 (20130101)
H01L 33/08 (20130101)
H01L 33/18 (20130101)
H01L 33/32 (20130101)

Devices Using the Process of Light Amplification by Stimulated Emission of Radiation [LASER] to Amplify or Generate Light; Devices Using Stimulated Emission of Electromagnetic Radiation in Wave Ranges Other Than Optical
H01S 5/021 (20130101)
H01S 5/1042 (20130101)
H01S 5/4006 (20130101)
H01S 5/32341 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10554015 Tassev
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) Government of the United States, as represented by the Secretary of the Air Force (Wright-Patterson AFB, Ohio)
ASSIGNEE(S) United States of America as represented by the Secretary of the Air Force (Wright Patterson AFB, Ohio)
INVENTOR(S) Vladimir Tassev (Beavercreek, Ohio)
ABSTRACT A method of making a quasi-phase-matching (QPM) structure comprising the steps of: applying a pattern to a substrate to define a plurality of growth regions and a plurality of voids; growing in a growth chamber a crystalline inorganic material on only the growth regions in the pattern, the crystalline inorganic material having a first polarity; applying an electric field within the growth chamber containing the patterned substrate with the crystalline inorganic material, wherein the electric field reaches throughout the growth chamber; and growing a crystalline organic material having a second polarity in the voids formed in the inorganic material under the influence of the electric field to influence the magnitude and the direction of the second polarity of the crystalline organic material, wherein the second polarity of the crystalline organic material is influenced to be different from the first polarity of the crystalline inorganic material in magnitude and/or direction.
FILED Thursday, January 25, 2018
APPL NO 15/879721
ART UNIT 2894 — Semiconductors/Memory
CURRENT CPC
Single-crystal-growth; Unidirectional Solidification of Eutectic Material or Unidirectional Demixing of Eutectoid Material; Refining by Zone-melting of Material; Production of a Homogeneous Polycrystalline Material With Defined Structure; Single Crystals or Homogeneous Polycrystalline Material With Defined Structure; After-treatment of Single Crystals or a Homogeneous Polycrystalline Material With Defined Structure; Apparatus Therefor
C30B 25/04 (20130101)
C30B 30/02 (20130101)

Devices Using the Process of Light Amplification by Stimulated Emission of Radiation [LASER] to Amplify or Generate Light; Devices Using Stimulated Emission of Electromagnetic Radiation in Wave Ranges Other Than Optical
H01S 5/0604 (20130101) Original (OR) Class
H01S 2304/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10554017 Han et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
APPLICANT(S) Yale University (New Haven, Connecticut)
ASSIGNEE(S) Yale University (New Haven, Connecticut)
INVENTOR(S) Jung Han (Woodbridge, Connecticut);  Yufeng Li (Shaanxi, China PRC);  Ge Yuan (New Haven, Connecticut)
ABSTRACT Edge-emitting laser diodes having high confinement factors and lattice-matched, porous cladding layers are described. The laser diodes may be formed from layers of III-nitride material. A cladding layer may be electrochemically etched to form a porous cladding layer having a high refractive index contrast with an active junction of the device. A transparent conductive oxide layer may be deposited to form a top-side cladding layer with high refractive index contrast and low resistivity.
FILED Thursday, May 19, 2016
APPL NO 15/574739
ART UNIT 2828 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/306 (20130101)

Devices Using the Process of Light Amplification by Stimulated Emission of Radiation [LASER] to Amplify or Generate Light; Devices Using Stimulated Emission of Electromagnetic Radiation in Wave Ranges Other Than Optical
H01S 5/305 (20130101)
H01S 5/2009 (20130101) Original (OR) Class
H01S 5/2081 (20130101)
H01S 5/3211 (20130101)
H01S 5/3213 (20130101)
H01S 5/3219 (20130101)
H01S 5/34333 (20130101)
H01S 2304/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10554207 Herr et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) Anna Y. Herr (Ellicott City, Maryland);  Quentin P. Herr (Ellicott City, Maryland);  Ryan Edward Clarke (Hanover, Maryland);  Harold Clifton Hearne, III (Baltimore, Maryland);  Alexander Louis Braun (Baltimore, Maryland);  Randall M. Burnett (Catonsbille, Maryland);  Timothy Chi-Chao Lee (Gaithersburg, Maryland)
ASSIGNEE(S) NORTHROP GRUMMAN SYSTEMS CORPORATION (Falls Church, Virginia)
INVENTOR(S) Anna Y. Herr (Ellicott City, Maryland);  Quentin P. Herr (Ellicott City, Maryland);  Ryan Edward Clarke (Hanover, Maryland);  Harold Clifton Hearne, III (Baltimore, Maryland);  Alexander Louis Braun (Baltimore, Maryland);  Randall M. Burnett (Catonsbille, Maryland);  Timothy Chi-Chao Lee (Gaithersburg, Maryland)
ABSTRACT Non-destructive read out (NDRO) circuits are provided for use in reciprocal quantum logic (RQL) superconducting systems. Each NDRO circuit includes a “body” circuit that provides a single or multi-state sub-critical bias current to one or many independent “tail” circuitries. Each “tail” has minimal effect on the “body” thereby preventing any interference or destruction to the state of the “body” circuitry. The circuits reduce device count and thereby increase circuit density, simplify and reduce the cost of fabrication, and provide functionality not available in existing designs, such as the ability to write a state and read it in the same operation cycle. The NDRO circuits provide more compact unit cells useful in memory or logic arrays, demanding fewer resources with increased functionality. The circuits also provide compact cells for AND, AND-OR, A-NOT-B, inverter, multiplexer, and demultiplexer gates.
FILED Tuesday, July 31, 2018
APPL NO 16/051058
ART UNIT 2844 — Electrical Circuits and Systems
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 10/00 (20190101)

Static Stores
G11C 11/44 (20130101)

Pulse Technique
H03K 3/38 (20130101)
H03K 19/195 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10554233 Dinc et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) Tolga Dinc (New York, New York);  Mark A. Ferriss (Tarrytown, New York);  Daniel Joseph Friedman (Sleepy Hollow, New York);  Wooram Lee (Briarcliff Manor, New York);  Bodhisatwa Sadhu (Fishkill, New York);  Alberto Valdes Garcia (Chappaqua, New York)
ABSTRACT Techniques that facilitate reconfigurable transmission of a radar frequency signal are provided. In one example, a system includes a signal generator and a power modulator. The signal generator provides a radar waveform signal from a set of radar waveform signals. The power modulator divides a local oscillator signal associated with a first frequency and a first amplitude into a first local oscillator signal and a second local oscillator signal. The power modulator also generates a radio frequency signal associated with a second frequency and a second amplitude based on the radar waveform signal, the first local oscillator signal and the second local oscillator signal.
FILED Thursday, August 03, 2017
APPL NO 15/667682
ART UNIT 3648 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 7/03 (20130101)
G01S 7/35 (20130101)
G01S 7/282 (20130101)
G01S 13/10 (20130101)
G01S 13/34 (20130101)
G01S 13/76 (20130101)
G01S 13/284 (20130101)
G01S 13/325 (20130101)
G01S 2013/0272 (20130101)

Demodulation or Transference of Modulation From One Carrier to Another
H03D 7/1441 (20130101)
H03D 7/1458 (20130101)
H03D 7/1483 (20130101)

Amplifiers
H03F 3/20 (20130101)

Transmission
H04B 1/0082 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10554288 Gandy et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Defense Threat Reduction Agency (DTRA)
APPLICANT(S) Applied Minds, LLC (Burbank, California)
ASSIGNEE(S) Applied Minds, LLC (Burbank, California)
INVENTOR(S) Charles L. Gandy (Annapolis, Maryland);  Clinton Blake Hope (Los Angeles, California);  Edward Francis Adams (Los Angeles, California);  Donald Gregory Lariviere (Glendale, California);  Houstin L. Lichtenwalner (Macungie, Pennsylvania)
ABSTRACT Disclosed are passive reflector radio communications systems, such as for UHF frequencies or greater than UHF frequencies, and related deployment systems and devices that provide underground communications. Embodiments of the system include reflector elements to provide passive radio communications, structural frameworks to support and orient the reflector elements, methods for calculating reflector size, shape, and position corresponding to a desired wavelength, and deployment methods and devices to install the communication system at a desired location. The passive reflectors can be placed in a folded or otherwise compact mode, for transport into underground tunnels. Once at the desired installation location, the system can be installed, with the reflectors positioned appropriately for the radio frequencies used at the location. Some of the embodiments include any of vertical or horizontal foldable reflector poles, reflective sheets, reflective mesh sheets and/or ropes, inflatable reflective pucks, and rapid deployment systems and methods.
FILED Monday, January 22, 2018
APPL NO 15/877281
ART UNIT 2649 — Telecommunications: Analog Radio Telephone; Satellite and Power Control; Transceivers, Measuring and Testing; Bluetooth; Receivers and Transmitters; Equipment Details
CURRENT CPC
Transmission
H04B 7/145 (20130101) Original (OR) Class

Transmission of Digital Information, e.g Telegraphic Communication
H04L 67/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10554312 Santra et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) U.S. Army Research Laboratory (Adelphi, Maryland)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Siddhartha Santra (Hyattsville, Maryland);  Brian T. Kirby (Baltimore, Maryland);  Vladimir S. Malinovsky (Clifton, New Jersey);  Michael Brodsky (Millburn, New Jersey)
ABSTRACT Methods and systems for measuring interferometric visibility of telescopic signals using resources having imperfect quantum entanglement are disclosed. The novel methodology employed by embodiments of the present invention takes into account the difficulty in creating entanglement between distance telescopes, and describes how to incorporate problems associated with distributing quantum entanglement into the measurement procedure. This allows the distance that two telescopes in an optical array are spaced apart to be increased while still interacting.
FILED Monday, May 14, 2018
APPL NO 15/979020
ART UNIT 2877 — Optics
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 23/04 (20130101)

Electric Digital Data Processing
G06F 17/14 (20130101)
G06F 17/15 (20130101)
G06F 17/16 (20130101)

Transmission
H04B 10/70 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Energy (DOE) 

US 10548608 Boyle et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) Lawrence Livermore National Security, LLC (Livermore, California);  The Texas A and M University System (College Station, Texas)
ASSIGNEE(S) Lawrenece Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Anthony J. Boyle (College Station, Texas);  Keith Hearon (Augusta, Georgia);  Duncan J. Maitland (College Station, Texas);  Landon D. Nash (College Station, Texas);  Thomas S. Wilson (San Leandro, California)
ABSTRACT An embodiment of the invention is a shape memory polymer (SMP) foam designed to recover its original shape through exposure to a solvent. Thermo-responsive SMPs are polymers designed to maintain a programmed secondary shape until heated above their transition temperature, upon which the polymer recovers its original, or primary, shape. The thermo-responsive SMP foam is programmed to its secondary shape prior to use, typically compression of the foam to a small volume, and remains in this programmed shape until exposed to a selected solvent such as dimethyl sulfoxide or ethyl alcohol. Upon exposure to the solvent, the transition temperature of the SMP foam decreases below the temperature of the environment and the SMP foam actuates to its primary shape. The SMP foam is tailored to actuate upon exposure to specific solvents while minimizing or preventing actuation when exposed to water or other solvents. This selective solvent actuation can be used to increase working time of a SMP foam device, that is, the time allowed for use of a device without undesired actuation, while maintaining functional SMP actuation. Solvent actuated SMP foams can be used in various applications including, but not limited to, treatment of aneurysms and arterio-venous malformations, tissue engineering, and wound healing.
FILED Tuesday, June 07, 2016
APPL NO 15/579217
ART UNIT 1765 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 17/12031 (20130101)
A61B 17/12113 (20130101)
A61B 17/12181 (20130101) Original (OR) Class
A61B 2017/00871 (20130101)
A61B 2017/00938 (20130101)
A61B 2017/00964 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 31/06 (20130101)
A61L 31/14 (20130101)
A61L 31/146 (20130101)
A61L 2400/16 (20130101)
A61L 2430/36 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10549214 DiPrete et al.
FUNDED BY
Department of Energy (DOE)
Office of Environmental Management (DOE-EM)
Savannah River National Laboratory (SRNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Savannah River Nuclear Solutions, LLC (SRNS) at Aiken, SC
APPLICANT(S) Savannah River Nuclear Solutions, LLC (Aiken, South Carolina)
ASSIGNEE(S) Savannah River Nuclear Solutions, LLC (Aiken, North Carolina)
INVENTOR(S) David P. DiPrete (Evans, Georgia);  Donald J. Pak (Martinez, Georgia);  Cecilia C. DiPrete (Evans, Georgia);  Scott H. Reboul (Aiken, South Carolina);  Tad S Whiteside (Aiken, South Carolina)
ABSTRACT A device for collection of residue from separation columns. A manifold provides for multiple sample ports that are fluidly connected to a vacuum port by at least one channel. Residue from the separation columns is pulled through the sample ports, into the channel, and then to the vacuum port. From the vacuum port the residue can be moved, under the force of the vacuum, directly to a drain or to a collection vessel connected with a drain.
FILED Friday, March 10, 2017
APPL NO 15/455262
ART UNIT 1777 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Separation
B01D 15/22 (20130101) Original (OR) Class

Chemical or Physical Laboratory Apparatus for General Use
B01L 3/00 (20130101)
B01L 3/50255 (20130101)
B01L 2400/049 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/28 (20130101)
G01N 1/405 (20130101)
G01N 30/06 (20130101)
G01N 30/46 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10549229 Baxter et al.
FUNDED BY
Department of Energy (DOE)
Office of Fossil Energy and Carbon Management (FECM)
National Energy Technology Laboratory (NETL)
APPLICANT(S) Larry Baxter (Orem, Utah);  Nathan Davis (Bountiful, Utah)
ASSIGNEE(S) Hall Labs LLC (Provo, Utah)
INVENTOR(S) Larry Baxter (Orem, Utah);  Nathan Davis (Bountiful, Utah)
ABSTRACT Devices, systems, and methods for separating a vapor from a gas are disclosed. A gas is passed through a direct-contact exchanger. The exchanger using a contact liquid to cool the gas. The gas comprises a vapor. A portion of the vapor is condensed as the gas passes through the direct-contact exchanger, producing a product liquid and a vapor-depleted gas. The product liquid is immiscible in the contact liquid. The product liquid is gravity settled from the contact liquid such that the contact liquid and the product liquid separate in the direct-contact exchanger.
FILED Wednesday, October 04, 2017
APPL NO 15/724725
ART UNIT 1772 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Separation
B01D 17/0208 (20130101)
B01D 53/002 (20130101) Original (OR) Class
B01D 53/18 (20130101)
B01D 53/1493 (20130101)
B01D 2252/103 (20130101)
B01D 2252/2021 (20130101)
B01D 2257/80 (20130101)
B01D 2257/7022 (20130101)
B01D 2258/0283 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10549261 Nenoff et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) Tina M. Nenoff (Albuquerque, New Mexico);  Dorina Florentina Sava Gallis (Albuquerque, New Mexico);  Marie Vernell Parkes (Albuquerque, New Mexico);  Jeffery Greathouse (Albuquerque, New Mexico)
ABSTRACT MOFs are disclosed that can efficiently adsorb oxygen from a gas stream, such as air. Systems and methods are also disclosed that utilize MOFs to separate oxygen from a gas stream. The separated oxygen may be used in a commercial process such as a combustion process.
FILED Monday, May 20, 2019
APPL NO 16/417181
ART UNIT 1776 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Separation
B01D 53/04 (20130101)
B01D 2253/204 (20130101)
B01D 2257/104 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/226 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550010 Darling et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Argonne National Laboratory (ANL)
Federally Funded Research and Development Center (FFRDC)
Operated by UChicago Argonne, LLC (UCHICAGO) at Argonne, IL
APPLICANT(S) UChicago Argonne, LLC (Chicago, Illinois)
ASSIGNEE(S) UChicago Argonne, LLC (Chicago, Illinois)
INVENTOR(S) Seth B. Darling (Chicago, Illinois);  Jeffrey W. Elam (Elmhurst, Illinois);  Anil U. Mane (Naperville, Illinois)
ABSTRACT A method of fabricating an oleophilic foam includes providing a foam comprising a base material. The base material is coated with an inorganic material using at least one of an atomic layer deposition (ALD), a molecular layer deposition (MLD) or sequential infiltration synthesis (SIS) process. The SIS process includes at least one cycle of exposing the foam to a first metal precursor for a first predetermined time and a first partial pressure. The first metal precursor infiltrates at least a portion of the base material and binds with the base material. The foam is exposed to a second co-reactant precursor for a second predetermined time and a second partial pressure. The second co-reactant precursor reacts with the first metal precursor, thereby forming the inorganic material on the base material. The inorganic material infiltrating at least the portion of the base material. The inorganic material is functionalized with an oleophilic material.
FILED Friday, December 11, 2015
APPL NO 14/967021
ART UNIT 1788 — Miscellaneous Articles, Stock Material
CURRENT CPC
Separation
B01D 15/265 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/223 (20130101)
B01J 20/262 (20130101)
B01J 20/3212 (20130101)
B01J 20/3217 (20130101)
B01J 20/3236 (20130101)
B01J 20/3285 (20130101)
B01J 20/3291 (20130101)
B01J 20/28045 (20130101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/288 (20130101) Original (OR) Class
C02F 2101/32 (20130101)
C02F 2103/007 (20130101)
C02F 2103/08 (20130101)
C02F 2201/008 (20130101)

Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 16/403 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550051 Li et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) North Carolina State University (Raleigh, North Carolina)
ASSIGNEE(S) North Carolina State University (Raleigh, North Carolina)
INVENTOR(S) Fanxing Li (Raleigh, North Carolina);  Luke M. Neal (Raleigh, North Carolina)
ABSTRACT Methods and systems are provided for oxidative dehydrogenation of a hydrocarbon feed stream to produce a product stream with improved ethylene yield. The methods can include the steps of (i) combining a recycle stream with the feed stream to form a reactor feed stream, (ii) contacting the reactor feed stream with an oxide-based redox catalyst to produce the product stream comprising ethylene and one or more byproducts selected from the group consisting of methane, ethane, other byproducts, and mixtures thereof, and (iii) removing all or a part of the methane and ethane from the product stream to produce the recycle stream. Systems for the oxidative dehydrogenation (ODH) of a hydrocarbon feed stream are also provided to produce a product stream with improved ethylene yield. The systems and methods can include an oxide-based redox catalyst, such as Mg6MnO8, Cu6PbO8, and Ni6MnO8.
FILED Thursday, February 02, 2017
APPL NO 15/422743
ART UNIT 1772 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Acyclic or Carbocyclic Compounds
C07C 5/42 (20130101) Original (OR) Class
C07C 2523/34 (20130101)
C07C 2523/835 (20130101)
C07C 2523/889 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550139 Dub et al.
FUNDED BY
Department of Energy (DOE)
Los Alamos National Security, LLC (LANS)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
APPLICANT(S) Triad National Security, LLC (Los Alamos, New Mexico)
ASSIGNEE(S) Triad National Security, LLC (Los Alamos, New Mexico)
INVENTOR(S) Pavel A. Dub (Los Alamos, New Mexico);  John Cameron Gordon (Los Alamos, New Mexico)
ABSTRACT Embodiments of the present disclosure relate generally to novel achiral and chiral sulfur-, nitrogen- and phosphorus-containing ligands, designated as NNS-type, P(O)NS-type, PNS-type, SNNS-type, SNNP(O)-type, or SNNP-type polydentate ligands and transition metal complexes of these ligands, including iridium complexes having PNS-type and NNS-type ligands. The catalysts derived from these ligands and transition metal complexes may be used in a wide range of catalytic reactions, including hydrogenation and transfer hydrogenation of unsaturated organic compounds, dehydrogenation of alcohols and boranes, various dehydrogenative couplings, chemoselective hydrogenation of α,β-unsaturated alcohols, and other catalytic transformations.
FILED Friday, December 09, 2016
APPL NO 15/375055
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 9/5304 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550343 Patel
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Corps of Engineers (USACE)
Engineer Research and Development Center (ERDC)
Construction Engineering Research Laboratory (CERL)
Department of Energy (DOE)
Office of Fossil Energy and Carbon Management (FECM)
APPLICANT(S) Nikhil Manubhai Patel (Grand Forks, North Dakota)
ASSIGNEE(S) Nikhil Manubhai Patel (Grand Forks, North Dakota)
INVENTOR(S) Nikhil Manubhai Patel (Grand Forks, North Dakota)
ABSTRACT The present invention discloses a gasifier and/or a gasification process that provides a long, uniform temperature zone in the gasifier, regardless of the particle size, chemical composition, and moisture content of the fuel by sandwiching a reduction zones between two oxidation zones. The gasifier and/or gasification process has a char that is more energy-dense and almost devoid of moisture that affords for an additional (or char) oxidation zone with a temperature that is higher than a first oxidation zone which is closer to a evaporation and devolatilization zone. As such, the additional (or char) oxidation zone contributes to augmenting the reduction zone temperature, thereby providing a favorable dual impact in improving syngas composition and near-complete conversion of the tar.
FILED Monday, May 28, 2018
APPL NO 15/990725
ART UNIT 1725 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Production of Producer Gas, Water-gas, Synthesis Gas From Solid Carbonaceous Material, or Mixtures Containing These Gases; Carburetting Air or Other Gases
C10J 3/08 (20130101) Original (OR) Class
C10J 3/22 (20130101)
C10J 3/26 (20130101)
C10J 3/723 (20130101)
C10J 2300/092 (20130101)
C10J 2300/093 (20130101)
C10J 2300/0946 (20130101)
C10J 2300/0956 (20130101)
C10J 2300/0959 (20130101)
C10J 2300/0976 (20130101)
C10J 2300/1246 (20130101)

Purifying or Modifying the Chemical Composition of Combustible Gases Containing Carbon Monoxide
C10K 1/024 (20130101)
C10K 1/026 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550384 Church et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Office of Science Consolidated Service Center (CSC)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) George M. Church (Brookline, Massachusetts);  Srivatsan Raman (Arlington, Massachusetts);  Noah D. Taylor (Boston, Massachusetts);  Jameson Rogers (Boston, Massachusetts)
ABSTRACT The present invention relates to genetically modified bacteria and methods of optimizing genetically modified bacteria for the production of a metabolite.
FILED Wednesday, February 26, 2014
APPL NO 14/775025
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1058 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550489 Willit et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Argonne National Laboratory (ANL)
Federally Funded Research and Development Center (FFRDC)
Operated by UChicago Argonne, LLC (UCHICAGO) at Argonne, IL
APPLICANT(S) James L. Willit (Batavia, Illinois);  Magdalena M. Tylka (Willow Springs, Illinois);  Mark A. Williamson (Naperville, Illinois);  Stanley G. Wiedmeyer (Glen Ellyn, Illinois);  Javier Figueroa (Andover, Kansas)
ASSIGNEE(S) UCHICAGO ARGONNE, LLC (Chicago, Illinois)
INVENTOR(S) James L. Willit (Batavia, Illinois);  Magdalena M. Tylka (Willow Springs, Illinois);  Mark A. Williamson (Naperville, Illinois);  Stanley G. Wiedmeyer (Glen Ellyn, Illinois);  Javier Figueroa (Andover, Kansas)
ABSTRACT A method for recycling molten salt from electrorefining processes, the method having the steps of collecting actinide metal using a first plurality of cathodes from an electrolyte bath, collecting rare earths metal using a second plurality of cathodes from the electrolyte bath, inserting the collected actinide metal and uranium into the bath, and chlorinating the inserted actinide metal and uranium. Also provided is a system for recycling molten salt, the system having a vessel adapted to receive and heat electrolyte salt, a first plurality of cathodes adapted to be removably inserted into the vessel, a second plurality of cathodes adapted to be removably inserted into the vessel, an anode positioned within the vessel so as to be coaxially aligned with the vessel, and a vehicle for inserting uranium into the salt.
FILED Monday, July 11, 2016
APPL NO 15/206914
ART UNIT 1794 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Processes for the Electrolytic Production, Recovery or Refining of Metals; Apparatus Therefor
C25C 3/34 (20130101) Original (OR) Class
C25C 7/005 (20130101)
C25C 7/06 (20130101)

Processes for the Electrolytic or Electrophoretic Production of Coatings; Electroforming; Apparatus Therefor
C25D 3/66 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550721 Hafner et al.
FUNDED BY
Department of Energy (DOE)
Office of Fossil Energy and Carbon Management (FECM)
APPLICANT(S) GENERAL ELECTRIC COMPANY (Schenectady, New York)
ASSIGNEE(S) GENERAL ELECTRIC COMPANY (Schenectady, New York)
INVENTOR(S) Matthew Troy Hafner (Honea Path, South Carolina);  Gary Michael Itzel (Simpsonville, South Carolina);  John McConnell Delvaux (Fountain Inn, South Carolina);  Sandip Dutta (Greenville, South Carolina)
ABSTRACT An apparatus is disclosed including a first and second article, a first interface volume disposed between and enclosed by the first article and second article, a cooling fluid supply, and at least one cooling fluid channel in fluid communication with the cooling fluid supply and the first interface volume. The first article includes a first material composition. The second article includes a second material composition. The at least one cooling fluid channel includes a heat exchange portion disposed in at least one of the first and second article downstream of the cooling fluid supply and upstream of the first interface volume. A turbine shroud is disclosed wherein the first and second articles are an outer and inner shroud. A turbine nozzle is disclosed wherein the first and second articles are an endwall and fairing.
FILED Thursday, March 24, 2016
APPL NO 15/080201
ART UNIT 3753 — Fluid Handling and Dispensing
CURRENT CPC
Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 5/187 (20130101)
F01D 9/041 (20130101)
F01D 11/08 (20130101)
F01D 25/12 (20130101) Original (OR) Class

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2220/32 (20130101)
F05D 2260/213 (20130101)
F05D 2260/2212 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550790 Ravi et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) Robert Bosch LLC (Broadview, Illinois);  Robert Bosch GmbH (Stuttgart, Germany)
ASSIGNEE(S) Robert Bosch LLC (Broadview, Illinois);  Robert Bosch GmbH (Stuttgart, Germany)
INVENTOR(S) Nikhil Ravi (Mountain View, California);  Joel Oudart (Mountain View, California);  Shyam Jade (Birmingham, Michigan);  Jason Schwanke (Southfield, Michigan);  Li Jiang (Ann Arbor, Michigan)
ABSTRACT An engine system uses data associated with at least one operating condition of an engine to set the engine system to an AI mode when the engine is in an SI mode 1) within first operating condition limits, and 2) when a rate of change of a first operating condition is within rate of change limits, maintain the engine system in the SI mode when the engine is outside of first operating condition limits or when the rate of change of the first operating condition is not within rate of change limits, set the engine system to the SI mode when the engine is in the AI mode outside second operating condition limits, and maintain the engine system in the AI mode when the engine is within second operating condition limits, wherein the second operating condition limits are different from the first operating condition limits.
FILED Wednesday, December 30, 2015
APPL NO 14/984038
ART UNIT 3747 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Controlling Combustion Engines
F02D 41/022 (20130101)
F02D 41/0225 (20130101)
F02D 41/3035 (20130101)
F02D 41/3064 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550889 Walter et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Pacific Northwest National Laboratory (PNNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Battelle Memorial Institute (BMI) at Richland, WA
APPLICANT(S) BATTELLE MEMORIAL INSTITUTE (Richland, Washington)
ASSIGNEE(S) Battelle Memorial Institute (Richland, Washington)
INVENTOR(S) Eric D. Walter (Richland, Washington);  Jesse A. Sears, Jr. (Kennewick, Washington);  Hardeep S. Mehta (Richland, Washington);  David W. Hoyt (Richland, Washington)
ABSTRACT Snap-in bushings are disclosed that enable sealing of sample chambers in MAS-NMR rotors for high pressure and/or high temperature operation that enhance pressure limits up to about 400 bar and temperature limits up to at least about 250° C.
FILED Monday, August 01, 2016
APPL NO 15/225688
ART UNIT 2867 — Printing/Measuring and Testing
CURRENT CPC
Shafts; Flexible Shafts; Elements or Crankshaft Mechanisms; Rotary Bodies Other Than Gearing Elements; Bearings
F16C 33/74 (20130101) Original (OR) Class

Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550984 Lynch et al.
FUNDED BY
Department of Energy (DOE)
Office of Nuclear Energy (DOE-NE)
APPLICANT(S) NuScale Power, LLC (Corvallis, Oregon)
ASSIGNEE(S) NUSCALE POWER, LLC (Corvallis, Oregon)
INVENTOR(S) John J. Lynch (Corvallis, Oregon);  Edward A. Rodriguez (Corvallis, Oregon);  Tamas R. Liszkai (Corvallis, Oregon)
ABSTRACT A pipe restraint assembly includes a restraint body configured to be removably attached to a portion of pipe. The portion of pipe is associated with a postulated pipe failure associated with a release of high pressure fluid. A plurality of apertures penetrate through the restraint body and are positioned proximate to a location of the postulated pipe failure. The apertures are configured to provide a number of passageways for the fluid to exit from the location of the postulated pipe failure and to be released outside of the restraint body. One or more restraint devices maintain the position of the apertures relative to the location of the postulated pipe failure.
FILED Friday, December 04, 2015
APPL NO 14/960007
ART UNIT 3679 — Wells, Earth Boring/Moving/Working, Excavating, Mining, Harvesters, Bridges, Roads, Petroleum, Closures, Connections, and Hardware
CURRENT CPC
Pipes; Joints or Fittings for Pipes; Supports for Pipes, Cables or Protective Tubing; Means for Thermal Insulation in General
F16L 23/167 (20130101)
F16L 55/005 (20130101) Original (OR) Class
F16L 55/07 (20130101)
F16L 2201/20 (20130101)
F16L 2201/30 (20130101)

Nuclear Power Plant
G21D 1/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551094 Moghaddam et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) University of Florida Research Foundation, Incorporated (Gainesville, Florida)
ASSIGNEE(S) UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (Gainesville, Florida)
INVENTOR(S) Saeed Moghaddam (Gainesville, Florida);  Devesh Chugh (Gainesville, Florida);  Sajjad Bigham (Hancock, Michigan)
ABSTRACT An absorber or desorber contains one or more micro-channels that have a 3-D structured heat-exchanging surface and a membrane on the microchannel situated distal to the 3-D structured heat-exchanging surface, where the membrane is permeable to a solvent of a solution employed in the absorber or desorber. The 3-D structured surface promotes mixing of hot and cold solution between the 3-D structured heat-exchanging surface and a vapor-exchanging surface proximal to the membrane. The mixing reduces the differences in concentration and temperature of the bulk solution and the solution at the vapor-exchanging surface to enhance the efficiency and rate of absorption or desorption of the solvent.
FILED Wednesday, June 29, 2016
APPL NO 15/196383
ART UNIT 3763 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Refrigeration Machines, Plants or Systems; Combined Heating and Refrigeration Systems; Heat-pump Systems
F25B 15/06 (20130101)
F25B 17/02 (20130101) Original (OR) Class
F25B 35/02 (20130101)
F25B 37/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551097 Cogswell et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) Carrier Corporation (Farmington, Connecticut)
ASSIGNEE(S) CARRIER CORPORATION (Palm Beach Gardens, Florida)
INVENTOR(S) Frederick J. Cogswell (Glastonbury, Connecticut);  Catherine Thibaud (South Windsor, Connecticut);  Parmesh Verma (South Windsor, Connecticut);  Bart A. Van Hassel (Weatogue, Connecticut);  Thomas D. Radcliff (Vernon, Connecticut);  Abdelrahman ElSherbini (Windsor, Connecticut);  Robert A. Chopko (Baldwinsville, New York)
ABSTRACT In one aspect, a refrigeration system is provided. The refrigeration system includes a refrigeration circuit configured to condition an air supply, a subcooling circuit configured to cool the refrigeration circuit, the subcooling circuit including a subcooling condenser, a subcooling heat exchanger, and at least one adsorption bed, and a heat generation system thermally coupled to the subcooling circuit.
FILED Friday, September 11, 2015
APPL NO 15/526488
ART UNIT 3763 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Refrigeration Machines, Plants or Systems; Combined Heating and Refrigeration Systems; Heat-pump Systems
F25B 17/08 (20130101)
F25B 25/02 (20130101) Original (OR) Class
F25B 27/02 (20130101)
F25B 40/02 (20130101)
F25B 2315/007 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551120 Baxter et al.
FUNDED BY
Department of Energy (DOE)
Office of Fossil Energy and Carbon Management (FECM)
National Energy Technology Laboratory (NETL)
APPLICANT(S) Larry Baxter (Orem, Utah);  Nathan Davis (Bountiful, Utah)
ASSIGNEE(S) Hall Labs LLC (Provo, Utah)
INVENTOR(S) Larry Baxter (Orem, Utah);  Nathan Davis (Bountiful, Utah)
ABSTRACT A method for cryogenic cooling without fouling is disclosed. The method comprises providing a first cryogenic liquid saturated with a dissolved gas; expanding the first cryogenic liquid into a separation vessel, separating into a vapor, a second cryogenic liquid, and a first solid; drawing the vapor into a heat exchanger and the second cryogenic liquid and the first solid out of the separation vessel; cooling the vapor against a coolant through the heat exchanger, causing the vapor to form a third cryogenic liquid and a second solid, the second solid dissolving in the third cryogenic liquid; and combining the second cryogenic liquid and the first solid with the third cryogenic liquid, producing a final cooled slurry. In this manner, the cryogenic cooling is accomplished without fouling.
FILED Monday, February 06, 2017
APPL NO 15/425412
ART UNIT 3763 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Separation
B01D 5/006 (20130101)
B01D 5/009 (20130101)
B01D 5/0012 (20130101)
B01D 5/0054 (20130101)
B01D 5/0069 (20130101)
B01D 5/0093 (20130101)
B01D 8/00 (20130101)

Chemical or Physical Laboratory Apparatus for General Use
B01L 5/00 (20130101)

Liquefaction, Solidification or Separation of Gases or Gaseous Mixtures by Pressure and Cold Treatment
F25J 3/061 (20130101)
F25J 3/067 (20130101) Original (OR) Class
F25J 3/0615 (20130101)
F25J 3/0635 (20130101)
F25J 3/0695 (20130101)
F25J 2205/20 (20130101)
F25J 2205/84 (20130101)
F25J 2205/90 (20130101)
F25J 2215/04 (20130101)
F25J 2235/60 (20130101)
F25J 2240/02 (20130101)
F25J 2240/40 (20130101)
F25J 2270/12 (20130101)
F25J 2270/904 (20130101)
F25J 2290/44 (20130101)

Capture, Storage, Sequestration or Disposal of Greenhouse Gases [GHG]
Y02C 10/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551247 Van Benthem et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) Mark Van Benthem (Albuquerque, New Mexico);  James A. Ohlhausen (Albuquerque, New Mexico)
ABSTRACT The present invention relates to methods for analyzing a chemical sample. For instance, the methods herein allow for global analysis of spectroscopy data in order to extract useful chemical properties from complicated multidimensional data. Such analysis can optionally employ data compression to further expedite computer-implemented computation. In particular, the methods herein provide global analysis of data matrices explained by both linear and non-linear terms.
FILED Monday, March 28, 2016
APPL NO 15/082922
ART UNIT 2894 — Semiconductors/Memory
CURRENT CPC
Measurement of Intensity, Velocity, Spectral Content, Polarisation, Phase or Pulse Characteristics of Infra-Red, Visible or Ultra-violet Light; Colorimetry; Radiation Pyrometry
G01J 3/42 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/31 (20130101)
G01N 21/64 (20130101)
G01N 23/083 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551330 Atre et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California);  STICHTING VOOR FUNDAMENTEEL ONDERZOEK DER MATERIE (Utrecht, Netherlands);  Ashwin C. Atre (Stanford, California);  Jennifer A. Dionne (Stanford, California);  Benjamin Brenny (Utrecht, Netherlands);  Toon Coenen (Utrecht, Netherlands);  Albert Polman (Utrecht, Netherlands)
ASSIGNEE(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California);  STICHTING VOOR FUNDAMENTEEL ONDERZOEK DER MATERIE (Utrecht, Netherlands)
INVENTOR(S) Ashwin C. Atre (Stanford, California);  Jennifer A. Dionne (Stanford, California);  Benjamin Brenny (Utrecht, Netherlands);  Toon Coenen (Utrecht, Netherlands);  Albert Polman (Utrecht, Netherlands)
ABSTRACT In one aspect, a cathodoluminescence (CL) spectroscopic tomography device includes a sample stage to support a sample. An electron beam source scans an electron beam over the sample to yield light emission by the sample. A reflective element directs the light emission by the sample to a light detector. A controller controls operation of the sample stage, the electron beam source, and the light detector. In one aspect, a CL spectroscopic tomography device includes an electron beam source which directs an electron beam at an object to yield an emission by the object. A detector detects the emission. A controller receives information from the detector related to the detected emission. The controller derives a two-dimensional (2D) CL map from the information related to the detected emission, and derives a three-dimensional (3D) CL tomogram from the 2D CL map.
FILED Wednesday, April 22, 2015
APPL NO 15/305329
ART UNIT 2881 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/00 (20130101)
A61B 5/0073 (20130101)
A61B 5/0075 (20130101)

Measurement of Intensity, Velocity, Spectral Content, Polarisation, Phase or Pulse Characteristics of Infra-Red, Visible or Ultra-violet Light; Colorimetry; Radiation Pyrometry
G01J 3/44 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 23/2254 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10552152 Beard et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) ARM Limited (Cambridge, United Kingdom)
ASSIGNEE(S) Arm Limited (Cambridge, United Kingdom)
INVENTOR(S) Jonathan Curtis Beard (Austin, Texas);  Wendy Elsasser (Austin, Texas);  Eric Van Hensbergen (Austin, Texas);  Stephan Diestelhorst (Austin, Texas)
ABSTRACT A data processing apparatus, and method of operation thereof, for executing instructions. The apparatus includes one or more host processors, each having a first processing unit, and a multi-level memory system. One or more levels of the memory system are tightly coupled to a corresponding second processing unit. At least one of the host processors includes an instruction scheduler that routes instructions selectively to at least one of the first and second processing units, dependent upon the availability of the processing units and the location, within the memory system, of data to be used when executing the instructions.
FILED Friday, May 27, 2016
APPL NO 15/166444
ART UNIT 2183 — Computer Architecture and I/O
CURRENT CPC
Electric Digital Data Processing
G06F 9/3004 (20130101) Original (OR) Class
G06F 9/3016 (20130101)
G06F 9/3802 (20130101)
G06F 12/084 (20130101)
G06F 12/0811 (20130101)
G06F 12/0875 (20130101)
G06F 12/0897 (20130101)
G06F 2212/62 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10552339 Basu et al.
FUNDED BY
Department of Energy (DOE)
Exascale Computing Project (ECP)
PathForward Project (PATHFORWARD)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) ADVANCED MICRO DEVICES, INC. (Santa Clara, California)
ASSIGNEE(S) Advanced Micro Devices, Inc. (Santa Clara, California)
INVENTOR(S) Arkaprava Basu (Austin, Texas);  Joseph L. Greathouse (Austin, Texas)
ABSTRACT An operating system (OS) of a processing system having a plurality of processor cores determines a cost associated with different mechanisms for performing a translation lookaside buffer (TLB) shootdown in response to, for example, a virtual address being remapped to a new physical address, and selects a TLB shootdown mechanism to purge outdated or invalid address translations from the TLB based on the determined cost. In some embodiments, the OS selects an inter-processor interrupt (IPI) as the TLB shootdown mechanism if the cost associated with sending an IPI is less than a threshold cost. In some embodiments, the OS compares the cost of using an IPI as the TLB shootdown mechanism versus the cost of sending a hardware broadcast to all processor cores of the processing system as the shootdown mechanism and selects the shootdown mechanism having the lower cost.
FILED Tuesday, June 12, 2018
APPL NO 16/005882
ART UNIT 2132 — Memory Access and Control
CURRENT CPC
Electric Digital Data Processing
G06F 9/4812 (20130101)
G06F 12/1027 (20130101) Original (OR) Class
G06F 2212/682 (20130101)
G06F 2212/683 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553194 Longo et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Kansas City National Security Campus (KCNSC)
NNSA Critical Mission Site
Operated by Honeywell Federal Manufacturing and Technologies, LLC (FM&T) at Kansas City, MO
APPLICANT(S) HONEYWELL FEDERAL MANUFACTURING and TECHNOLOGIES, LLC (Kansas City, Missouri)
ASSIGNEE(S) Honeywell Federal Manufacturing and Technologies, LLC (Kansas City, Missouri)
INVENTOR(S) Daniel Longo (Kansas City, Missouri);  Russell Stewart (Kansas City, Missouri);  Bryce Hullet (Kansas City, Missouri)
ABSTRACT A portable sound-masking device for placing on a roll-up door having a number of horizontally-extending elements. The sound-masking device has a fixture, a magnet, and a transducer. The fixture has an inner face, an outer face, and a pair of spaced-apart tabs protruding from the inner face, the tabs being configured to engage one of the horizontally-extending elements of the roll-up door. The magnet is fastened to the inner face of the fixture and provides a force that tethers the sound-masking device to the roll-up door. The transducer is fastened to the outer face and is configured to emit sound-masking noise.
FILED Tuesday, December 04, 2018
APPL NO 16/208628
ART UNIT 2688 — Dynamic Storage Systems; Mechanical parts of Disk Drives
CURRENT CPC
Sound-producing Devices; Methods or Devices for Protecting Against, or for Damping, Noise or Other Acoustic Waves in General; Acoustics Not Otherwise Provided for
G10K 11/175 (20130101) Original (OR) Class

Secret Communication; Jamming of Communication
H04K 3/82 (20130101)
H04K 2203/12 (20130101)

Loudspeakers, Microphones, Gramophone Pick-ups or Like Acoustic Electromechanical Transducers; Deaf-aid Sets; Public Address Systems
H04R 2201/021 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553697 Armstrong et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) Andrew Armstrong (Albuquerque, New Mexico);  Albert G. Baca (Albuquerque, New Mexico);  Andrew A. Allerman (Tijeras, New Mexico);  Carlos Anthony Sanchez (Belen, New Mexico);  Erica Ann Douglas (Albuquerque, New Mexico);  Robert Kaplar (Albuquerque, New Mexico)
ABSTRACT Methods are provided for fabricating a HEMT (high-electron-mobility transistor) that involve sequential epitaxial growth of III-nitride channel and barrier layers, followed by epitaxial regrowth of further III-nitride material through a window in a mask layer. The regrowth takes place on the barrier layer, only in the access region or regions. Devices made according to the disclosed methods are also provided.
FILED Tuesday, April 16, 2019
APPL NO 16/385193
ART UNIT 2893 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/18 (20130101)
H01L 21/182 (20130101)
H01L 21/0254 (20130101)
H01L 21/0262 (20130101)
H01L 21/746 (20130101)
H01L 21/2036 (20130101)
H01L 21/2056 (20130101)
H01L 21/02642 (20130101)
H01L 21/30621 (20130101)
H01L 29/778 (20130101)
H01L 29/7781 (20130101)
H01L 29/7782 (20130101)
H01L 29/7786 (20130101)
H01L 29/66431 (20130101) Original (OR) Class
H01L 29/66462 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553782 Ketterson et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Argonne National Laboratory (ANL)
Federally Funded Research and Development Center (FFRDC)
Operated by UChicago Argonne, LLC (UCHICAGO) at Argonne, IL
APPLICANT(S) Qorvo US, Inc. (Greensboro, North Carolina)
ASSIGNEE(S) Qorvo US, Inc. (Greensboro, North Carolina)
INVENTOR(S) Andrew Arthur Ketterson (Dallas, Texas);  Xing Gu (Allen, Texas);  Yongjie Cui (Plano, Texas);  Xing Chen (Plainfield, Illinois)
ABSTRACT A passive magnetic device (PMD) has a base electrode, a multi-port signal structure (MPSS), and a substrate therebetween. The MPSS has a central plate residing in a second plane and at least two port tabs spaced apart from one another and extending from the central plate. The substrate has a central portion that defines a mesh structure between the base electrode and the central plate of the multi-port signal structure. A plurality of magnetic pillars are provided within the mesh structure, wherein each of the plurality of the magnetic pillars are spaced apart from one another and surrounded by a corresponding portion of the mesh structure. The PMD may provide a magnetically self-biased device that may be used as a radio frequency (RF) circulator, an RF isolator, and the like.
FILED Wednesday, February 21, 2018
APPL NO 15/901142
ART UNIT 2814 — Semiconductors/Memory
CURRENT CPC
Magnets; Inductances; Transformers; Selection of Materials for Their Magnetic Properties
H01F 1/015 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 43/02 (20130101) Original (OR) Class

Waveguides; Resonators, Lines, or Other Devices of the Waveguide Type
H01P 1/36 (20130101)
H01P 1/38 (20130101)

Transmission
H04B 7/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553866 Shao-Horn et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Yang Shao-Horn (Cambridge, Massachusetts);  Kevin May (Ancaster, Canada);  Jin Suntivich (Bangkok, Thailand)
ASSIGNEE(S) MASSACHUSETTS INSTITUTE OF TECHNOLOGY (Cambridge, Massachusetts)
INVENTOR(S) Yang Shao-Horn (Cambridge, Massachusetts);  Kevin May (Ancaster, Canada);  Jin Suntivich (Bangkok, Thailand)
ABSTRACT The oxygen evolution reaction (OER)-catalyzing activity of transition metal perovskite oxide catalysts depends on the occupancy of the σ-bonding orbital of eg symmetry parentage of the active cation. Catalysts having preferred values of eg orbital filling can have a high intrinsic activity for catalysis of the OER.
FILED Tuesday, July 19, 2011
APPL NO 13/185939
ART UNIT 1794 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Electrolytic or Electrophoretic Processes for the Production of Compounds or Non-metals; Apparatus Therefor
C25B 1/04 (20130101)
C25B 11/0463 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/485 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553871 Masarapu et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
U.S. State Government
State of California
California Energy Commission (CEC)
APPLICANT(S) Charan Masarapu (Fremont, California);  Haixia Deng (Fremont, California);  Yongbong Han (San Francisco, California);  Yogesh Kumar Anguchamy (Newark, California);  Subramanian Venkatachalam (Pleasanton, California);  Sujeet Kumar (Newark, California);  Herman A. Lopez (Sunnyvale, California)
ASSIGNEE(S) Zenlabs Energy, Inc. (Fremont, California)
INVENTOR(S) Charan Masarapu (Fremont, California);  Haixia Deng (Fremont, California);  Yongbong Han (San Francisco, California);  Yogesh Kumar Anguchamy (Newark, California);  Subramanian Venkatachalam (Pleasanton, California);  Sujeet Kumar (Newark, California);  Herman A. Lopez (Sunnyvale, California)
ABSTRACT Improved high energy capacity designs for lithium ion batteries are described that take advantage of the properties of high specific capacity anode active compositions and high specific capacity cathode active compositions. In particular, specific electrode designs provide for achieving very high energy densities. Furthermore, the complex behavior of the active materials is used advantageously in a radical electrode balancing design that significantly reduced wasted electrode capacity in either electrode when cycling under realistic conditions of moderate to high discharge rates and/or over a reduced depth of discharge.
FILED Friday, May 04, 2012
APPL NO 13/464034
ART UNIT 1723 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 1/24 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 2/024 (20130101)
H01M 2/1646 (20130101)
H01M 4/38 (20130101)
H01M 4/131 (20130101)
H01M 4/134 (20130101)
H01M 4/386 (20130101)
H01M 4/485 (20130101)
H01M 4/505 (20130101)
H01M 4/525 (20130101)
H01M 4/582 (20130101) Original (OR) Class
H01M 4/622 (20130101)
H01M 4/625 (20130101)
H01M 10/446 (20130101)
H01M 10/0525 (20130101)
H01M 2220/20 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553874 Elam et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Argonne National Laboratory (ANL)
Federally Funded Research and Development Center (FFRDC)
Operated by UChicago Argonne, LLC (UCHICAGO) at Argonne, IL
APPLICANT(S) UCHICAGO ARGONNE, LLC (Chicago, Illinois)
ASSIGNEE(S) UChicago Argonne, LLC (Chicago, Illinois)
INVENTOR(S) Jeffrey W. Elam (Elmhurst, Illinois);  Lin Chen (Westmont, Illinois)
ABSTRACT A hybrid protective coating includes an inorganic component and an organic component such that the inorganic component includes at least one of a metal oxide, a metal fluoride, or combination thereof, and the organic component includes at least one metalcone.
FILED Friday, August 04, 2017
APPL NO 15/669771
ART UNIT 1715 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Processes for Applying Fluent Materials to Surfaces, in General
B05D 7/50 (20130101)
B05D 7/56 (20130101)

Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 16/22 (20130101)
C23C 16/40 (20130101)
C23C 16/45527 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/366 (20130101)
H01M 4/382 (20130101)
H01M 4/0423 (20130101)
H01M 4/628 (20130101) Original (OR) Class
H01M 4/1395 (20130101)
H01M 2004/027 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553890 Zhang et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Argonne National Laboratory (ANL)
Federally Funded Research and Development Center (FFRDC)
Operated by UChicago Argonne, LLC (UCHICAGO) at Argonne, IL
APPLICANT(S) UCHICAGO ARGONNE, LLC (Chicago, Illinois)
ASSIGNEE(S) UCHICAGO ARGONNE, LLC (Chicago, Illinois)
INVENTOR(S) Zhengcheng Zhang (Naperville, Illinois);  Chi Cheung Su (Westmont, Illinois);  Lei Cheng (Naperville, Illinois)
ABSTRACT The present invention provides an aqueous redox flow battery comprising a negative electrode immersed in an aqueous liquid negative electrolyte, a positive electrode immersed in an aqueous liquid positive electrolyte, and a cation-permeable separator between the negative electrolyte from the positive electrolyte. During charging and discharging, the electrolytes are circulated over their respective electrodes. The electrolytes each comprise a redox reactant. Redox reactant of the positive electrolyte comprises a compound of Formula (I) as described in the specification.
FILED Friday, June 23, 2017
APPL NO 15/631239
ART UNIT 1725 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 8/023 (20130101)
H01M 8/188 (20130101) Original (OR) Class
H01M 8/04753 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10554049 Stewart et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
Office of Science (DOE-SC)
Lawrence Berkeley National Laboratory (LBNL)
Federally Funded Research and Development Center (FFRDC)
Operated by University of California (UC BERKELEY) at Berkeley, CA
APPLICANT(S) The Regents of The University of California (Oakland, California)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Emma Mary Stewart (Danville, California);  Ciaran Martin Roberts (Berkeley, California);  Emre can Kara (San Mateo, California);  Michaelangelo David Tabone (Kensington, California)
ABSTRACT Techniques are described for disaggregation of renewable energy generation on an electricity distribution system. Aggregate power measurements are identified a distribution substation. Active power load of the distribution substation and active power generated by renewable energy sites can be disaggregated from the aggregate power measurements.
FILED Monday, March 20, 2017
APPL NO 15/463749
ART UNIT 2857 — Printing/Measuring and Testing
CURRENT CPC
Circuit Arrangements or Systems for Supplying or Distributing Electric Power; Systems for Storing Electric Energy
H02J 3/383 (20130101) Original (OR) Class
H02J 3/386 (20130101)
H02J 13/0006 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10554151 Post et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) Lawrence Livermore National Security, LLC (Livermore, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Richard F. Post (Walnut Creek, California);  Edward G. Cook (Livermore, California)
ABSTRACT A novel motor drive system has been described for use in electrostatic generator/motor systems based on the time variation of capacity of a rotating condenser comprised of segmented rotor and stator elements. It takes advantage of the fact that the motor action of such a system depends only on the rms value of the drive pulses, which therefore can be formed simply by periodically interrupting a high-frequency ac wave train. This new circuitry simplifies the drive system and takes advantage of recent developments of devices used in the art of inversion of dc voltages to high-frequency (tens of kiloHz) ac.
FILED Wednesday, October 10, 2018
APPL NO 16/157022
ART UNIT 2837 — Electrical Circuits and Systems
CURRENT CPC
Electric Machines Not Otherwise Provided for
H02N 1/004 (20130101)
H02N 1/08 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10554172 Deceglie et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
National Renewable Energy Laboratory (NREL)
Federally Funded Research and Development Center (FFRDC)
Operated by Alliance for Sustainable Energy, LLC (ASE) at Golden, CO
APPLICANT(S) Alliance for Sustainable Energy, LLC (Golden, Colorado)
ASSIGNEE(S) Alliance for Sustainable Energy, LLC (Golden, Colorado)
INVENTOR(S) Michael Gardner Deceglie (Golden, Colorado);  Timothy J. Silverman (Golden, Colorado)
ABSTRACT The present disclosure relates to a method that includes applying a first condition to a photovoltaic (PV) device, and applying a second condition to the PV device, where the first condition results in a first luminescing of a surface of the PV device at a first intensity, the second condition results in a second luminescing of the surface at a second intensity, measuring the first intensity using a detector to create a first representation of the surface, measuring the second intensity using the detector to create a second representation of the surface, and comparing the first representation with the second representation to create a third representation of the surface that identifies a defect in the surface, if present.
FILED Friday, March 09, 2018
APPL NO 15/916862
ART UNIT 2868 — Printing/Measuring and Testing
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/66 (20130101)
G01N 21/9501 (20130101)

Generation of Electric Power by Conversion of Infra-red Radiation, Visible Light or Ultraviolet Light, e.g Using Photovoltaic [PV] Modules
H02S 50/15 (20141201) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

National Science Foundation (NSF) 

US 10548319 Gokel et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) The Curators of the University of Missouri (Columbia, Missouri)
ASSIGNEE(S) The Curators of the University of Missouri (Columbia, Missouri)
INVENTOR(S) George W. Gokel (Chesterfield, Missouri);  Mohit B. Patel (St. Louis, Missouri)
ABSTRACT The disclosure provides a method for increasing the lateral root development of a plant by exposing said plant to a composition containing a synthetic amphiphile. By increasing the number of lateral roots, the surface area of the root structure is increased, making the plants better able to survive such stresses as drought or low nutrients.
FILED Friday, August 07, 2015
APPL NO 15/502449
ART UNIT 1616 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 43/72 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548519 Arias et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
National Science Foundation (NSF)
Directorate for Education and Human Resources (EHR)
Division of Graduate Education (DGE)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Ana Claudia Arias (Berkeley, California);  Claire Lochner (Berkeley, California);  Adrien Pierre (Berkeley, California);  Yasser Khan (Berkeley, California)
ABSTRACT Pulse oximeter devices include a first light emitting element that emits red light, a second light emitting element that emits green light or IR light; and a sensor element that detects red and green (or IR) light and that outputs signals representing detected red and green (or IR) light. The pulse oximeter device further includes a flexible substrate, wherein the first light emitting element, the second light emitting element and the sensor element are formed on the flexible substrate. The sensor element is configured to detect the emitted red and green light transmitted through tissue containing blood, and in certain aspects, the sensor element is configured to detect the emitted red and green (or IR) light reflected by tissue containing blood. A signal processing element (e.g., a processor) receives and processes the signals representing detected red and green (or IR) light output by the sensor element to produce signals representing blood oxygenation content.
FILED Tuesday, January 24, 2017
APPL NO 15/414397
ART UNIT 3791 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/024 (20130101)
A61B 5/0205 (20130101)
A61B 5/6815 (20130101)
A61B 5/6826 (20130101)
A61B 5/14552 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548564 Mauldin, Jr. et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
APPLICANT(S) Rivanna Medical LLC (Charlottesville, Virginia)
ASSIGNEE(S) Rivanna Medical, LLC (Charlottesville, Virginia)
INVENTOR(S) Frank William Mauldin, Jr. (Charlottesville, Virginia);  Kevin Owen (Crozet, Virginia)
ABSTRACT Systems and methods for processing ultrasound data are provided. The disclosure includes using at least one computer hardware processor to perform obtaining ultrasound data generated based, at least in part, on one or more ultrasound signals from an imaged region of a subject, the ultrasound data comprising fundamental frequency ultrasound data and harmonic frequency ultrasound data, calculating shadow intensity data based at least in part on the harmonic frequency ultrasound data, generating, based at least in part on the fundamental frequency ultrasound data, an indication of bone presence in the imaged region, generating, based at least in part on the shadow intensity data, an indication of tissue presence in the imaged region, and generating an ultrasound image of the subject at least in part by combining the indication of bone presence and the indication of tissue presence.
FILED Tuesday, February 16, 2016
APPL NO 15/044425
ART UNIT 3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 8/461 (20130101)
A61B 8/0875 (20130101) Original (OR) Class
A61B 8/4254 (20130101)
A61B 8/5207 (20130101)
A61B 8/5223 (20130101)
A61B 8/5269 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548628 Swaney et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
Directorate for Education and Human Resources (EHR)
Division of Graduate Education (DGE)
APPLICANT(S) Vanderbilt University (Nashville, Tennessee)
ASSIGNEE(S) VANDERBILT UNIVERSITY (Nashville, Tennessee)
INVENTOR(S) Philip J. Swaney (Nashville, Tennessee);  Robert J. Webster, III (Nashville, Tennessee)
ABSTRACT A steerable surgical needle (10) includes an elongated needle shaft (12), a beveled tip portion (14), and a flexural element (16) that connects the needle shaft (12) with the tip portion (14) and permits the tip portion to deflect relative to the needle shaft. A method for steering the surgical needle (10) through tissue includes the steps of advancing the needle in the body tissue to induce tip flexure which causes the needle to follow a curved trajectory, and rotating the needle about its longitudinal axis in place, without advancement, to remove the tip flexure.
FILED Thursday, March 13, 2014
APPL NO 14/208508
ART UNIT 3771 — Medical & Surgical Instruments, Treatment Devices, Surgery and Surgical Supplies
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 17/3403 (20130101) Original (OR) Class
A61B 17/3417 (20130101)
A61B 2017/003 (20130101)
A61B 2017/3454 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/1007 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10548630 Swaney et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Vanderbilt University (Nashville, Tennessee)
ASSIGNEE(S) VANDERBILT UNIVERSITY (Nashville, Tennessee)
INVENTOR(S) Philip J. Swaney (Nashville, Tennessee);  Ray Lathrop (Nashville, Tennessee);  Jessica Burgner (Hannover, Germany);  Kyle Weaver (Thompson Station, Tennessee);  Hunter B. Gilbert (Nashville, Tennessee);  Robert J. Webster (Nashville, Tennessee);  David B. Comber (Nashville, Tennessee)
ABSTRACT The present invention relates to a system and apparatus for implementing a method for identifying tube parameters of a curved tube of an active cannula for operating on a target in a patient. The method includes the step (a) of acquiring a model of the patient anatomy including the target. The method also includes the step (b) of selecting a set of parameters characterizing a curved tube. The method also includes the step (c) of computing a workspace for an active cannula having the selected curved tube parameters. The method also includes the step (d) of comparing the workspace to the anatomical model to determine the degree to which an active cannula having the selected curved tube parameters covers the target. The method also includes the step (e) of repeating steps (b) through (d) through a defined number of curved tube parameter sets. The method also includes the step (f) of identifying the curved tube parameters that provide an active cannula with an optimal degree of target coverage.
FILED Tuesday, February 11, 2014
APPL NO 14/177864
ART UNIT 3771 — Medical & Surgical Instruments, Treatment Devices, Surgery and Surgical Supplies
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 17/3421 (20130101) Original (OR) Class
A61B 2017/3443 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10549255 Huang et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
NASA Shared Services Center (NSSC)
National Science Foundation (NSF)
Directorate of Geosciences (GEO)
Division of Earth Sciences (EAR)
APPLICANT(S) Brown University (Providence, Rhode Island)
ASSIGNEE(S) BROWN UNIVERSITY (Providence, Rhode Island)
INVENTOR(S) Yongsong Huang (Barrington, Rhode Island);  Jose C. Aponte (Silver Spring, Maryland);  Rafael Tarozo (Providence, Rhode Island);  James Dillon (Pawtucket, Rhode Island)
ABSTRACT Methods, compositions, devices and kits having a novel chromatographic material are provided herein for separating and identifying organic molecules and compounds, for example molecules and compounds containing electron rich functional groups such as carbon-carbon double bonds. The methods, compositions, and kits include a metal-thiolate chromatographic medium (MTCM) with a sulfur-containing functional group or a metal-selenolate chromatographic medium (MSCM) comprising a selenium-containing functional group covalently attached to a support medium, such that the sulfur-containing functional group or selenium-containing functional group is bound to at least one metal atom. The MTCM and/or MSCM has affinity and specificity to compounds having one or more carbon-carbon double bonds, and performs a highly efficient and rapid separation of samples yielding non-overlapping peaks of purified materials compared to traditional media.
FILED Wednesday, February 06, 2013
APPL NO 13/760497
ART UNIT 1777 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Separation
B01D 15/10 (20130101)
B01D 15/38 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/0233 (20130101)
B01J 20/0262 (20130101) Original (OR) Class
B01J 20/283 (20130101)
B01J 20/284 (20130101)
B01J 20/285 (20130101)
B01J 20/287 (20130101)
B01J 20/3242 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10549270 Kanatzidis et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Northwestern University (Evanston, Illinois)
ASSIGNEE(S) Northwestern University (Evanston, Illinois)
INVENTOR(S) Mercouri G. Kanatzidis (Wilmette, Illinois);  Debajit Sarma (Chicago, Illinois);  Emmanouil Manos (Evanston, Illinois)
ABSTRACT Composite ion-exchange materials for use in an ion-exchange column are provided. Also provided are ion-exchange columns packed with the materials and methods for using the materials to remove metal ions from samples, such as waste water samples. The composite ion-exchange materials comprise a composite material comprising a metal chalcogenide and an alginate, wherein the composite material is mixed with a granular material.
FILED Thursday, November 20, 2014
APPL NO 14/548952
ART UNIT 1779 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Separation
B01D 15/361 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 39/02 (20130101) Original (OR) Class
B01J 39/09 (20170101)
B01J 47/018 (20170101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/42 (20130101)
C02F 1/288 (20130101)
C02F 2001/425 (20130101)
C02F 2101/006 (20130101)
C02F 2101/20 (20130101)
C02F 2103/10 (20130101)
C02F 2103/34 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10549483 Turner et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) Kevin Turner (Wayne, Pennsylvania);  Helen Minsky (Philadelphia, Pennsylvania)
ABSTRACT A structured composite surface includes a backing layer and a plurality of composite posts in contact with the backing layer, each composite post having a core made of a first material and an outer shell made of a second material, the outer shell is in contact with and surrounding the core, the core has a Young's modulus of at least 50 times greater than the outer shell. A method of transfer printing includes pressing a stamp including at least one composite post to a substrate, the at least one composite post having a core made of a first material and an outer shell made of a second material, the outer shell is in contact with and surrounding the core, the core has a Young's modulus at least 50 times greater than the outer shell, and retracting the stamp from the substrate by applying a shear load to the stamp.
FILED Thursday, May 28, 2015
APPL NO 15/311536
ART UNIT 1766 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Processes for Applying Fluent Materials to Surfaces, in General
B05D 1/02 (20130101)
B05D 3/007 (20130101)

Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 65/48 (20130101) Original (OR) Class

Indexing Scheme Associated With Subclass B29C, Relating to Particular Articles
B29L 2031/756 (20130101)

Photomechanical Production of Textured or Patterned Surfaces, e.g for Printing, for Processing of Semiconductor Devices; Materials Therefor; Originals Therefor; Apparatus Specially Adapted Therefor;
G03F 7/0002 (20130101)
G03F 7/20 (20130101)
G03F 7/26 (20130101)
G03F 7/162 (20130101)
G03F 7/0385 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10549504 Baer et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Eric Baer (Cleveland Heights, Ohio);  Anne Hiltner (Cleveland, Ohio)
ASSIGNEE(S) CASE WESTERN RESERVE UNIVERSITY (Cleveland, Ohio)
INVENTOR(S) Eric Baer (Cleveland Heights, Ohio);  Anne Hiltner (Cleveland, Ohio)
ABSTRACT A multilayer film includes an extruded first polymer layer confined between extruded second polymer layers. The first polymer layer includes a high aspect ratio crystalline lamellae. The multilayer film is substantially impermeable to gas diffusion.
FILED Monday, December 07, 2009
APPL NO 12/631964
ART UNIT 1787 — Miscellaneous Articles, Stock Material
CURRENT CPC
Layered Products, i.e Products Built-up of Strata of Flat or Non-flat, e.g Cellular or Honeycomb, Form
B32B 7/02 (20130101) Original (OR) Class

Technical Subjects Covered by Former US Classification
Y10T 428/265 (20150115)
Y10T 428/31544 (20150401)
Y10T 428/31725 (20150401)
Y10T 428/31786 (20150401)
Y10T 428/31938 (20150401)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550003 Hersam et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Northwestern University (Evanston, Illinois)
ASSIGNEE(S) NORTHWESTERN UNIVERSITY (Evanston, Illinois)
INVENTOR(S) Mark C. Hersam (Wilmette, Illinois);  Xiaolong Liu (Evanston, Illinois)
ABSTRACT Articles comprising a boron allotrope and an organic compound having a lateral interface one with the other, together with method(s) of preparation of such articles.
FILED Thursday, February 08, 2018
APPL NO 15/892124
ART UNIT 1761 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Non-metallic Elements; Compounds Thereof;
C01B 35/04 (20130101) Original (OR) Class

Indexing Scheme Relating to Structural and Physical Aspects of Solid Inorganic Compounds
C01P 2002/20 (20130101)
C01P 2002/60 (20130101)
C01P 2004/90 (20130101)
C01P 2006/40 (20130101)
C01P 2006/90 (20130101)

Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 16/04 (20130101)
C23C 16/22 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 51/0011 (20130101)
H01L 51/0053 (20130101)
H01L 51/0096 (20130101)
H01L 2251/301 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550291 Hardin et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Industrial Innovation and Partnerships (IIP)
APPLICANT(S) Hitachi Chemical Co., Ltd. (Tokyo, Japan)
ASSIGNEE(S) Hitachi Chemical Co., Ltd. (Tokyo, Japan)
INVENTOR(S) Brian E. Hardin (San Carlos, California);  Stephen T. Connor (San Francisco, California);  Craig H. Peters (Belmont, California)
ABSTRACT Oxidation-resistant electrically-conductive metal particles (ORCMP) are disclosed. ORCMPs are comprised of a base-metal core, an oxidation-resistant first shell, and an optional conductive second shell. ORCMPs are low cost alternatives to silver particles in metal fillers for low-temperature, electrically-conductive adhesives. Adhesives including ORCMPs, organic vehicles, and optional conductive metal particles such as silver were formulated to yield conductive films upon curing at low temperatures. Such films can be used in many electronic devices where low-temperature, low cost films are needed.
FILED Monday, August 22, 2016
APPL NO 15/243847
ART UNIT 1761 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Use of Inorganic or Non-macromolecular Organic Substances as Compounding Ingredients
C08K 7/06 (20130101)
C08K 9/02 (20130101)
C08K 2003/0806 (20130101)
C08K 2003/2286 (20130101)
C08K 2003/2293 (20130101)
C08K 2201/001 (20130101)
C08K 2201/003 (20130101)

Adhesives; Non-mechanical Aspects of Adhesive Processes in General; Adhesive Processes Not Provided for Elsewhere; Use of Materials as Adhesives
C09J 7/10 (20180101)
C09J 9/02 (20130101) Original (OR) Class
C09J 11/04 (20130101)
C09J 163/00 (20130101)
C09J 2201/602 (20130101)
C09J 2203/326 (20130101)
C09J 2205/102 (20130101)
C09J 2463/00 (20130101)

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 1/22 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550365 Biggs et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S) The Trustees of Columbia University in the City of New York (New York, New York)
INVENTOR(S) Manus J. P. Biggs (Galway, Ireland);  Ryan Cooper (Oak Ridge, Tennessee);  Jinyu Liao (New York, New York);  Teresa Anne Fazio (Poughkeepsie, New York);  Carl Fredrik Oskar Dahlberg (Stockholm, Sweden);  Jeffrey William Kysar (New York, New York);  Samuel Jonas Wind (White Plains, New York)
ABSTRACT An elastomeric substrate comprises a surface with regions of heterogeneous rigidity, wherein the regions are formed by exposing the elastomeric substrate to an energy source to form the regions such that the regions include a rigidity pattern comprising spots.
FILED Monday, April 10, 2017
APPL NO 15/483754
ART UNIT 1712 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0068 (20130101) Original (OR) Class
C12N 5/0663 (20130101)
C12N 2533/30 (20130101)
C12N 2535/00 (20130101)
C12N 2535/10 (20130101)
C12N 2537/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551313 Li et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Engineering Education and Centers (EEC)
APPLICANT(S) Chenzhong Li (Miami, Florida);  Maedeh Mozneb (Doral, Florida);  Amirali Nilchian (Davie, Florida)
ASSIGNEE(S) The Florida International University Board of Trustees (Miami, Florida)
INVENTOR(S) Chenzhong Li (Miami, Florida);  Maedeh Mozneb (Doral, Florida);  Amirali Nilchian (Davie, Florida)
ABSTRACT Surface plasmon resonance (SPR) based sensing systems and methods for sensing rhythmic beating characteristics of living cells are provided. An SPR based sensing system can include: an SPR sensing surface capable of generating SPR upon stimulation by incident light and configured to sense contractions, expansions, and/or movements of a plurality of living cells on the SPR sensing surface; and a cell culture module for culturing the living cells on the SPR sensing surface. In addition, the SPR based sensing system can perform a real-time analysis of one or more analytes secreted from the living cells by including a coating on the SPR sensing surface.
FILED Monday, April 15, 2019
APPL NO 16/383723
ART UNIT 2886 — Optics
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/59 (20130101) Original (OR) Class
G01N 33/4833 (20130101)
G01N 2021/5903 (20130101)
G01N 2201/0446 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551330 Atre et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California);  STICHTING VOOR FUNDAMENTEEL ONDERZOEK DER MATERIE (Utrecht, Netherlands);  Ashwin C. Atre (Stanford, California);  Jennifer A. Dionne (Stanford, California);  Benjamin Brenny (Utrecht, Netherlands);  Toon Coenen (Utrecht, Netherlands);  Albert Polman (Utrecht, Netherlands)
ASSIGNEE(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California);  STICHTING VOOR FUNDAMENTEEL ONDERZOEK DER MATERIE (Utrecht, Netherlands)
INVENTOR(S) Ashwin C. Atre (Stanford, California);  Jennifer A. Dionne (Stanford, California);  Benjamin Brenny (Utrecht, Netherlands);  Toon Coenen (Utrecht, Netherlands);  Albert Polman (Utrecht, Netherlands)
ABSTRACT In one aspect, a cathodoluminescence (CL) spectroscopic tomography device includes a sample stage to support a sample. An electron beam source scans an electron beam over the sample to yield light emission by the sample. A reflective element directs the light emission by the sample to a light detector. A controller controls operation of the sample stage, the electron beam source, and the light detector. In one aspect, a CL spectroscopic tomography device includes an electron beam source which directs an electron beam at an object to yield an emission by the object. A detector detects the emission. A controller receives information from the detector related to the detected emission. The controller derives a two-dimensional (2D) CL map from the information related to the detected emission, and derives a three-dimensional (3D) CL tomogram from the 2D CL map.
FILED Wednesday, April 22, 2015
APPL NO 15/305329
ART UNIT 2881 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/00 (20130101)
A61B 5/0073 (20130101)
A61B 5/0075 (20130101)

Measurement of Intensity, Velocity, Spectral Content, Polarisation, Phase or Pulse Characteristics of Infra-Red, Visible or Ultra-violet Light; Colorimetry; Radiation Pyrometry
G01J 3/44 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 23/2254 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551744 Hart et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  The Regents of the University of Michigan (Ann Arbor, Michigan)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  The Regents of the University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Anastasios John Hart (Waban, Massachusetts);  Christopher Ryan Oliver (Commerce, Michigan);  Adam Gregory Stevens (Midland, Michigan);  Jieyuan Wu (Suzhou, China PRC);  Chad Robert Archer (Midland, Michigan)
ABSTRACT Systems, devices, and methods for printing on surfaces of three-dimensional objects are provided. The systems, devices, and methods allow for images, and three-dimensional structures, to be printed onto a surface of a three-dimensional object. The surface of the three-dimensional object can have many different shapes, including an arbitrary or non-uniform shape having multiple curves. In one exemplary embodiment, the method includes associating a pattern of polygons with a surface of a three-dimensional object and then scaling a pattern of polygons associated with an image to be printed onto the surface with the pattern of polygons associated with the surface. One or more polygons of the scaled pattern of polygons are then progressively projected onto the surface, and a photosensitive material associated with the surface is cured to set projected image portion on the surface. Systems, devices, and other methods for printing onto surfaces of three-dimensional objects are also provided.
FILED Tuesday, May 28, 2019
APPL NO 16/423529
ART UNIT 1717 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Photomechanical Production of Textured or Patterned Surfaces, e.g for Printing, for Processing of Semiconductor Devices; Materials Therefor; Originals Therefor; Apparatus Specially Adapted Therefor;
G03F 7/2051 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10551869 Vrudhula et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Sarma Vrudhula (Chandler, Arizona);  Aykut Dengi (Tempe, Arizona);  Niranjan Kulkarni (Tempe, Arizona)
ASSIGNEE(S) Arizona Board of Regents on behalf of Arizona State University (Scottsdale, Arizona)
INVENTOR(S) Sarma Vrudhula (Chandler, Arizona);  Aykut Dengi (Tempe, Arizona);  Niranjan Kulkarni (Tempe, Arizona)
ABSTRACT This disclosure relates generally to digital synchronous circuits that introduce clock skew without requiring clock buffers in a clock network. In one embodiment, the digital synchronous circuit includes a first flip flop and a second flip flop. The first flip flop is synchronized to be transparent and to be opaque in accordance with a first clock signal while the second flip flop is configured such that the second flip flop is synchronized to be transparent and to be opaque in accordance with a second clock signal. However, the second flip flop is configured to generate the first clock signal such that the second flip flop provides the first clock signal in a first clock state in response the second flip flop becoming transparent and provides the first clock signal in a second clock state in response the second flip flop becoming opaque thereby providing a clock skew without clock buffers.
FILED Monday, February 27, 2017
APPL NO 15/443444
ART UNIT 2186 — Computer Architecture and I/O
CURRENT CPC
Electric Digital Data Processing
G06F 1/10 (20130101)
G06F 1/12 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10552756 Ipek et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computing and Communication Foundations (CCF)
APPLICANT(S) Engin Ipek (Rochester, New York);  Ben Feinberg (Rochester, New York);  Shibo Wang (Rochester, New York);  Mahdi N. Bojnordi (Rochester, New York);  Ravi Patel (Victor, New York);  Eby G. Friedman (Rochester, New York)
ASSIGNEE(S) University of Rochester (Rochester, New York)
INVENTOR(S) Engin Ipek (Rochester, New York);  Ben Feinberg (Rochester, New York);  Shibo Wang (Rochester, New York);  Mahdi N. Bojnordi (Rochester, New York);  Ravi Patel (Victor, New York);  Eby G. Friedman (Rochester, New York)
ABSTRACT An energy efficient rapid single flux quantum (ERSFQ) logic register wheel includes a circular shift register having a plurality of destructive read out (DRO) cells. Each entry of the circular shift register includes a data block, a tag, and a valid bit. A compare and control logic is coupled to the circular shift register to compare a source specifier or a destination register specifier against a register tag stored in the wheel following each cycle of the register wheel. At least one or more read ports and at least one or more write ports are coupled to the circular shift register to write to or to read from a different entry each in the register wheel following each cycle of the register wheel. A RSFQ clearable FIFO with flushing and a crosspoint memory topology for integrating MRAM devices with ERSFQ circuits are also described.
FILED Thursday, November 10, 2016
APPL NO 15/774503
ART UNIT 2844 — Electrical Circuits and Systems
CURRENT CPC
Electric Digital Data Processing
G06F 7/381 (20130101)
G06F 9/3004 (20130101)
G06F 9/3016 (20130101)
G06F 9/30105 (20130101)

Computer Systems Based on Specific Computational Models
G06N 10/00 (20190101) Original (OR) Class

Static Stores
G11C 11/44 (20130101)
G11C 11/161 (20130101)
G11C 11/1673 (20130101)
G11C 11/1675 (20130101)
G11C 19/32 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 27/18 (20130101)
H01L 27/222 (20130101)
H01L 39/223 (20130101)
H01L 43/02 (20130101)

Pulse Technique
H03K 19/195 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553711 Lemaitre et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) University of Florida Research Foundation, Inc. (Gainesville, Florida)
ASSIGNEE(S) University of Florida Research Foundation, Inc. (Gainesville, Florida)
INVENTOR(S) Maxime G. Lemaitre (Gainesville, Florida);  Xiao Chen (Gainesville, Florida);  Bo Liu (Gainesville, Florida);  Mitchell Austin McCarthy (Gainesville, Florida);  Andrew Gabriel Rinzler (Newberry, Florida)
ABSTRACT Various aspects of tunable barrier transistors that can be used in high power electronics are provided. In one example, among others, a tunable barrier transistor includes an inorganic semiconducting layer; a source electrode including a nano-carbon film disposed on the inorganic semiconducting layer; a gate dielectric layer disposed on the nano-carbon film; and a gate electrode disposed on the gate dielectric layer over at least a portion of the nano-carbon film. The nano-carbon film can form a source-channel interface with the inorganic semiconducting layer. A gate field produced by the gate electrode can modulate a barrier height at the source-channel interface. The gate field may also modulate a barrier width at the source-channel interface.
FILED Friday, April 24, 2015
APPL NO 15/305227
ART UNIT 2896 — Semiconductors/Memory
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 10/00 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 29/45 (20130101)
H01L 29/517 (20130101)
H01L 29/0673 (20130101)
H01L 29/778 (20130101) Original (OR) Class
H01L 29/1606 (20130101)
H01L 51/0048 (20130101)
H01L 51/0562 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553793 Jha et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) University of Cincinnati (Cincinnati, Ohio)
ASSIGNEE(S) University of Cincinnati (Cincinnati, Ohio)
INVENTOR(S) Rashmi Jha (Wyoming, Ohio);  Andrew Rush (Cincinnati, Ohio);  Eric Herrmann (Beavercreek, Ohio)
ABSTRACT Systems and methods of use and fabrication are described for a non-volatile resistive random access memory (RRAM) multi-terminal device including a first electrode, a second electrode, a metal oxide disposed between the first electrode and the second electrode, and an at least first gate configured to apply a voltage bias to change a resistive state in the metal oxide.
FILED Thursday, March 28, 2019
APPL NO 16/367637
ART UNIT 2824 — Semiconductors/Memory
CURRENT CPC
Static Stores
G11C 13/004 (20130101)
G11C 13/0069 (20130101)
G11C 2013/0045 (20130101)
G11C 2013/0078 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 27/2436 (20130101)
H01L 27/2463 (20130101)
H01L 45/146 (20130101) Original (OR) Class
H01L 45/1206 (20130101)
H01L 45/1253 (20130101)
H01L 45/1625 (20130101)
H01L 45/1675 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553875 Greer et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Education and Human Resources (EHR)
Division of Graduate Education (DGE)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) California Institute of Technology (Pasadena, California)
ASSIGNEE(S) California Institute of Technology (Pasadena, California)
INVENTOR(S) Julia R. Greer (San Marino, California);  Lucas R. Meza (Pasadena, California);  Lauren C. Montemayor (Pasadena, California);  Xun W. Gu (Pasadena, California)
ABSTRACT A scaffold includes struts that intersect at nodes. In some instances, a cross section of the cores has at least one dimension less than 100 microns. The core can be a solid, liquid or a gas. In some instances, one or more shell layers are positioned on the core.
FILED Wednesday, April 16, 2014
APPL NO 14/254824
ART UNIT 1723 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Capacitors; Capacitors, Rectifiers, Detectors, Switching Devices or Light-sensitive Devices, of the Electrolytic Type
H01G 11/26 (20130101)
H01G 11/30 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/72 (20130101) Original (OR) Class
H01M 8/0247 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 60/13 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10554154 Majidi et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
APPLICANT(S) CARNEGIE MELLON UNIVERSITY, a Pennsylvania Non-Profit Corporation (Pittsburgh, Pennsylvania)
ASSIGNEE(S) CARNEGIE MELLON UNIVERSITY (Pittsburgh, Pennsylvania)
INVENTOR(S) Carmel Majidi (Pittsburgh, Pennsylvania);  Steven Collins (Pittsburgh, Pennsylvania);  Stuart Diller (Pittsburgh, Pennsylvania)
ABSTRACT An electrostatic clutch is described comprising a plurality of micron-scale thickness electrodes, adjacent electrodes being separated by a thin film of dielectric material. A power source and controller apply a voltage across two electrodes, causing an electrostatic force to develop. When engaged, a force can be transferred through the clutch. A tensioning device maintains the alignment of the clutch when the electrodes are disengaged, but permits movement in at least one direction. In some embodiments, multiple clutches are connected to an output to provide variable force control and a broad range of torque input and output values. Moreover, the clutch can be used as an energy-recycling actuator that captures mechanical energy from negative work movements, and returns energy during positive work movements.
FILED Tuesday, July 16, 2019
APPL NO 16/513593
ART UNIT 3655 — Material and Article Handling
CURRENT CPC
Couplings for Transmitting Rotation; Clutches; Brakes
F16D 27/00 (20130101)
F16D 28/00 (20130101)

Electric Machines Not Otherwise Provided for
H02N 13/00 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10554458 Ibrahim et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) NORTHEASTERN UNIVERSITY (Boston, Massachusetts)
ASSIGNEE(S) NORTHEASTERN UNIVERSITY (Boston, Massachusetts)
INVENTOR(S) Mahmoud Ayman Ahmed Ibrahim (Boston, Massachusetts);  Marvin Onabajo (Jamaica Plain, Massachusetts)
ABSTRACT Techniques and architectures for providing FSK signal modulation using mixing for the generation of the two output frequencies are described. In an embodiment, a frequency-shift keying (FSK) transmitter may be operative to provide transmission of wireless signals. The FSK transmitter may include a high-frequency generator to generate at least one high-frequency wave signal based on a fixed frequency signal, a low-frequency generator to generate at least one low-frequency wave signal based on the fixed frequency signal, and at least one mixer to mix the at least one high-frequency wave signal and the at least one low-frequency wave signal to generate a logic signal, the logic signal comprising one of a logic 0 signal or a logic 1 signal based on digital input data.
FILED Wednesday, April 04, 2018
APPL NO 15/945452
ART UNIT 2631 — Digital Communications
CURRENT CPC
Modulation
H03C 3/09 (20130101)

Impedance Networks, e.g Resonant Circuits; Resonators
H03H 7/38 (20130101)

Pulse Technique
H03K 5/00006 (20130101)

Automatic Control, Starting, Synchronisation, or Stabilisation of Generators of Electronic Oscillations or Pulses
H03L 7/16 (20130101)
H03L 7/0992 (20130101)

Transmission
H04B 1/04 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 27/12 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

National Aeronautics and Space Administration (NASA) 

US 10549255 Huang et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
NASA Shared Services Center (NSSC)
National Science Foundation (NSF)
Directorate of Geosciences (GEO)
Division of Earth Sciences (EAR)
APPLICANT(S) Brown University (Providence, Rhode Island)
ASSIGNEE(S) BROWN UNIVERSITY (Providence, Rhode Island)
INVENTOR(S) Yongsong Huang (Barrington, Rhode Island);  Jose C. Aponte (Silver Spring, Maryland);  Rafael Tarozo (Providence, Rhode Island);  James Dillon (Pawtucket, Rhode Island)
ABSTRACT Methods, compositions, devices and kits having a novel chromatographic material are provided herein for separating and identifying organic molecules and compounds, for example molecules and compounds containing electron rich functional groups such as carbon-carbon double bonds. The methods, compositions, and kits include a metal-thiolate chromatographic medium (MTCM) with a sulfur-containing functional group or a metal-selenolate chromatographic medium (MSCM) comprising a selenium-containing functional group covalently attached to a support medium, such that the sulfur-containing functional group or selenium-containing functional group is bound to at least one metal atom. The MTCM and/or MSCM has affinity and specificity to compounds having one or more carbon-carbon double bonds, and performs a highly efficient and rapid separation of samples yielding non-overlapping peaks of purified materials compared to traditional media.
FILED Wednesday, February 06, 2013
APPL NO 13/760497
ART UNIT 1777 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Separation
B01D 15/10 (20130101)
B01D 15/38 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/0233 (20130101)
B01J 20/0262 (20130101) Original (OR) Class
B01J 20/283 (20130101)
B01J 20/284 (20130101)
B01J 20/285 (20130101)
B01J 20/287 (20130101)
B01J 20/3242 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10549516 Palmieri et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) United States of America as represented by the Administrator of NASA (Washington, District of Columbia)
ASSIGNEE(S) UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF NASA (Washington, District of Columbia)
INVENTOR(S) Frank L. Palmieri (Hampton, Virginia);  John W. Connell (Yorktown, Virginia);  Christopher J. Wohl, Jr. (Portsmouth, Virginia)
ABSTRACT A method for bonding composite substrates includes coupling a first co-cure prepreg layer having a first off-set amine to epoxide molar ratio onto a surface of a first composite substrate and coupling a second co-cure prepreg layer having a second off-set amine to epoxide molar ratio onto a surface of a second composite substrate. The first and second composite substrates are cured to the first and second co-cure prepreg layers, respectively, using a first cure cycle (including B-stage and cure temperatures) to form a first and a second co-cure prepreg layer portion. The method further includes coupling the first co-cure prepreg layer portion to the second co-cure prepreg layer portion and applying a second cure cycle to cure the first co-cure prepreg layer portion of the first composite substrate to the second co-cure prepreg layer portion of the second composite substrate to form a monolithic covalently bonded composite structure.
FILED Friday, September 08, 2017
APPL NO 15/699433
ART UNIT 1766 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 65/02 (20130101)
B29C 65/14 (20130101)
B29C 65/4835 (20130101)
B29C 65/5014 (20130101)
B29C 65/5057 (20130101)
B29C 66/43 (20130101)
B29C 66/71 (20130101)
B29C 66/71 (20130101)
B29C 66/0242 (20130101)
B29C 66/721 (20130101)
B29C 66/919 (20130101)
B29C 66/1122 (20130101)
B29C 66/73752 (20130101)
B29C 66/73754 (20130101)
B29C 66/73941 (20130101)
B29C 66/81455 (20130101)
B29C 66/91445 (20130101)
B29C 66/91921 (20130101)
B29C 70/30 (20130101)

Indexing Scheme Associated With Subclasses B29B, B29C or B29D, Relating to Moulding Materials or to Materials for Reinforcements, Fillers or Preformed Parts, e.g Inserts
B29K 2063/00 (20130101)

Layered Products, i.e Products Built-up of Strata of Flat or Non-flat, e.g Cellular or Honeycomb, Form
B32B 5/022 (20130101)
B32B 5/024 (20130101)
B32B 5/026 (20130101)
B32B 5/26 (20130101)
B32B 7/12 (20130101)
B32B 27/08 (20130101)
B32B 27/12 (20130101)
B32B 27/18 (20130101)
B32B 27/20 (20130101)
B32B 27/26 (20130101)
B32B 27/34 (20130101)
B32B 27/36 (20130101)
B32B 27/38 (20130101) Original (OR) Class
B32B 27/40 (20130101)
B32B 27/42 (20130101)
B32B 27/281 (20130101)
B32B 37/14 (20130101)
B32B 2250/04 (20130101)
B32B 2260/023 (20130101)
B32B 2260/046 (20130101)
B32B 2262/10 (20130101)
B32B 2262/14 (20130101)
B32B 2262/105 (20130101)
B32B 2262/106 (20130101)
B32B 2262/0253 (20130101)
B32B 2262/0261 (20130101)
B32B 2262/0269 (20130101)
B32B 2262/0276 (20130101)
B32B 2264/10 (20130101)
B32B 2264/102 (20130101)
B32B 2264/104 (20130101)
B32B 2270/00 (20130101)
B32B 2305/72 (20130101)
B32B 2305/74 (20130101)
B32B 2305/076 (20130101)
B32B 2305/77 (20130101)
B32B 2307/536 (20130101)
B32B 2307/558 (20130101)
B32B 2309/02 (20130101)
B32B 2605/18 (20130101)

Adhesives; Non-mechanical Aspects of Adhesive Processes in General; Adhesive Processes Not Provided for Elsewhere; Use of Materials as Adhesives
C09J 5/06 (20130101)
C09J 2463/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10549845 Epstein et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
Neil A Armstrong Flight Research Center (AFRC)
APPLICANT(S) UNITED TECHNOLOGIES CORPORATION (Farmington, Connecticut)
ASSIGNEE(S) United Technologies Corporation (Farmington, Connecticut)
INVENTOR(S) Alan H. Epstein (Lexington, Massachusetts);  Gabriel L. Suciu (Glastonbury, Connecticut);  Jesse M. Chandler (South Windsor, Connecticut)
ABSTRACT A propulsion system for an aircraft including at least two main gas turbine engines and a plurality of dedicated boundary layer ingestion fans. The propulsion system is arranged such that a combined thrust produced by the boundary layer ingestion fans is less than 20 percent of a total thrust of the main engines and the boundary layer ingestion fans. The boundary layer ingestion fans are controllable and selectively turned off at lower speeds.
FILED Friday, May 26, 2017
APPL NO 15/606051
ART UNIT 3643 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Aeroplanes; Helicopters
B64C 1/0009 (20130101)
B64C 21/06 (20130101) Original (OR) Class
B64C 23/02 (20130101)

Equipment for Fitting in or to Aircraft; Flying Suits; Parachutes; Arrangements or Mounting of Power Plants or Propulsion Transmissions in Aircraft
B64D 2033/0226 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10552651 Fink et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) United States of America as represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia)
ASSIGNEE(S) United States of America as represented by the Administrator of the National Aeronautics and Space (Washington, District of Columbia)
INVENTOR(S) Patrick W. Fink (Missouri City, Texas);  Gregory Y. Lin (Friendswood, Texas);  Timothy F. Kennedy (Sugar Land, Texas);  Phong H. Ngo (Friendswood, Texas)
ABSTRACT A radio frequency identification (RFID) system for frequency multiplexing includes, in an exemplary embodiment, an RFID interrogator configured for generating an RFID signal, wherein a channel frequency of the RFID signal changes over time; at least one antenna or transmission line; and a diplexer coupling the RFID interrogator and the antennas or transmission lines and configured for distributing the RFID signal to each of the antennas or transmission lines, respectively, depending on the channel frequency of the RFID signal generated. The antennas or transmission lines are configured to transmit an electromagnetic wave in response to and at the channel frequency of the RFID signal distributed thereto. Other embodiments include RFID systems and methods including a frequency selective surface and both similar and different components and aspects for frequency multiplexing.
FILED Wednesday, June 28, 2017
APPL NO 15/635843
ART UNIT 2688 — Dynamic Storage Systems; Mechanical parts of Disk Drives
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 7/10356 (20130101) Original (OR) Class

Antennas, i.e Radio Aerials
H01Q 15/0013 (20130101)

Transmission
H04B 1/713 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 5/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Agriculture (USDA) 

US 10548322 Dhingra et al.
FUNDED BY
Department of Agriculture (USDA)
National Institute of Food and Agriculture (NIFA)
APPLICANT(S) Washington State University (Pullman, Washington)
ASSIGNEE(S) Washington State University (Pullman, Washington)
INVENTOR(S) Amit Dhingra (Pullman, Washington);  Christopher Hendrickson (Pullman, Washington);  Seanna Hewitt (Pullman, Washington)
ABSTRACT Methods of controlling the maturation of plants and/or plant products (e.g. fruit, vegetable, ornamentals, etc.) by manipulating Alternative Oxidase (AOX) activity. An increase in activity hastens the maturation process while a decrease in activity slows or stops maturation.
FILED Friday, March 10, 2017
APPL NO 15/456330
ART UNIT 1663 — Plants
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 3/00 (20130101)
A01N 59/02 (20130101) Original (OR) Class

Preserving, e.g by Canning, Meat, Fish, Eggs, Fruit, Vegetables, Edible Seeds; Chemical Ripening of Fruit or Vegetables; the Preserved, Ripened, or Canned Products
A23B 7/154 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10550353 Catchmark et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) The Penn State Research Foundation (University Park, Pennsylvania)
ASSIGNEE(S) The Penn State Research Foundation (University Park, Pennsylvania)
INVENTOR(S) Jeffrey Catchmark (University Park, Pennsylvania);  Kai Chi (University Park, Pennsylvania)
ABSTRACT Multi-surfactant systems where two or more surfactant molecules are coupled to control the spatial distribution of polar groups of the combined surfactant molecules are disclosed. The system can be implemented by an aqueous medium including an associate charge constant surfactant and charge variable surfactant. The charge variable surfactant has at least one neutral end group at one pH value of the medium and at least one either an anionic polar group or a cationic polar group at a different pH value of the medium. The charge constant surfactant has at least one, and preferably two or more groups that does not change charge at the one or different pH values of the aqueous medium. The multi-surfactant system can be coupled or connected to the surface of a substrate where the arrangement of the two or more coupled surfactant molecules control the polarity of the substrate surface.
FILED Friday, May 20, 2016
APPL NO 15/572129
ART UNIT 1761 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Detergent Compositions; Use of Single Substances as Detergents; Soap or Soap-making; Resin Soaps; Recovery of Glycerol
C11D 1/04 (20130101) Original (OR) Class
C11D 1/40 (20130101)
C11D 1/50 (20130101)
C11D 1/52 (20130101)
C11D 1/83 (20130101)
C11D 1/86 (20130101)
C11D 1/835 (20130101)
C11D 3/222 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Commerce (DOC) 

US 10552300 Kuhn et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S) NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY (Gaithersburg, Maryland)
ASSIGNEE(S) UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF COMMERCE (Gaithersburg, Maryland)
INVENTOR(S) D. Richard Kuhn (Columbia, Maryland);  Raghu N. Kacker (North Potomac, Maryland)
ABSTRACT A process for testing a program includes: receiving a variable comprising a plurality of input values; producing a plurality of equivalence classes for the input values; producing a representative value per equivalence class; producing, by a processor, a primary covering array comprising a plurality of primary vectors; producing a secondary covering array comprising a plurality of secondary vectors; providing the secondary vectors to the program; and producing a result vector comprising a plurality of result entries to test the program. A computer system for testing the program includes: a memory; and a processor, in communication with the memory, wherein the computer system is configured to perform the process for testing the program. A computer program product for testing the program includes: a non-transitory computer readable storage medium readable by a processor and storing program code for execution by the processor to perform the process.
FILED Tuesday, February 09, 2016
APPL NO 15/019448
ART UNIT 2191 — Interprocess Communication and Software Development
CURRENT CPC
Electric Digital Data Processing
G06F 11/3676 (20130101) Original (OR) Class
G06F 11/3692 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553897 Udovic
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S) NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY (Gaithersburg, Maryland)
ASSIGNEE(S) GOVERNEMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF COMMERCE (Gaithersburg, Maryland)
INVENTOR(S) Terrence John Udovic (Washington, District of Columbia)
ABSTRACT A process for making a superionic conducting salt includes: combining a primary salt and an impact member, the primary salt including an ordered phase and being an ionic conductor; impacting the primary salt with the impact member; and converting the primary salt to the superionic conducting salt in response to impacting the primary salt with the impact member at a conversion temperature to make the superionic conducting salt, the conversion temperature optionally being less than a thermally activated transition temperature that thermally converts the primary salt to the superionic conducting salt in an absence of the impacting the primary salt, and the superionic conducting salt including a superionic conductive phase in a solid state at less than the thermally activated transition temperature.
FILED Friday, June 03, 2016
APPL NO 15/172641
ART UNIT 1725 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Non-metallic Elements; Compounds Thereof;
C01B 35/026 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 10/052 (20130101)
H01M 10/054 (20130101)
H01M 10/0562 (20130101) Original (OR) Class
H01M 2300/0068 (20130101)
H01M 2300/0091 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Homeland Security (DHS) 

US 10553093 Fry et al.
FUNDED BY
Department of Homeland Security (DHS)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
ASSIGNEE(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
INVENTOR(S) Mark A. Fry (Atlantic City, New Jersey);  Barry T. Smith (Atlantic City, New Jersey)
ABSTRACT A security system to detect motions and/or features associated with a traveler, the security system includes a camera configured to capture an image series of the traveler in an Eulerian or Lagrangian frame of reference, wherein the captured image series contains motions and features associated with the traveler; an alarm system configured to produce an alert signal; and an electronic control unit. The electronic control unit is configured to magnify the motions and features associated with the traveler to generate frame of reference perceptible motions and features, detect characteristic kinematic behaviors of the perceptible motions and features, measure characteristic kinematic quantities of the characteristic kinematic behaviors, determine the presence of features that deviate from a threshold value for the characteristic kinematic quantities, and activate the alarm system to produce the alert signal.
FILED Tuesday, January 29, 2019
APPL NO 16/260801
ART UNIT 2482 — Recording and Compression
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/00771 (20130101)

Image Data Processing or Generation, in General
G06T 5/20 (20130101)
G06T 7/20 (20130101)
G06T 7/70 (20170101)

Signalling or Calling Systems; Order Telegraphs; Alarm Systems
G08B 13/19697 (20130101) Original (OR) Class

Pictorial Communication, e.g Television
H04N 7/183 (20130101)
H04N 7/188 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10553128 Mounts, Jr.
FUNDED BY
Department of Homeland Security (DHS)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
ASSIGNEE(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
INVENTOR(S) Jack B. Mounts, Jr. (Glynco, Georgia)
ABSTRACT A water rollover simulation system includes a simulation training device. The simulation training device is connected to a track, wherein one end of the track is submerged in water. The simulation training device begins a simulation on another portion of the track not submerged in water, moves toward the end of the track, and completes the simulation by allowing one or more trainees to escape the simulation training device while the simulation training device is submerged under water. The water rollover simulation system includes various safety features. The safety features can be activated automatically after a predetermined amount of time, or manually via a remote control system.
FILED Tuesday, March 15, 2016
APPL NO 15/070662
ART UNIT 3715 — Amusement and Education Devices
CURRENT CPC
Educational or Demonstration Appliances; Appliances for Teaching, or Communicating With, the Blind, Deaf or Mute; Models; Planetaria; Globes; Maps; Diagrams
G09B 9/00 (20130101)
G09B 9/02 (20130101)
G09B 9/003 (20130101)
G09B 9/06 (20130101) Original (OR) Class
G09B 9/042 (20130101)
G09B 9/052 (20130101)
G09B 9/085 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Justice (DOJ) 

US 10550395 Xiao et al.
FUNDED BY
Department of Justice (DOJ)
Office of Justice Programs (OJP)
National Institute of Justice (NIJ)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) Yi Xiao (Miami, Florida);  Haixiang Yu (Miami, Florida)
ASSIGNEE(S) THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (Miami, Florida)
INVENTOR(S) Yi Xiao (Miami, Florida);  Haixiang Yu (Miami, Florida)
ABSTRACT The subject invention provides methods, assays and products for detecting small-molecules in a sample, in particular, in both clinical and field settings. The method for detecting a small-molecule target in a sample comprises providing a sample, contacting the sample with an aptamer-based sensor selective for the small-molecule target, and sensitively and rapidly detecting the small-molecule target in the sample. Specifically, the method utilizes EATR-amplified small-molecule sensors based on cooperative binding split aptamers (CBSAs).
FILED Friday, April 06, 2018
APPL NO 15/947315
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/115 (20130101) Original (OR) Class
C12N 2310/16 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/92 (20130101)
G01N 33/946 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Veterans Affairs (DVA) 

US 10548860 Nicolls et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California);  THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (Washington, District of Columbia);  THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland)
ASSIGNEE(S) The Board Of Trustees of The Leland Stanford Junior University (Stanford, California);  The United States Government as Represented By The Department Of Veterans Affairs (Washington, District of Columbia);  The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Mark R. Nicolls (Palo Alto, California);  Jayakumar Rajadas (Cupertino, California);  Geoffrey C. Gurtner (Woodside, California);  Xinguo Jiang (Palo Alto, California);  Gundeep Dhillon (Stanford, California);  Gregg L. Semenza (Reisterstown, Maryland)
ABSTRACT Formulations and methods are provided for improving the function, i.e. clinical outcome, of solid organ transplants. Lung transplantation is of particular interest. In the methods of the invention, a nanoparticle formulation comprising an effective dose of an iron chelator active agent in nanoparticle form, including without limitation, deferoxamine (DFO), deferasirox (DFX), and deferiprone (DFP), etc. suspended in a carrier compatible with the tissue of interest, is topically applied to the surface of tissues at the site of anastomosis. The nanoparticles are comprised of the active agent and a pharmaceutically acceptable stabilizer.
FILED Tuesday, January 29, 2019
APPL NO 16/260989
ART UNIT 1619 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/5123 (20130101)
A61K 9/5138 (20130101)
A61K 9/5146 (20130101)
A61K 9/5161 (20130101)
A61K 9/5169 (20130101)
A61K 31/164 (20130101) Original (OR) Class
A61K 31/436 (20130101)
A61K 31/4196 (20130101)
A61K 31/4412 (20130101)
A61K 45/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Security Agency (NSA) 

US 10552749 Riabov et al.
FUNDED BY
Department of Defense (DOD)
National Security Agency (NSA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Anton Viktorovich Riabov (Ann Arbor, Michigan);  Shirin Sohrabi Araghi (Port Chester, New York);  Octavian Udrea (Ossining, New York)
ABSTRACT A mechanism is provided for computing a solution to a plan recognition problem. The plan recognition problem includes the model and a partially ordered sequence of observations or traces. The plan recognition is transformed into an AI planning problem such that a planner can be used to compute a solution to it. The approach is general. It addresses unreliable observations: missing observations, noisy observations (or observations that need to be discarded), and ambiguous observations). The approach does not require plan libraries or a possible set of goals. A planner can find either one solution to the resulting planning problem or multiple ranked solutions, which maps to the most plausible solution to the original problem.
FILED Tuesday, December 08, 2015
APPL NO 14/962714
ART UNIT 2123 — AI & Simulation/Modeling
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 5/045 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Small Business Administration (SBA) 

US 10550441 Petropoulos
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) MONOGRAM BIOSCIENCES, INC. (South San Francisco, California)
ASSIGNEE(S) Monogram BioSciences, Inc. (South San Francisco, California)
INVENTOR(S) Christos J. Petropoulos (Half Moon Bay, California)
ABSTRACT The invention provides a method for determining whether a human immunodeficiency virus is resistance to a viral entry inhibitor. The methods are particularly useful for determining resistance to inhibitors that act by a non-competitive mechanism. In certain aspects, the methods comprise determining whether an HIV population is resistant to an HIV entry inhibitor, comprising determining a log-sigmoid inhibition curve comprising data points for entry of the HIV population in the presence of varying concentrations of the HIV entry inhibitor, wherein if the entry of the HIV population cannot be completely inhibited by the HIV entry inhibitor, the HIV population is resistant to the HIV entry inhibitor.
FILED Monday, December 09, 2013
APPL NO 14/100467
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/703 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

U.S. State Government 

US 10553871 Masarapu et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
U.S. State Government
State of California
California Energy Commission (CEC)
APPLICANT(S) Charan Masarapu (Fremont, California);  Haixia Deng (Fremont, California);  Yongbong Han (San Francisco, California);  Yogesh Kumar Anguchamy (Newark, California);  Subramanian Venkatachalam (Pleasanton, California);  Sujeet Kumar (Newark, California);  Herman A. Lopez (Sunnyvale, California)
ASSIGNEE(S) Zenlabs Energy, Inc. (Fremont, California)
INVENTOR(S) Charan Masarapu (Fremont, California);  Haixia Deng (Fremont, California);  Yongbong Han (San Francisco, California);  Yogesh Kumar Anguchamy (Newark, California);  Subramanian Venkatachalam (Pleasanton, California);  Sujeet Kumar (Newark, California);  Herman A. Lopez (Sunnyvale, California)
ABSTRACT Improved high energy capacity designs for lithium ion batteries are described that take advantage of the properties of high specific capacity anode active compositions and high specific capacity cathode active compositions. In particular, specific electrode designs provide for achieving very high energy densities. Furthermore, the complex behavior of the active materials is used advantageously in a radical electrode balancing design that significantly reduced wasted electrode capacity in either electrode when cycling under realistic conditions of moderate to high discharge rates and/or over a reduced depth of discharge.
FILED Friday, May 04, 2012
APPL NO 13/464034
ART UNIT 1723 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 1/24 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 2/024 (20130101)
H01M 2/1646 (20130101)
H01M 4/38 (20130101)
H01M 4/131 (20130101)
H01M 4/134 (20130101)
H01M 4/386 (20130101)
H01M 4/485 (20130101)
H01M 4/505 (20130101)
H01M 4/525 (20130101)
H01M 4/582 (20130101) Original (OR) Class
H01M 4/622 (20130101)
H01M 4/625 (20130101)
H01M 10/446 (20130101)
H01M 10/0525 (20130101)
H01M 2220/20 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

United States Postal Service (USPS) 

US 10549319 Dearing et al.
FUNDED BY
United States Postal Service (USPS)
APPLICANT(S) Unites States Postal Service (Washington, District of Columbia)
ASSIGNEE(S) United States Postal Service (Washington, District of Columbia)
INVENTOR(S) Stephen M. Dearing (Oak Hill, Virginia);  Carla F. Sherry (Annandale, Virginia)
ABSTRACT Methods, systems and devices for item processing. The systems can include a PASS module that can include features that receive inputs relating to an item for processing and provide those inputs to other components and/or modules of a PASS system and/or of another system. The PASS system can include a variety of modules, including the PASS module, and can collect information and/or inputs from the variety of modules of the PASS system and use that information in item processing. The methods of item processing can use the PASS system and the PASS module to perform a variety of functions including, for example, revenue protection, sorting of items, task management, sampling and data collection, redirecting if enroute items, and personnel management.
FILED Tuesday, September 25, 2018
APPL NO 16/141839
ART UNIT 2663 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Postal Sorting; Sorting Individual Articles, or Bulk Material Fit to be Sorted Piece-meal, e.g by Picking
B07C 7/005 (20130101) Original (OR) Class
B07C 2301/0058 (20130101)

Ticket-issuing Apparatus; Fare-registering Apparatus; Franking Apparatus
G07B 2017/00443 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Government Rights Acknowledged 

US 10553020 Hainline et al.
FUNDED BY
APPLICANT(S) Raytheon Company (Waltham, Massachusetts)
ASSIGNEE(S) Ratheon Company (Waltham, Massachusetts)
INVENTOR(S) Allen Hainline (Rowlett, Texas);  Richard W. Ely (Lewisville, Texas)
ABSTRACT A method can include determining, based on elevation data of a geographic region corresponding to a location at which an image was captured and a solar elevation angle at a time the image was captured, whether each pixel of the image is a shadow or a non-shadow to create a shadow mask of the image, generating an eroded shadow mask that includes the shadow mask with a specified number of pixels from a perimeter of each shadow in the shadow mask changed to respective values corresponding to non-shadows, generating a dilated shadow mask that includes the specified number of pixels in the shadow mask changed to values corresponding to shadows, and refining the shadow mask using the eroded shadow mask and the dilated shadow mask to create a refined shadow mask.
FILED Tuesday, March 20, 2018
APPL NO 15/926285
ART UNIT 2616 — Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory
CURRENT CPC
Image Data Processing or Generation, in General
G06T 15/60 (20130101) Original (OR) Class
G06T 17/05 (20130101)
G06T 2215/12 (20130101)
G06T 2215/16 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

How To Use This Page 

THE FEDINVENT PATENT DETAILS PAGE

Each week, FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding by the US Federal Government. The FedInvent Patent Details page is a companion to the weekly FedInvents Patents Report.

This week's information is published in the FedInvent Patents report for Tuesday, February 04, 2020.

The FedInvent Weekly Patent Details Page contains a subset of patent information to provide a deeper dive into the week’s taxpayer-funded patents to help the reader better understand where a patent fits in the federal innovation ecosphere.

HOW IS THE INFORMATION ORGANIZED?

Patents are organized by the funding agency. Within each group, the patents are organized in numeric order. A patent funded by more than one agency will appear in the section of each of the agencies that funded the research and development that resulted in the invention. This approach gives the reader a complete view of the department or agency activity for the week.

WHAT INFORMATION WILL I FIND?

THE PANEL
There is a panel for each patent that contains the patent number and the title of the patent. When you click the panel, it opens to reveal the following information:

FUNDED BY
The agencies that funded the grants, contracts, or other research agreements that resulted in the patent. FedInvent includes as much information on the source of the funding as possible. The information is presented in a hierarchy going from the Federal Department down to the agencies, subagencies, and offices that funded the work. Here are two examples:

Department of Health and Human Services (HHS)
     National Institutes of Health (NIH)
         National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Department of Defense (DOD)
     Defense Advanced Research Projects Agency (DARPA)
         Army Research Office (ARO)

We do our best to provide detailed information about the funding. In some cases, the patent only reports limited information on the origins of the funding. FedInvents presents what it can confirm. We add the patents without the information required by the Bayh-Dole Act to our list of patents worthy of further investigation.

APPLICANT(S) and ASSIGNEES
FedInvent includes both the Applicants and the Assignees because having both provides more information about where the inventive work was done and by what organizations. Many organizations — universities, corporations, and federal agencies — standardize the Assignee/Owner information by the time a patent is granted. In the case of federal patents, many of the patents use the agency headquarters information for patent assignment.

Showing just the headquarters address would make Washington, DC the epicenter of all taxpayer-funded research and development. Providing both the applicant information and the assignee information provides a more accurate picture of where important taxpayer funded innovation is happening in America. Here are two examples from two different patents:

APPLICANT: U.S. Army Research Laboratory, Adelphi, MD
ASSIGNEE: The United States of America as represented by the Secretary of the Army Washington, DC

APPLICANT: Optech Ventures, LLC (Torrance, California)
ASSIGNEE(S): The Regents of the University of California (Oakland, California); Optech Ventures, LLC (Torrance, California)

INVENTOR(S)
The inventors appear in the same order as they appear on the patent. FedInvents presents the names in first name/last name order because they are easier to read than the last name/first name order of the names on the USPTO patent documents.

ABSTRACT
The abstract as it appears on the patent.

FILED
The date of the patent application including the day of the week.

APPL NO
This is the patent application serial number. If you’d like to learn more about how application serial numbers work you can go to the Lists Page.

ART UNIT
Patent data includes the Art Unit where a patent was examined. (The Art Unit isn’t available for published patent applications.) The Art Unit provides insight into what group of patent examiners prosecuted the patent application and the subject matter that the examiners work on. For example:

3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices

You can learn more about ART UNITS on the FedInvent Patents Weekly panel called About Tech Center or you can find information on the FedInvent Lists Page.

CURRENT CPC
Current CPC provides a list of the Cooperative Patent Classification symbols assigned to the patent. These are the CPC symbols assigned at the time the patent was granted.

The FedInvent Project is a patent classification maximalist endeavor or put another way, we believe that more you understand about patent classification the more you'll learn about the nature of the invention and the types of work that the federal government is funding.

The symbol presented in BOLD is the symbol identified as the "first" classification which is the most relevant classification on the patent. The date that follows the symbol is the date of the most recent revision to the art classed there.

  • A61B 1/149 (20130101)
  • A61B 1/71 (20130101)
  • A61B 1/105 (20130101)

The CPC symbols match the classifications found on the PDF version of the patent. Over time, the classifications on the full-text version of the patent change to reflect how USPTO organizes patent art to support its examiners. The two sets of CPCs don’t always match.

VIEW PATENT
As of June 2021, we include two ways to view a patent at USPTO. FedInvent provides a link to the Full-Text Version of the patent and a link to the PDF version of the patent.

HOW DO I FIND A SPECIFIC PATENT ON A PAGE?

You can use the Command F or Control F to find a specific patent you are interested in.

HOW DO I GET HERE?

You navigate to the details of a patent by clicking the information icon that follows a patent on the FedInvent Patents Weekly Report.

You can also reach this page using the weekly page link that looks like this:

https://wayfinder.digital/fedinvent/patents-2020/fedinvent-patents-20200204.html

Just update the date portion of the URL. Tuesdays for patents. Thursdays for pre-grant publication of patent applications.

Download a copy of the How To Use This Page

HAVE MORE QUESTIONS?

info@wayfinder.digital